Shared Decision-Making in End-of-Life Care: Integrating Ethical Frameworks, Clinical Models, and Digital Tools for Patient-Centered Outcomes

Chloe Mitchell Dec 03, 2025 316

This article synthesizes current evidence and best practices for implementing shared decision-making (SDM) in end-of-life care, addressing a critical need for patient-centered approaches in serious illness.

Shared Decision-Making in End-of-Life Care: Integrating Ethical Frameworks, Clinical Models, and Digital Tools for Patient-Centered Outcomes

Abstract

This article synthesizes current evidence and best practices for implementing shared decision-making (SDM) in end-of-life care, addressing a critical need for patient-centered approaches in serious illness. It explores the ethical foundations and conceptual models of SDM, examines practical methodologies and digital decision aids for clinical application, analyzes implementation barriers and optimization strategies across diverse healthcare settings, and evaluates outcome measures and comparative effectiveness. For researchers and biomedical professionals, this review highlights the imperative to develop validated SDM interventions that honor patient autonomy while navigating complex clinical, cultural, and ethical challenges in end-of-life decision-making. Evidence indicates that effective SDM can reduce decisional conflict, improve care alignment with patient values, and potentially decrease aggressive non-beneficial treatments at life's end.

The Ethical and Conceptual Foundations of Shared Decision-Making in End-of-Life Care

Shared decision-making (SDM) represents a collaborative process that navigates a middle path between paternalistic and consumerist models of clinical decision-making [1]. In serious illness and end-of-life contexts, this approach recognizes the autonomy and responsibility of both health professionals and patients, aiming for an ethical balance that respects patient preferences while leveraging professional expertise [1]. The fundamental challenge in SDM lies in reconciling the need for patient autonomy with the reality that patients often lack stable, well-formed preferences when facing novel and evolving medical situations [1]. This is particularly relevant in end-of-life care, where cultural norms, socio-economic disparities, and communication barriers further complicate decision-making processes [2].

Contemporary research reveals significant variations in how SDM is understood and implemented across healthcare settings. In low and middle-income countries like Bangladesh, for instance, profound disparities exist in end-of-life awareness and preferences across different healthcare settings, driven by socio-economic, cultural, and institutional factors [2]. Even in high-income countries, the implementation of SDM faces challenges related to over-medicalization, socio-economic disparities, and the need for better integration of palliative care [2]. This application note provides a structured framework for implementing and researching SDM in serious illness contexts, with specific protocols and analytical tools designed to advance both clinical practice and research methodologies.

Conceptual Framework and Theoretical Foundations

Narrow versus Broad Conceptions of Shared Decision-Making

The theoretical underpinnings of SDM can be categorized into narrow and broad conceptions, each with distinct implications for clinical practice and research. Narrow conceptions focus primarily on eliciting existing patient preferences and combining them with evidence-based professional knowledge [1]. This approach operates under three key propositions: (1) patients have preferences about interventions and health states that professionals should elicit and take seriously; (2) this process respects patient autonomy and provides data for good decision-making; and (3) mutual discussion should focus on combining professional knowledge with patient preferences [1].

In contrast, broader conceptions recognize that patients frequently lack clear, stable preferences when confronting serious illness and may need support in constructing, checking, and prioritizing their values [1]. This perspective acknowledges that preferences may be based on misunderstandings or lack of information and may require careful exploration and reflection. The broader conception thus envisions a more facilitative role for health professionals in helping patients develop and clarify preferences consistent with their deeply held values [1].

Dual-Process Cognitive Framework in Decision-Making

A dual-process account of decision-making provides valuable insights into how visualizations and decision aids influence SDM processes. This framework proposes two types of decision mechanisms: Type 1 processes produce fast, computationally light decisions with minimal working memory demands, while Type 2 processes facilitate slower, more contemplative decisions that require significant working memory capacity and cognitive control [3]. Understanding this distinction is crucial for designing decision support tools that can engage both processing types appropriately based on decision complexity and context [3].

The following diagram illustrates the cognitive pathways in shared decision-making:

G Start Clinical Decision Point Paternalistic Paternalistic Model: Professional decides Start->Paternalistic Consumerist Consumerist Model: Patient decides alone Start->Consumerist Shared Shared Decision-Making: Collaborative process Start->Shared Type1 Type 1 Processing: Fast, automatic Minimal working memory Shared->Type1 Type2 Type 2 Processing: Slow, deliberate Significant working memory Shared->Type2 Outcome1 Decision Output: Preference-consistent Evidence-informed Type1->Outcome1 Type2->Outcome1

Andersen's Behavioral Model in End-of-Life Decision Contexts

Andersen's Behavioral Model of Health Services Use provides a valuable framework for understanding factors influencing palliative and hospice care decisions [4]. This model categorizes influencing factors into three domains: predisposing factors (sociodemographics, attitudes), enabling factors (resources, support systems), and need factors (perceived or evaluated health status) [4]. Research has identified sixteen specific factors within this framework that affect decisions regarding palliative care and hospice use in community settings [4].

Quantitative Assessment of Decision-Making Factors

Recent research examining end-of-life care awareness, preferences, and decision-making factors among critically ill older adult patients in Bangladesh reveals significant disparities across healthcare settings. The table below summarizes key findings from a cross-sectional study involving 1,270 patients with chronic or advanced illnesses [2].

Table 1: End-of-Life Care Awareness and Preferences Across Healthcare Settings in Bangladesh

Metric Private Hospitals Public Hospitals Community Settings Statistical Significance
Palliative Care Awareness 70% 31% 7.1% p < 0.01
Health Insurance Coverage Not specified Not specified 1.7% Not specified
Family Openness to EoL Discussions 81% 21% 7.1% Not specified
Advance Care Planning Awareness Highest Intermediate Lowest p < 0.01

Multiple logistic regression analysis revealed that older adults (≥ 60 years) were significantly more likely to prefer home care (OR = 2.96, p = 0.004), avoid hospitalization (OR = 17.55, p < 0.001), and choose home death (OR = 10.29, p < 0.001) [2]. Greater understanding of palliative care (OR = 7.38, p < 0.001) and hospice comfort (OR = 25.26, p < 0.001) strongly predicted documentation of end-of-life preferences [2]. Proxy appointment was significantly associated with prior discussions (AOR = 4.11), while trust in healthcare providers reduced the likelihood (AOR = 0.39) [2].

Decision Factor Classification Using Andersen's Model

Systematic review of decision-making factors related to palliative care and hospice use in community settings has identified and categorized sixteen specific factors using Andersen's Behavioral Model [4]. The table below organizes these evidence-based factors for researcher assessment.

Table 2: Decision-Making Factors for Palliative Care and Hospice Use

Category Specific Factors Research Assessment Approach
Predisposing Factors Age, Education level, People in household, Experiences with institutional care, Death experiences Demographic surveys, Structured interviews
Enabling Factors Physician's disclosure, Communication partner, Communication context, Information about options Communication analysis, Resource mapping
Need Factors Acknowledgement of terminal status, Knowledge, Perception, End-of-life wishes, Caregiver's commitment, Preference for dying at home, Health condition Clinical assessments, Preference elicitation tools

Experimental Protocols for Shared Decision-Making Research

Modified Delphi Protocol for Consensus Development

The Scandinavian end-of-life care consensus study provides a robust methodological framework for developing SDM guidelines [5]. This protocol employs a three-round Delphi process with multidisciplinary expert panels including physicians, nurses, palliative care specialists, and former patients or family members [5].

Protocol Implementation Steps:

  • Advisory Board Construction: Convene a multidisciplinary board (16 members recommended) with balanced representation of relevant perspectives [5]
  • Domain Identification: Board members submit potential domains of importance; collaboratively review for language clarity and merge overlapping domains [5]
  • Pilot Testing: Assess content and face validity with 14-20 clinicians not eligible for main study; refine wording based on feedback [5]
  • Delphi Round 1: Distribute electronic survey to national expert respondents and local clinical respondents; use 9-point Likert scale (1-3: Not important, 4-6: Important, 7-9: Extremely important) for domain rating [5]
  • Content Analysis: Employ inductive content analysis focusing on manifest content; discuss and revise statements through advisory board [5]
  • Delphi Round 2: Send generated statements to national expert respondents only; use 5-point Likert scale (1: Strongly disagree to 5: Strongly agree); define consensus a priori as >70% agreement [5]
  • Final Round 3: Rephrase non-consensus statements based on comments and redistribute for rating [5]

The Scandinavian implementation achieved 59 consensus statements across 10 domains after three rounds, including communication at admission, withholding/withdrawing therapy, spiritual needs, symptom management, and bereavement care [5].

Based on the Bangladesh study methodology, the following protocol enables systematic assessment of SDM factors across diverse healthcare settings [2].

Study Design and Sampling:

  • Implement cross-sectional design with stratified sampling technique
  • Ensure proportional representation from each administrative region based on elderly population size
  • Calculate sample size using Cochran's formula with design effect adjustment: n₀ = Z²·p·(1−p)/e² * D
  • Include patients aged ≥50 years with chronic illnesses or hospitalized patients aged ≥18 years with life expectancy <1 year
  • Utilize random sampling from sub-district registries, hospital lists, and community databases

Data Collection Instruments:

  • Develop structured questionnaires based on synthesized internationally validated tools
  • Include socio-demographics, end-of-life awareness, preferences, and experiences
  • Conduct forward/back translation following WHO procedures for linguistic validation
  • Pilot test with 25+ patients across settings to ensure comprehensibility

Statistical Analysis Plan:

  • Employ multiple logistic regression analysis to examine predictors of end-of-life preferences
  • Calculate odds ratios with confidence intervals and significance levels
  • Include both univariate and multivariate analyses with adjustment for potential confounders

Visualization Approaches for Decision Support

Cognitive Framework for Visualization Design

Visualization design for SDM should account for the dual-process nature of decision-making [3]. Effective visualizations support both Type 1 (rapid, intuitive) and Type 2 (deliberative, analytical) processing through appropriate representation of complex information [3]. The systematic literature review on visualization effects indicates that information visualization can improve decision quality and speed, with more mixed effects on variables such as decision confidence [6].

The following diagram illustrates the strategic implementation workflow for shared decision-making:

G A Stakeholder Engagement (Patients, Families, Providers) B Preference Elicitation and Values Clarification A->B C Option Presentation with Visual Decision Aids B->C D Deliberative Dialogue and Consensus Building C->D E Decision Documentation and Implementation D->E F Continuous Assessment and Preference Reassessment E->F F->B

Dashboard Implementation for Decision Support

Interactive dashboards represent a powerful tool for implementing visualization in SDM contexts [7]. Three dashboard types support different decision needs: active dashboards display real-time data, strategic dashboards show trends over time, and analytical dashboards present advanced analytics [7]. During the COVID-19 pandemic, visualization techniques displaying oxygen saturation levels and treatment responses in real-time proved vital for clinical decision-making [7].

Implementation Framework:

  • Data Integration: Combine multiple interactive reports within existing healthcare system software [7]
  • User Customization: Tailor display based on user characteristics (expertise, numeracy, cognitive style) [6]
  • Task Alignment: Match visualization complexity to decision complexity [6]
  • Iterative Refinement: Use cognitive walkthroughs and usability testing to optimize designs [3]

The Researcher's Toolkit: Reagents and Materials

Table 3: Essential Research Tools for Shared Decision-Making Studies

Tool Category Specific Instrument Application and Function
Survey Instruments Structured EoL Preference Questionnaire Adapted from validated international tools; assesses awareness, preferences, experiences
Consensus Development Tools Modified Delphi Protocol Systematic approach to developing consensus statements across multidisciplinary panels
Data Visualization Platforms ParaView, Gephi, REDCap Cloud-based platforms for generating and hosting scientific graphics; facilitate collaboration
Statistical Analysis Software IBM SPSS, JASP, R Provide interactive visualization systems and advanced statistical analysis capabilities
Quality Assessment Tools Mixed Methods Appraisal Tool (MMAT) 2018 Assess quality of quantitative, qualitative, and mixed-methods studies
Communication Analysis Frameworks Andersen's Behavioral Model Categorizes decision factors into predisposing, enabling, and need factors

This application note provides researchers with comprehensive frameworks and methodologies for investigating shared decision-making in serious illness contexts. The integrated model addressing both narrow and broad conceptions of SDM, combined with practical assessment protocols and visualization strategies, enables systematic investigation of this critical healthcare domain. The structured approaches to consensus development, cross-cultural assessment, and decision support visualization facilitate rigorous research that can advance both theoretical understanding and practical implementation of patient-centered care in serious illness and end-of-life contexts.

Future research directions should include development of more nuanced conceptualizations of the autonomy-supportive role of health professionals, investigation of cultural adaptations of SDM models across diverse healthcare settings, and exploration of how digital visualization tools can optimally support both Type 1 and Type 2 decision processes in clinical encounters.

End-of-life (EoL) care presents a complex interface of clinical practice, patient values, and ethical reasoning. The principles of autonomy, beneficence, nonmaleficence, and justice provide a fundamental framework for navigating the ethical challenges inherent in EoL decision-making within a shared decision-making model [8] [9]. Advances in modern medicine have prolonged life expectancy, simultaneously creating ethical dilemmas about when to discontinue life-prolonging interventions that may not cure underlying conditions [8]. In a research context focused on shared decision-making, understanding these principles is paramount for developing ethical guidelines, designing clinical studies, and creating interventions that respect patient preferences while upholding medical professionalism.

The shared decision-making model emphasizes collaboration among patients, families, and healthcare providers, making the application of these principles particularly nuanced [4]. For researchers and drug development professionals, this framework offers a structured approach to evaluating EoL care interventions, ensuring they are not only clinically effective but also ethically sound. This document provides detailed application notes and experimental protocols to standardize the ethical assessment of EoL care strategies within research settings, with a specific focus on integrating these principles into the shared decision-making paradigm.

Core Ethical Principles: Definitions and Theoretical Framework

Principle Definitions and Conceptual Boundaries

The four ethical principles constitute a universal framework for biomedical ethics, though their application and weighting may differ across cultures and clinical contexts [8] [9].

  • Autonomy derives from the philosophical concept of self-determination and is grounded in the recognition that all persons possess intrinsic worth [9]. In healthcare, it manifests as the patient's right to make informed decisions about their care, including the right to refuse treatment, even when life-sustaining [10]. This principle requires physicians to respect patients' values and preferences, providing all necessary information for informed consent while refraining from coercion [9].

  • Beneficence represents the physician's obligation to act for the patient's benefit, extending beyond merely avoiding harm to actively promoting welfare, preventing harm, and removing harmful conditions [9]. This positive requirement distinguishes it from nonmaleficence and supports moral rules that protect and defend patient rights [9]. In EoL contexts, beneficence often involves advocating for approaches that deliver the best possible care aligned with patient goals [8].

  • Nonmaleficence, embodied by the maxim "primum non nocere" (first, do no harm), obligates physicians to avoid causing unnecessary harm to patients [8] [9]. This principle supports several specific moral rules: do not kill, do not cause pain or suffering, do not incapacitate, do not cause offense, and do not deprive others of the goods of life [9]. In application, it requires careful weighing of benefits against burdens of all interventions, particularly in difficult EoL decisions about withholding or withdrawing treatment [9].

  • Justice concerns fairness in the distribution of healthcare resources and requires impartiality in service delivery [8]. This principle mandates that healthcare providers advocate for fair and appropriate treatment of all patients, particularly important when evaluating the allocation of advanced medical therapies that may provide limited benefit at the end of life [8]. Justice also encompasses fair access to palliative and hospice care services across diverse populations [4].

Conceptual Diagram of Ethical Decision-Making

The following diagram illustrates the dynamic relationship between the core ethical principles and their application in end-of-life shared decision-making:

EthicsFramework SharedDecisionMaking Shared Decision-Making Process Autonomy Autonomy Patient Self-Determination SharedDecisionMaking->Autonomy Beneficence Beneficence Acting for Patient Benefit SharedDecisionMaking->Beneficence Nonmaleficence Nonmaleficence Avoiding Harm SharedDecisionMaking->Nonmaleficence Justice Justice Fair Resource Distribution SharedDecisionMaking->Justice ClinicalApplication Clinical Application: - Advance Directives - Treatment Limitation Decisions - Symptom Management - Resource Allocation Autonomy->ClinicalApplication ResearchApplication Research Application: - Study Design - Outcome Measurement - Participant Recruitment - Ethical Review Autonomy->ResearchApplication Beneficence->ClinicalApplication Beneficence->ResearchApplication Nonmaleficence->ClinicalApplication Nonmaleficence->ResearchApplication Justice->ClinicalApplication Justice->ResearchApplication

Diagram 1: Interrelationship of ethical principles in EoL decision-making. This framework demonstrates how the four principles collectively inform both clinical practice and research design within a shared decision-making model.

Quantitative Assessment of End-of-Life Decision-Making Factors

Socioeconomic and Institutional Disparities in EoL Care Awareness

Recent research examining EoL care awareness across healthcare settings in Bangladesh reveals profound disparities driven by socioeconomic, cultural, and institutional factors [2]. These findings highlight the critical role of justice in addressing inequitable access to palliative care information and services.

Table 1: Awareness of Palliative Care and Advance Directives Across Healthcare Settings [2]

Setting Palliative Care Awareness Advance Care Planning Awareness Advance Directive Documentation Family Openness about EoL Issues
Private Hospitals 70% 65.2% 58.7% 81%
Public Hospitals 31% 28.9% 22.3% 21%
Community Settings 7.1% 6.3% 4.1% 7.1%

The data demonstrates striking gradients in awareness and documentation across settings, with private hospital patients showing approximately 10-fold higher rates of advance directive documentation compared to community settings [2]. These disparities present significant implications for autonomy, as patients without awareness of EoL options cannot exercise meaningful self-determination. For researchers, these findings underscore the importance of accounting for institutional and socioeconomic variables when designing EoL studies and developing recruitment strategies that ensure representative sampling across diverse populations.

Multiple logistic regression analysis of data from 1,270 patients with chronic or advanced illnesses has identified significant predictors of EoL care preferences [2]. Understanding these factors is essential for designing patient-centered interventions that respect autonomy while acknowledging the complex factors that shape decision-making.

Table 2: Predictors of End-of-Life Care Preferences [2]

Predictor Variable Outcome Variable Adjusted Odds Ratio P-value
Age ≥ 60 years Preference for home care 2.96 0.004
Age ≥ 60 years Avoidance of hospitalization 17.55 <0.001
Age ≥ 60 years Preference for home death 10.29 <0.001
Greater understanding of palliative care Documentation of EoL preferences 7.38 <0.001
Perception of hospice comfort Documentation of EoL preferences 25.26 <0.001
Prior discussions about EoL care Appointment of healthcare proxy 4.11 <0.05
Trust in healthcare providers Appointment of healthcare proxy 0.39 <0.05

The strong association between understanding palliative care and documentation of EoL preferences (OR=7.38) highlights the importance of patient education in facilitating autonomous decision-making [2]. Interestingly, greater trust in healthcare providers was associated with decreased likelihood of appointing a healthcare proxy (OR=0.39), possibly indicating that patients with high trust levels may feel less urgency to formalize decision-making arrangements [2]. For researchers, these findings identify potential moderating variables that should be measured in EoL studies and suggest that educational interventions targeting palliative care understanding may significantly impact the expression of patient preferences.

Experimental Protocols for Ethical Decision-Making Research

Protocol for Assessing Decision-Making Factors in Palliative Care Utilization

This protocol provides a systematic methodology for investigating factors influencing palliative care and hospice decision-making, based on Andersen's Behavioral Model of Health Services Use (BMHSU) [4].

Study Design: Cross-sectional or longitudinal observational design using mixed methods (quantitative surveys supplemented with qualitative interviews) to capture the multidimensional nature of decision-making factors [4].

Population and Sampling:

  • Target Population: Adult patients (≥50 years) with chronic or advanced illnesses and their family caregivers [2] [4].
  • Sampling Method: Stratified sampling to ensure proportional representation across healthcare settings (private hospitals, public hospitals, community settings) and geographic regions [2].
  • Inclusion Criteria: Patients with life expectancy <1 year due to severe disease progression; ability to provide informed consent; availability of family caregiver for participation [2].
  • Exclusion Criteria: Patients in emergency or unstable conditions; inability to communicate preferences; absence of surrogate decision-maker for cognitively impaired patients [2].

Data Collection Instruments and Measures:

  • Structured questionnaires adapted from validated international tools (e.g., National End of Life Survey, Pallium Canada Palliative Medicine Survey) [2].
  • Assessment of predisposing factors (age, education, household composition, prior experiences with institutional care, death experiences) [4].
  • Assessment of enabling factors (physician disclosure practices, communication partners and contexts, information about options) [4].
  • Assessment of need factors (acknowledgment of terminal status, knowledge and perceptions of EoL care, EoL wishes, caregiver commitment, preference for dying at home, health condition) [4].
  • Validated measures of EoL decision-making, including the MacArthur Competence Assessment Tool for Treatment (MacCAT-T), Decisional Conflict Scale (DCS), and Decision Regret Scale (DRS) [11].

Analytical Approach:

  • Multiple logistic regression analysis to identify independent predictors of EoL preferences and palliative care utilization [2].
  • Thematic analysis of qualitative interviews to identify emergent themes in decision-making processes [4].
  • Integration of quantitative and qualitative findings to develop comprehensive models of EoL decision-making [4].

Ethical Considerations:

  • Protocol approval by institutional review board with special attention to vulnerability of terminally ill populations [4].
  • Sensitive communication of study purpose with emphasis on voluntary participation [2].
  • Ongoing assessment of decision-making capacity with surrogate consent procedures for cognitively impaired patients [11].

Protocol for Evaluating Decision-Making Capacity in End-of-Life Contexts

This protocol addresses the critical assessment of decision-making capacity in patients with serious illness, a fundamental prerequisite for respecting autonomy in EoL care and research.

Assessment Framework: Decision-making capacity evaluation should assess four key abilities [9] [10]:

  • Ability to communicate a specific choice
  • Understanding of relevant clinical information
  • Appreciation of the situation and its consequences
  • Ability to reason about treatment options

Assessment Procedure:

  • Standardized disclosure of diagnosis, prognosis, treatment options (including risks/benefits), and likely outcomes of treatment refusal [10].
  • Open-ended questioning to assess understanding and reasoning (e.g., "Can you tell me in your own words what you understand about your medical condition?") [10].
  • Assessment of consistency of decision with patient's longstanding values and preferences [11].
  • Evaluation of voluntary nature of decision, free from undue influence [11].

Assessment Tools:

  • MacArthur Competence Assessment Tool for Treatment (MacCAT-T): Provides structured assessment of the four capacity domains [11].
  • Semi-structured clinical interview: Flexible approach tailored to specific decision context [10].

Documentation:

  • Detailed documentation of assessment process, including questions asked and patient responses [10].
  • Clear statement regarding presence or absence of decision-making capacity with supporting evidence [10].
  • When appropriate, involvement of mental health specialists for formal capacity evaluation, particularly in cases of disagreement or uncertainty [10].

Special Considerations for Research:

  • For patients with fluctuating capacity, timing of assessment to coincide with lucid periods [11].
  • For patients with progressive cognitive impairment, advance assessment of capacity for specific EoL decisions when possible [11].
  • Involvement of surrogate decision-makers when capacity is impaired, with instruction to use substituted judgment standard (what patient would want) rather than best interests standard [8] [10].

The Scientist's Toolkit: Research Reagents and Materials

Table 3: Essential Research Instruments for End-of-Life Decision-Making Studies

Research Instrument Application in EoL Research Key Domains Assessed Validation Populations
MacArthur Competence Assessment Tool for Treatment (MacCAT-T) Assessment of decision-making capacity for treatment decisions Understanding, appreciation, reasoning, expression of choice Patients with mental illness, cancer, older adults [11]
Decisional Conflict Scale (DCS) Measurement of uncertainty in decision-making Uncertainty, factors contributing to uncertainty, perceived effective decision-making Patients facing medical decisions, family caregivers [11]
Decision Regret Scale (DRS) Assessment of distress after healthcare decisions Regret, dissatisfaction with decision Patients following treatment decisions [11]
Structured Advance Directive Documentation Standardization of preference documentation Treatment limitations, surrogate decision-makers, goals of care Various patient populations [8]
Palliative Care Knowledge Assessment Measurement of understanding of palliative care options Awareness, knowledge of services, misconceptions Critically ill patients, general population [2]
End-of-Life Preference Assessment Tool Documentation of specific care preferences Location of care, desired interventions, communication preferences Older adults, chronically ill populations [2]

Application Notes for Implementing Ethical Principles in Research

Operationalizing Autonomy in Study Design

Respecting patient autonomy in EoL research requires specific methodological considerations beyond standard informed consent procedures:

  • Advance Directive Integration: Research protocols should incorporate mechanisms for documenting and honoring advance directives, including living wills and healthcare proxy appointments [8]. This is particularly important in longitudinal studies where participants may experience cognitive decline.

  • Capacity Assessment Integration: Studies involving patients with serious illness should include standardized capacity assessment procedures at enrollment and at key decision points, with clear protocols for surrogate decision-maker involvement when capacity is impaired [11] [10].

  • Cultural Adaptation of Consent Materials: Recognition that autonomy norms vary across cultures, with some populations preferring family-centered decision-making approaches [9]. Consent processes should be adapted to accommodate these variations while maintaining ethical rigor.

  • Dynamic Consent Processes: Implementation of ongoing consent processes that revisit decisions as clinical status changes, particularly important in studies involving progressive illnesses where patient preferences may evolve [11].

Balancing Beneficence and Nonmaleficence in Intervention Studies

Clinical trials involving terminally ill populations present unique challenges in balancing potential benefits against harms:

  • Benefit Assessment: Research interventions should be evaluated for potential benefits meaningful to EoL patients, which may differ from traditional clinical outcomes (e.g., quality of life versus survival) [8]. This aligns with the principle of beneficence through promoting patient-defined welfare.

  • Harm Minimization Protocols: Explicit protocols for monitoring and managing potential harms, including pain, discomfort, and burden associated with research participation [9]. The principle of nonmaleficence requires special vigilance in vulnerable populations.

  • Futility Considerations: Clear criteria for defining futility in intervention studies, with procedures for discontinuing interventions that are no longer providing benefit or are causing disproportionate harm [10].

  • Double Effect Management: Recognition that symptom management at end of life may have the foreseen but unintended consequence of hastening death [9]. Research protocols should include ethical frameworks for managing this principle, particularly in studies involving pain management or sedation.

Applying Justice in Participant Recruitment and Resource Allocation

The principle of justice requires attention to equitable participation in research and fair distribution of research resources:

  • Equitable Recruitment Strategies: Proactive approaches to ensure representation of diverse populations in EoL research, including patients from varying socioeconomic backgrounds, healthcare settings, and geographic locations [2].

  • Resource Allocation Frameworks: Transparent criteria for allocating limited research resources (e.g., access to experimental interventions) that prioritize fairness and scientific validity rather than extraneous factors [8].

  • Cross-Setting Research Designs: Study designs that explicitly compare EoL care across different healthcare settings (private, public, community) to identify and address disparities in care quality and access [2].

  • Burden-Benefit Distribution Analysis: Evaluation of whether the burdens and benefits of research participation are fairly distributed across participant groups, with particular attention to avoiding exploitation of vulnerable populations [4].

Decision-Making Framework for Ethical Challenges in EoL Research

The following diagram illustrates a systematic approach to resolving ethical conflicts in end-of-life care research, integrating the four core principles within a shared decision-making model:

EthicalDecisionFlow Start Identify Ethical Dilemma in EoL Research Step1 Assess Patient Capacity and Preferences Start->Step1 Step2 Evaluate Benefits/Harms of Interventions Step1->Step2 PrincipleA Autonomy Assessment: - Advance directives - Current preferences - Decision consistency Step1->PrincipleA Step3 Consider Resource Allocation Implications Step2->Step3 PrincipleB Beneficence Assessment: - Potential benefits - Quality of life impact - Patient goals alignment Step2->PrincipleB PrincipleC Nonmaleficence Assessment: - Burden of intervention - Risk of harm - Symptom management Step2->PrincipleC Step4 Apply Ethical Principles Framework Step3->Step4 PrincipleD Justice Assessment: - Fair access - Resource distribution - Equity considerations Step3->PrincipleD Resolution Reach Shared Decision Document Rationale Step4->Resolution PrincipleA->Step4 PrincipleB->Step4 PrincipleC->Step4 PrincipleD->Step4

Diagram 2: Ethical decision-making framework for EoL research. This workflow provides a systematic approach to resolving ethical conflicts by integrating assessments across all four principles before reaching a shared decision.

The principles of autonomy, beneficence, nonmaleficence, and justice provide an indispensable framework for conducting ethically sound research in end-of-life care. Within a shared decision-making model, these principles guide study design, participant recruitment, intervention development, and outcome assessment. The application notes and protocols presented here offer researchers and drug development professionals practical tools for implementing this ethical framework across diverse research contexts.

Future directions in EoL research ethics should include development of more sensitive capacity assessment tools for cognitively impaired populations [11], standardized measures for evaluating the application of ethical principles in clinical practice [11], and intervention studies specifically designed to address disparities in EoL care access and quality [2]. By systematically integrating ethical principles throughout the research process, investigators can generate evidence that not only advances scientific knowledge but also enhances the quality and equity of care for patients at the end of life.

Advance care planning (ACP) is a process that supports adults in understanding and sharing their personal values, life goals, and preferences regarding future medical care [12]. Within shared decision-making models for end-of-life care, ACP provides a critical framework for ensuring patient autonomy even when decision-making capacity is diminished. This process has evolved from a narrow focus on completing legal documents to a holistic, continuous process of communication and preparation for medical decision-making [12]. For researchers and clinicians working in end-of-life care, understanding the distinct roles, applications, and evidence base for various ACP tools—including living wills, healthcare proxies, and Portable Medical Orders for Life-Sustaining Treatment (POLST)—is essential for designing effective interventions and conducting meaningful research.

This article provides a comprehensive overview of these key ACP components within the context of shared decision-making research, presenting quantitative evidence of their impact, detailed experimental protocols for studying their implementation, and conceptual frameworks to guide future scientific inquiry.

Core Components of Advance Care Planning: Definitions and Distinctions

The ACP ecosystem comprises several distinct but complementary documents and processes, each serving different functions within the healthcare decision-making continuum. Understanding these distinctions is crucial for proper implementation and research design.

Table 1: Key Components of Advance Care Planning

Component Definition Primary Function Population Legal Status
Living Will A legal document outlining preferences for specific medical treatments under defined circumstances [13] Provides instructional directives for future care All competent adults Legal document
Healthcare Proxy Appointment of a surrogate decision-maker (also called healthcare power of attorney) [13] Designates agent to make decisions when patient lacks capacity All competent adults Legal document
POLST Form A set of portable medical orders addressing critical treatment decisions [14] Translates preferences into immediately actionable medical orders Seriously ill or frail patients near end-of-life Medical order

As evidenced in Table 1, these components serve different but complementary roles. Advance directives (including living wills and healthcare proxies) are legal documents completed by patients to provide guidance for future, unknown medical situations and to appoint a surrogate decision-maker [14]. In contrast, the POLST form is a medical order set completed by healthcare professionals that translates patient preferences into immediately actionable orders for current medical conditions [14]. This distinction has significant implications for both clinical application and research methodologies.

The POLST paradigm is specifically designed for patients with serious illness or frailty who are at risk for a life-threatening clinical event [14]. Unlike advance directives, POLST forms are specifically designed to be recognized by emergency medical personnel and facilitate continuity of care across settings [14].

Quantitative Evidence of Advance Care Planning Outcomes

Recent systematic reviews and meta-analyses provide robust quantitative evidence supporting the efficacy of ACP interventions. A 2025 meta-review of 39 reviews demonstrated significant impacts across multiple outcome domains defining successful ACP [12].

Table 2: Evidence for Advance Care Planning Intervention Outcomes from Meta-Review of 39 Reviews

Outcome Domain Number of Reviews Supporting Significant Effect Key Findings
Healthcare Utilization 15 reviews Significantly decreased hospital utilization aligned with patient preferences [12]
Care Consistency with Goals 14 reviews Significant increases in patients receiving care consistent with their goals [12]
Documentation of Preferences 12 reviews Significant increases in patients documenting their preferences [12]
Decisional Conflict 8 reviews showed decrease; 5 showed no effect Mixed evidence on impact on decisional conflict [12]
Surrogate Congruence 8 reviews Increased congruence between patient wishes and surrogate reports of wishes [12]

The meta-review found that ACP was "scarcely evidenced to have a detrimental impact on any patient outcomes," supporting its implementation as a safe and effective practice [12]. The heterogeneity of interventions, however, presents challenges for synthesizing research data and establishing standardized protocols [12].

Implementation rates remain a significant challenge, with a 2025 survey reporting that only about 37% of U.S. adults have completed a health care directive [13]. This documentation gap underscores the critical need for further research into barriers and implementation strategies.

Conceptual Framework and Workflow Diagrams

Advance Care Planning Document Relationships

The following diagram illustrates the conceptual relationship between different ACP documents and their position within the decision-making continuum:

G cluster_preparation Preparation & Planning cluster_implementation Medical Implementation Patient Patient AD Advance Directive (Living Will + Healthcare Proxy) Patient->AD Values Values & Goal Discussions Patient->Values POLST POLST Form (Medical Orders) AD->POLST Informs Values->POLST Guides

Advance Care Planning Implementation Workflow

The operational workflow for implementing ACP within clinical and research settings involves multiple stages and decision points:

G Start Patient Engagement in ACP Process Assess Health Status Assessment Start->Assess ADPath Complete Advance Directive (Living Will + Healthcare Proxy) Assess->ADPath All Adults POLSTPath Seriously Ill/Frail? Near End-of-Life? ADPath->POLSTPath POLSTComplete Complete POLST Form with Healthcare Professional POLSTPath->POLSTComplete Yes Document Document in Medical Record POLSTPath->Document No POLSTComplete->Document Share Share with Providers, Proxy, Family Document->Share Review Regular Review & Update Process Share->Review

Experimental Protocols and Assessment Methodologies

Protocol for Studying ACP Intervention Efficacy

Objective: To evaluate the impact of a structured ACP intervention on patient-reported and clinical outcomes.

Population: Adults (≥18 years) with advanced, life-limiting illnesses. Exclusion criteria include inability to provide informed consent or non-availability of a surrogate decision-maker [12].

Intervention Protocol:

  • Baseline Assessment: Collect demographic data, disease characteristics, and baseline measures using standardized tools (see Research Toolkit).
  • Structured ACP Session: Conduct facilitated discussion using a validated guide (e.g., Respecting Choices, Five Wishes) covering:
    • Values and goals for medical care
    • Treatment preferences in specific clinical scenarios
    • Selection of healthcare proxy
    • Discussion of POLST appropriateness if applicable
  • Documentation: Complete relevant ACP documents with notarization/witnessing as required by state law.
  • Medical Record Integration: Scan documents into electronic health record with appropriate flags for accessibility.
  • Follow-up Assessments: Conduct at 3, 6, and 12 months to assess primary and secondary outcomes.

Outcome Measures:

  • Primary: Goal-concordant care (patient-reported or surrogate-reported)
  • Secondary: Documentation completeness, decisional conflict, healthcare utilization, quality of life measures

Protocol for Assessing Cross-Cultural ACP Implementation

Objective: To identify cultural, institutional, and individual barriers to ACP implementation in diverse populations.

Methodology: Adapted from the Bangladesh cross-sectional study design [2] with multi-site implementation.

Data Collection:

  • Structured Surveys: Administer validated instruments assessing ACP awareness, preferences, and completion.
  • Healthcare Provider Interviews: Conduct semi-structured interviews exploring perceived barriers and facilitators.
  • System-Level Assessment: Document institutional policies, resource availability, and regulatory frameworks.

Analysis Plan:

  • Quantitative: Multiple logistic regression to identify predictors of ACP documentation
  • Qualitative: Thematic analysis using constant comparison method
  • Integrated: Categorization of factors using Andersen's Behavioral Model of Health Services Use (predisposing, enabling, and need factors) [4]

The Researcher's Toolkit: Measures and Materials

Table 3: Essential Research Tools for Advance Care Planning Studies

Tool/Measure Domain Assessed Application in ACP Research Citation
MacCAT-T Decision-making capacity Assesses patient capacity for treatment decisions; particularly relevant in cognitively impaired populations [11]
Decisional Conflict Scale (DCS) Decisional conflict Measures uncertainty in decision-making; useful for evaluating ACP intervention efficacy [11]
Decision Regret Scale (DRS) Post-decision satisfaction Assesses regret following ACP decisions; valuable longitudinal outcome measure [11]
ACP Documentation Audit Tool Documentation completeness Standardized assessment of ACP document presence and quality in medical records [15] [16]
POLST Form Completion Assessment Medical order specificity Evaluates appropriateness and completeness of POLST form completion [14]

Implementation Challenges and Research Gaps

Despite robust evidence supporting ACP efficacy, significant implementation challenges persist. Research identifies several key barriers from both patient and provider perspectives:

Patient/Family Factors: Lack of awareness, prognostic misunderstanding, emotional barriers, and cultural factors that may preclude discussions [2] [17]. In some Asian cultures, for instance, families may shield patients from prognosis information, complicating ACP implementation [2].

Healthcare System Factors: Time constraints, inadequate reimbursement, insufficient training in communication skills, and difficulty accessing completed documents across care settings [17]. A 2025 study of Chinese physicians found that limited communication time due to workload was reported as a barrier by 43% of physicians [17].

Measurement Challenges: The field lacks consensus on optimal outcome measures, particularly for assessing decision-making ability rather than just preferences [11]. Most existing measures focus on decisional preferences, conflict, or regret rather than the capacity to make informed EoL decisions [11].

Future research priorities include developing validated measures of decision-making ability specific to EoL contexts, testing implementation strategies to overcome identified barriers, and conducting cost-effectiveness analyses of various ACP delivery models. The 2025 refresh of palliative care research priorities continues to identify "exploring the barriers to people's wishes being acted upon with regards to care and treatment" as a high priority [12].

Advance care planning, comprising living wills, healthcare proxies, and POLST forms, represents a critical component of shared decision-making in end-of-life care research and practice. Substantial evidence demonstrates that ACP interventions significantly increase goal-concordant care, improve documentation of preferences, and reduce unwanted healthcare utilization. The distinct roles of various ACP documents—with advance directives providing foundational guidance and POLST forms creating actionable medical orders—create a complementary system for honoring patient values across the health trajectory.

For researchers, key challenges include developing better measures of decision-making ability, testing implementation strategies across diverse populations, and establishing standardized outcome measures that facilitate cross-study comparison. The protocols and frameworks presented herein provide a foundation for rigorous scientific inquiry in this rapidly evolving field, with the ultimate goal of ensuring that patient values and preferences guide medical care throughout the life course, particularly during serious illness and at the end of life.

Application Notes: Global Patterns in End-of-Life Decision-Making

End-of-life (EoL) decision-making represents a critical interface between clinical practice, patient values, and cultural belief systems. Within shared decision-making (SDM) models for EoL care research, understanding global variations is essential for developing culturally responsive interventions. This document synthesizes current evidence on how cultural norms, religious values, and healthcare infrastructures shape EoL decisions across different global contexts, providing application notes and experimental protocols for researchers investigating SDM in palliative and EoL care settings.

Culture and spirituality serve as fundamental frameworks through which patients and families perceive illness, suffering, and death, directly influencing preferences regarding medical communication, treatment interventions, and care processes [18]. In an increasingly globalized healthcare landscape, researchers and clinicians must recognize how culturally and spiritually dictated values significantly influence EoL care and related decision-making processes [18]. These frameworks shape how patients and families perceive concepts such as illness, suffering, and death, as well as their preferences regarding medical communication and interventions [18].

Comparative Cultural Frameworks in EoL Decision-Making

Table 1: Cultural Dimensions Influencing End-of-Life Decision-Making Across Selected Regions

Region/Country Decision-Making Model Truth Disclosure Preferences Spiritual/Religious Influences Family Involvement
Arab Middle East Collective, family-centric [18] Protective nondisclosure common [18] [19] Islamic beliefs emphasizing sanctity of life, divine will [18] Strong family involvement; decisions often deferred to family [18]
United Kingdom Individual autonomy-focused [18] Full disclosure standard [18] Personal, often secular spirituality [18] Patient-centered with advance directives [18]
East Asia Family-mediated [19] Partial or nondisclosure to protect patient [19] Buddhist, Confucian traditions [19] Family as primary decision-makers [19]
United States Patient autonomy [19] Full disclosure with informed consent [19] Diverse religious and secular perspectives [19] Variable, with increasing use of advance care planning [19]
Bangladesh Family-centered with limited patient autonomy [2] Limited disclosure; family protection [2] Islamic and Hindu traditions [2] Family as primary caregivers and decision-makers [2]

Table 2: Healthcare System Factors Influencing EoL Care Delivery

Country/Region Palliative Care Integration Advance Care Planning Prevalence Economic Factors Provider Training in Cultural Competence
High-Income Countries (e.g., UK, Australia) Well-integrated in healthcare systems [20] Established legal frameworks and higher documentation rates [18] Higher per capita spending on EoL care [20] Increasingly incorporated into medical curricula [21]
Middle-Income Countries (e.g., Bangladesh) Limited integration; focus on acute care [2] Low awareness and documentation [2] Significant out-of-pocket expenses; limited insurance [2] Minimal structured training [2]
Arab Middle East Developing with religious influences [18] Limited by family-centric decision models [18] Variable by country resources [18] Emerging recognition of need [18]

Key Findings from Recent Global Studies

Recent research reveals substantial disparities in EoL decision patterns across cultural and economic contexts. The ETHICUS-2 study, encompassing 199 ICUs across 36 countries, demonstrated significant variations in EoL decisions based on gross national income (GNI) [22]. In high-income countries, withholding (37%) and withdrawing (43%) life-sustaining measures were the most common EoL pathways, while failed cardiopulmonary resuscitation was most frequent in lower-middle-income countries (70.7%) [22].

A cross-sectional study in Bangladesh highlighted profound disparities in EoL awareness across healthcare settings, with palliative care awareness highest in private hospitals (70%), followed by public (31%) and community settings (7.1%) [2]. Older adults (≥60 years) were more likely to prefer home care (OR=2.96), avoid hospitalization (OR=17.55), and choose home death (OR=10.29) [2].

Cultural barriers significantly impact EoL care delivery, with linguistic and communicative barriers hindering trust-building between patients, families, and professionals [23]. Western healthcare systems often struggle with the imposition of Westernized views on dying processes, disregarding rituals, values, and meanings unique to other cultures [23].

Experimental Protocols

Objective: To quantitatively assess and compare EoL decision-making preferences across diverse cultural groups within healthcare settings.

Background: Understanding cultural variations in EoL preferences is fundamental to implementing effective shared decision-making models. This protocol provides a standardized methodology for investigating how cultural backgrounds influence preferences regarding truth disclosure, family involvement, treatment limitations, and spiritual care at the end of life.

Materials and Reagents:

  • Structured Questionnaire: Adapted from validated instruments including the National End of Life Survey (Ireland), Pallium Canada Palliative Medicine Survey, and Australian Commission on Safety and Quality in Health Care's Clinician Surveys [2].
  • Frommelt Attitude Toward Care of the Dying (FATCOD) Scale: Validated tool for assessing attitudes toward care of dying patients [18].
  • Demographic Data Collection Form: Capturing age, gender, religious affiliation, ethnic background, education level, and prior experiences with EoL care.
  • Multilingual Translation Services: For questionnaire adaptation and administration in participants' primary languages following WHO-recommended procedures [2].
  • Electronic Data Capture System: Tablet computers or online survey platforms with secure data storage.

Procedure:

  • Participant Recruitment: Employ stratified sampling across healthcare settings (public hospitals, private facilities, community settings) to ensure diverse representation [2]. Target sample size of 1,270 participants provides adequate power for cross-cultural comparisons.
  • Cultural Adaptation of Instruments: Conduct forward translation of materials into target languages by bilingual experts, followed by back-translation and reconciliation by panel review to ensure conceptual equivalence [2].
  • Data Collection: Train research assistants in culturally sensitive administration of surveys. Obtain informed consent with particular attention to cultural norms around documentation. Conduct pilot testing with 25 participants to assess comprehensibility [2].
  • Quantitative Assessment: Administer structured questionnaires capturing:
    • Awareness of EoL care options
    • Preferences regarding truth disclosure and decision-making autonomy
    • Attitudes toward life-sustaining treatments
    • Spiritual and religious considerations
    • Family communication preferences
  • Statistical Analysis: Employ multiple logistic regression to identify predictors of EoL preferences while controlling for demographic variables. Use cross-tabulations with chi-square tests to examine associations between cultural backgrounds and specific EoL preferences.

Quality Control: Regular audit of data collection procedures, inter-rater reliability assessments for qualitative coding, and validation of translated instruments through cognitive interviewing techniques.

Protocol 2: Qualitative Exploration of Healthcare Professional Experiences with Cultural Diversity in EoL Care

Objective: To explore difficulties perceived by healthcare professionals when providing EoL care to culturally diverse patients.

Background: Nursing and medical professionals often face challenges when navigating cultural differences in EoL care settings. This phenomenological approach captures rich narratives about these experiences to inform cultural competence training and system-level interventions.

Materials and Reagents:

  • Semi-Structured Interview Guide: Developed through literature review and pilot tested for appropriateness and comprehension [23].
  • Digital Audio Recorders: For capturing detailed interview data.
  • Transcription Software and Services: For verbatim transcription of interviews.
  • Qualitative Data Analysis Software (e.g., Atlas.ti version 23): For organizing and coding qualitative data [23].
  • Field Notebooks: For recording observational data and researcher reflections.

Procedure:

  • Participant Selection: Use purposive sampling to recruit nursing professionals working in palliative care units with experience caring for culturally diverse patients [23]. Sample size determined by data saturation, typically achieved with 10-15 participants.
  • Ethical Considerations: Obtain institutional ethics committee approval. Provide detailed study information emphasizing voluntary participation and right to withdraw. Ensure confidentiality through use of pseudonyms and secure data storage [23].
  • Data Collection: Conduct in-person, semi-structured interviews in private settings using an interview guide covering:
    • Experiences with linguistic and communication barriers
    • Challenges related to cultural differences in beliefs, rituals, and expectations
    • Perceived support networks and resources
    • Emotional impact of providing cross-cultural EoL care
    • Suggestions for improving culturally competent care
  • Data Analysis: Employ discourse analysis based on the Taylor & Bogdan model [23]:
    • Conduct line-by-line coding of transcribed interviews
    • Identify relationships and potentially contradictory content
    • Develop categories, sub-themes, and candidate themes through iterative review
    • Refine themes to capture essence of participant experiences
  • Member Checking: Provide participants with summary of themes and representative quotes to verify accuracy of interpretation [23].

Quality Assurance: Adhere to Consolidated Criteria for Reporting Qualitative Studies (COREQ) guidelines. Ensure scientific rigor through attention to credibility, confirmability, and transferability. Maintain detailed audit trails of analytical decisions.

Protocol 3: Implementation and Evaluation of Shared Decision-Making Tools in Electronic Health Records

Objective: To implement and assess the integration of shared decision-making tools within electronic health record systems to support culturally competent EoL care.

Background: Despite recognition of SDM as an ethical imperative, operationalization in clinical practice remains challenging. Integration of SDM tools into EHR systems shows promise for promoting SDM in routine clinical workflows, particularly for diverse patient populations facing EoL decisions.

Materials and Reagents:

  • EHR-Integrated SDM Templates: Customized for EoL decision contexts with attention to cultural variations in decision-making preferences.
  • Patient Decision Aids: Developed according to International Patient Decision Aid Standards (IPDAS) and Ottawa Decision Support Framework [24].
  • SDM Measurement Tools: Validated instruments for assessing SDM implementation success (e.g., COLLABORATE, SDM-Q-9).
  • Health Literacy Assessment Tools: For ensuring appropriateness of materials across diverse educational backgrounds.
  • Multilingual Patient Education Materials: Addressing common EoL decision points in patients' primary languages.

Procedure:

  • Needs Assessment: Conduct stakeholder interviews with clinicians, patients, families, and system administrators to identify key decision points and cultural considerations for SDM tool development.
  • Tool Development: Create SDM tools that:
    • Incorporate patient values and preferences clarification exercises
    • Provide culturally tailored information on prognosis, treatment options, risks, and benefits
    • Support discussion of spiritual and religious considerations
    • Accommodate varying preferences for family involvement
  • EHR Integration: Implement SDM tools within existing EHR systems through:
    • Customized templates for EoL conversations and documentation
    • Clinical decision support prompts triggered by specific patient criteria
    • Documentation tools for recording patient values and preferences
  • Implementation Strategy: Develop multifaceted implementation approach including:
    • Clinician education on SDM and cultural competence
    • Workflow analysis and modification to accommodate SDM processes
    • Patient and family engagement strategies
  • Evaluation: Assess implementation success through mixed methods:
    • Quantitative metrics: SDM tool use rates, documentation completeness
    • Qualitative assessment: Clinician and patient experiences with SDM tools
    • Clinical outcomes: Goal-concordant care, patient and family satisfaction

Quality Improvement: Use plan-do-study-act cycles to refine SDM tools and implementation strategies based on ongoing evaluation. Pay particular attention to addressing disparities in SDM tool use across diverse patient populations.

Visualization of Cultural Influences on EoL Decision-Making

G CulturalContext Cultural Context ReligiousBeliefs Religious/Spiritual Beliefs CulturalContext->ReligiousBeliefs FamilyStructure Family Structure & Dynamics CulturalContext->FamilyStructure SocioEconomic Socio-Economic Factors CulturalContext->SocioEconomic HealthcareSystem Healthcare System Infrastructure CulturalContext->HealthcareSystem ConceptOfDeath Concept of Death & Afterlife ReligiousBeliefs->ConceptOfDeath Shapes SufferingMeaning Meaning of Suffering ReligiousBeliefs->SufferingMeaning Defines EoL EoL ReligiousBeliefs->EoL DecisionModel Decision-Making Model (Individual vs Collective) FamilyStructure->DecisionModel Determines TruthDisclosure Truth Disclosure Preferences FamilyStructure->TruthDisclosure Influences CaregiverRoles Caregiver Roles & Responsibilities FamilyStructure->CaregiverRoles Establishes AccessToCare Access to Palliative & EoL Care Services SocioEconomic->AccessToCare Affects HealthLiteracy Health Literacy & Information Processing SocioEconomic->HealthLiteracy Impacts ResourceAllocation Resource Allocation Decisions SocioEconomic->ResourceAllocation Guides LegalFrameworks Legal & Ethical Frameworks HealthcareSystem->LegalFrameworks Provides ProviderTraining Provider Training & Competencies HealthcareSystem->ProviderTraining Determines FundingModels Funding & Payment Models HealthcareSystem->FundingModels Establishes EoLDecision EoL Decision Outcomes ConceptOfDeath->EoLDecision Informs Rituals EoL Rituals & Practices DecisionModel->EoLDecision Directs AccessToCare->EoLDecision Constraints LegalFrameworks->EoLDecision Governs TreatmentLimitations Treatment Limitation Decisions EoLDecision->TreatmentLimitations CareSetting Preferred Care Setting EoLDecision->CareSetting CommunicationPatterns Communication Patterns & Information Sharing EoLDecision->CommunicationPatterns

Diagram 1: Cultural Influence Pathways in EoL Decision-Making. This visualization maps the complex relationships between cultural factors and EoL decision processes, highlighting how religious beliefs, family structures, socio-economic factors, and healthcare systems collectively influence decision outcomes.

The Scientist's Toolkit: Research Reagents and Materials

Table 3: Essential Research Materials for Cross-Cultural EoL Decision-Making Studies

Research Tool Category Specific Instrument/Resource Primary Application Key Considerations
Validated Assessment Tools Frommelt Attitude Toward Care of the Dying (FATCOD) Scale [18] Measuring healthcare provider attitudes toward caring for dying patients Requires cultural validation for different populations
Shared Decision-Making Questionnaires (SDM-Q-9, COLLABORATE) [24] Assessing quality and extent of shared decision-making in clinical encounters May need adaptation for cultural conceptions of decision-making
Quality of Death Index [20] Comparing quality of EoL care across countries and systems Incorporates quantitative and qualitative indicators
Methodological Frameworks Ottawa Decision Support Framework [24] Developing and evaluating patient decision aids Provides standardized checklists for decision aid development
Consolidated Criteria for Reporting Qualitative Studies (COREQ) [23] Ensuring comprehensive reporting of qualitative research Essential for maintaining methodological rigor in qualitative studies
Data Collection Instruments Structured EoL Care Preference Questionnaires [2] Quantifying patient and family preferences across cultural groups Requires careful translation and cultural adaptation
Semi-Structured Interview Guides [23] Exploring lived experiences of patients, families, and providers Should include probes for cultural and spiritual considerations
Analysis Resources Qualitative Data Analysis Software (Atlas.ti, NVivo) [23] Organizing and analyzing qualitative data Facilitates systematic coding of complex narrative data
Multivariate Statistical Analysis Packages (SPSS, R) [2] Analyzing quantitative data on EoL preferences and decisions Essential for controlling confounding variables in cross-cultural comparisons

The integration of cultural understanding into EoL care research requires methodologically rigorous approaches that acknowledge the profound influence of cultural norms, religious values, and healthcare systems on decision-making processes. The application notes and experimental protocols provided here offer frameworks for investigating these complex relationships while maintaining scientific rigor and cultural sensitivity.

Future research should prioritize the development and validation of culturally adapted assessment tools, implementation studies of shared decision-making models across diverse healthcare settings, and intervention trials testing strategies for improving cultural competence among EoL care providers. Particular attention should be paid to underrepresented ethnic and cultural groups to better understand their unique perspectives on death, dying, and medical decision-making [19].

As global populations continue to diversify and age simultaneously, research that illuminates the complex interplay between culture, healthcare systems, and EoL decision-making will become increasingly vital for ensuring that EoL care remains both medically appropriate and culturally congruent.

This application note explores the multifaceted barriers to patient participation in shared decision-making (SDM), particularly within end-of-life (EOL) care contexts. Through a systematic analysis of current literature, we identify and categorize obstacles related to patient capacity, communication challenges, and health literacy. The document provides researchers and clinicians with structured data, detailed experimental protocols, and practical tools to investigate and address these barriers, ultimately aiming to enhance the implementation of patient-centered SDM models in serious illness care.

Shared decision-making (SDM) is a collaborative process where patients and healthcare providers jointly make healthcare decisions based on clinical evidence and patient preferences, values, and goals [25] [26]. Within end-of-life care research, effective SDM is crucial for ensuring care aligns with patient wishes, yet significant barriers impede its implementation. Patient participation remains limited despite recognized benefits, including reduced decision conflict and improved care concordance [25] [27]. This document delineates the primary barriers—spanning patient capacity, communication challenges, and health literacy—and provides a methodological toolkit for researchers aiming to develop and test interventions to overcome these obstacles in palliative and EOL care settings.

Structured Analysis of Key Barriers

Barriers to effective patient participation in SDM are interconnected and operate across multiple levels. The following subsections and tables provide a synthesized overview of these challenges, with quantitative data highlighting their prevalence and impact.

Table 1: Capacity and Motivation-Related Barriers in SDM and EOL Care

Barrier Category Specific Factor Exemplary Quantitative Findings Primary Source
Psychological Capability Limited understanding of disease/prognosis 38.1% of non-concordant EOL care cases involved "limited understanding of medical interventions" [27]. Systematic Review [27]
Reflective Motivation Unaddressed emotional distress 84.5% of non-concordant EOL care cases attributed to "families being too distressed... unable to let go" [27]. Longitudinal Retrospective Cohort [27]
Automatic Motivation Fear of the disease (e.g., cancer) Identified as a key automatic motivation barrier in SDM [25]. Systematic Review [25]
Disease-Centered Beliefs Clinician belief in their primary responsibility for decision-making 67% of surveyed physicians felt SDM takes more time than regular decision-making [28]. Mixed-Methods Study [28]

Table 2: Communication, Literacy, and Opportunity-Related Barriers

Barrier Category Specific Factor Exemplary Quantitative Findings Primary Source
Health Literacy Misunderstanding of EOL terminology Less than 30% of elderly dialysis patients could correctly define common EOL terms (e.g., "prognosis," "hospice") [29]. Qualitative Descriptive Study [29]
Provider Communication Reluctance to initiate EOL conversations Only 13% of elderly dialysis patients had discussed EOL preferences with their physician [29]. Qualitative Descriptive Study [29]
Social Opportunity Lack of social/family support Identified as a key barrier to SDM for patients undergoing surgery for ulcerative colitis [30]. Qualitative Study [30]
Physical Opportunity Lack of time and supplemental resources Lack of time and resources cited as barriers to both SDM and palliative care research capacity [25] [31]. Systematic Review [25], Mixed Methods Study [31]

Experimental Protocols for Barrier Investigation

To advance the field, standardized methodologies for investigating these barriers are essential. The following protocols are adapted from recent high-quality studies.

Protocol 1: Qualitative Exploration of Patient and Provider SDM Experiences

This protocol is adapted from studies on ulcerative colitis and advance care planning (ACP) to explore lived experiences and perceived barriers [30] [32].

  • 1. Research Design: A qualitative study using semi-structured interviews and focus groups. The Consolidated Criteria for Reporting Qualitative Research (COREQ) should be followed [28].
  • 2. Participant Recruitment:
    • Population: Purposively sample key stakeholders (e.g., patients with serious illnesses, family caregivers, physicians, nurses, social workers).
    • Setting: Recruit from clinical sites, patient registries, and support groups to ensure diversity.
    • Sample Size: Aim for 20-30 participants per major stakeholder group, or until thematic saturation is achieved.
  • 3. Data Collection:
    • Instrument Development: Develop a semi-structured interview guide based on the research question and existing literature (e.g., COM-B model [25]).
    • Example Prompts: "Can you describe the process of making decisions about your treatment?"; "What factors made it easier or more difficult to participate in these discussions?"; "What were the biggest barriers to having conversations about palliative care/ACP?" [30] [32].
    • Procedure: Conduct one-on-one interviews and focus groups in private settings. Audiotape and transcribe all sessions verbatim.
  • 4. Data Analysis:
    • Coding: Use a team-based approach to develop a codebook. Employ both deductive (based on pre-existing theories/frameworks) and inductive (emerging from the data) coding strategies.
    • Thematic Analysis: Conduct iterative, line-by-line coding to identify emergent themes and patterns. Use qualitative data analysis software (e.g., NVivo) to manage data.
    • Validation: Resolve coding discrepancies through team discussion and consensus to ensure reliability.

Protocol 2: Quantitative Assessment of Health Literacy in EOL Decision-Making

This protocol is modeled on a study investigating health literacy among elderly dialysis patients [29].

  • 1. Research Design: A cross-sectional, descriptive study incorporating quantitative and qualitative components.
  • 2. Participant Recruitment:
    • Population: Patients with advanced, life-limiting illnesses (e.g., stage IV cancer, ESRD, advanced heart failure).
    • Inclusion Criteria: Adults (e.g., ≥ 65 years), English-speaking, and with capacity to consent.
    • Sampling: Purposively sample to ensure diversity in age, disease vintage, and race/ethnicity.
  • 3. Data Collection:
    • Functional Health Literacy Assessment: Within a broader semi-structured interview, assess comprehension of key EOL and treatment terminology (e.g., "prognosis," "hospice," "palliative care," "dialysis").
    • Procedure: For each term, ask: "What does the word [term] mean to you?" Code responses based on a pre-defined guide of correct definitions.
    • Additional Metrics: Collect data on patient demographics, clinical history, and prior engagement in ACP or EOL conversations.
  • 4. Data Analysis:
    • Quantitative Analysis: Calculate descriptive statistics (frequencies, percentages) for the proportion of participants able to correctly define each term. Analyze for correlations with demographic variables using chi-square tests or logistic regression.
    • Qualitative Analysis: Thematically analyze open-ended responses to understand misconceptions and the context of patients' understanding.

The following workflow visualizes the multi-method approach to investigating barriers to patient participation:

Start Start: Investigate Barriers to Patient Participation SubProblem1 Qualitative Exploration of Lived Experiences Start->SubProblem1 SubProblem2 Quantitative Assessment of Health Literacy Start->SubProblem2 Method1 Method: Semi-structured Interviews & Focus Groups SubProblem1->Method1 Method2 Method: Cross-sectional Survey with Terminology Assessment SubProblem2->Method2 Analysis1 Analysis: Thematic Analysis using COM-B Framework Method1->Analysis1 Analysis2 Analysis: Descriptive Stats & Correlation Analysis Method2->Analysis2 Output1 Output: Thematic Framework of Barrier Categories Analysis1->Output1 Output2 Output: Quantified Literacy Gaps and Misconceptions Analysis2->Output2 Synthesis Synthesis: Integrated Findings for Intervention Design Output1->Synthesis Output2->Synthesis End Outcome: Evidence-Based SDM Protocol Synthesis->End

The Scientist's Toolkit: Research Reagents and Materials

This section outlines essential tools and resources for conducting research on SDM barriers, as identified in the literature.

Table 3: Key Research Reagent Solutions for SDM and EOL Care Studies

Tool Name Type/Classification Primary Function in Research Exemplary Application Context
COM-B Model [25] Theoretical Framework Systematically categorize barriers and facilitators into Capability, Opportunity, and Motivation components. Designing studies, analyzing qualitative data on implementation barriers.
Mixed Methods Appraisal Tool (MMAT) [25] [33] Methodological Tool Critically appraise the quality of qualitative, quantitative, and mixed-methods studies in systematic reviews. Ensuring methodological rigor in evidence synthesis.
Semi-structured Interview Guide [30] [29] Data Collection Instrument Collect rich, in-depth qualitative data on patient and provider experiences, perceptions, and barriers. Exploring nuanced reasons behind low participation in ACP or SDM.
EOL Terminology Comprehension Assessment [29] Functional Literacy Measure Quantify patient understanding of key terms used in EOL and advance care planning conversations. Identifying specific knowledge gaps that hinder informed decision-making.
Patient Decision Aids (PDAs) [26] [24] Intervention Tool Support SDM by providing structured information on options, risks, benefits, and clarifying patient values. Testing the efficacy of tools in improving knowledge and reducing decisional conflict in clinical trials.
Electronic Health Record (EHR)-Integrated SDM Tools [24] Health IT Intervention Embed SDM processes and PDAs into clinical workflow to promote routine use and documentation. Implementing and scaling SDM interventions in real-world healthcare settings.

Overcoming barriers to patient participation in SDM for end-of-life care requires a multifaceted and rigorously researched approach. The barriers related to capacity, communication, and health literacy are significant but not insurmountable. By employing the structured analysis, detailed experimental protocols, and specialized tools outlined in this application note, researchers and clinicians can contribute to the development of more effective, equitable, and patient-centered shared decision-making models. Future work must focus on implementing and evaluating interventions, such as health literacy-sensitive communication training and EHR-integrated decision aids, to ensure that patient voices are truly heard and respected in their most critical healthcare decisions.

Implementing Shared Decision-Making: Frameworks, Tools, and Clinical Applications

Within the domain of patient-centered care, particularly in palliative and end-of-life contexts, structured communication models are essential for guiding high-stakes decisions. Shared decision-making (SDM) represents a collaborative process where patients, families, and clinicians work together to make medical decisions aligned with patient goals and values [34]. This is especially critical in settings like the cardiac intensive care unit (CICU), where patients often face decisions about aggressive or life-sustaining therapies amidst high mortality rates [34]. This article details two established SDM frameworks—the Three-Talk Model and the REMAP framework—providing application notes and experimental protocols for researchers and clinical scientists aiming to implement and study these models in real-world settings.

Model Fundamentals: Three-Talk Approach and REMAP Framework

The Three-Talk Model for Shared Decision-Making

The Three-Talk Model is a practical framework for learning and achieving SDM in clinical practice. Initially published in 2012 and revised in 2017 through a multistage consultation process, it outlines three core conversational steps [35] [36]. The model emphasizes a process of collaboration and deliberation, initiated by providing support when introducing options, followed by strategies to compare and discuss trade-offs, before final deliberation based on informed patient preferences [35].

The table below summarizes the core tasks and scripts for each stage of the revised Three-Talk Model.

Table 1: The Revised Three-Talk Model of Shared Decision-Making

Stage Core Tasks Example Scripts
Team Talk - Acknowledge that a decision needs to be made and that the patient's views matter.- Provide support and information.- Elicit patient goals and values. "The next step is to think about the different options available. I’d like us to make this decision together." [35]
Option Talk - Compare the available alternatives.- Use principles of risk communication.- Discuss benefits, harms, and probabilities in accessible language. "Let’s compare the choices. Here are the pros and cons of each option." [35] [36]
Decision Talk - Arrive at a decision that reflects the patient's informed preferences.- Guided by the clinician's expertise and experience.- Make a plan or defer based on patient readiness. "Given what matters most to you, which option seems best?" [35]

The REMAP Framework for Goals of Care Conversations

The REMAP framework is a mnemonically structured model developed specifically for conducting goals of care conversations, often in the context of serious illness or palliative care [37] [34]. It provides a flexible structure that clinicians, from residents to attending physicians, can use to learn these complex conversational skills [37]. Its core innovation lies in its direct integration of emotion management and goal alignment into the decision-making process.

The table below delineates the components of the REMAP framework.

Table 2: The REMAP Framework for Goals of Care Conversations

Component Description Key Actions
Reframe Frame the conversation within the context of the patient's current medical situation and the need to establish goals. Connect the conversation to the bigger picture of the patient's illness.
Expect emotion Acknowledge and make space for the patient's and family's emotional response. Use empathy to build rapport and validate feelings.
Map patient goals Explore the patient's values, hopes, and what matters most to them in their life and care. Ask about goals beyond just medical outcomes, such as function or family.
Align with goals Use the mapped goals to inform which medical options are most aligned with the patient's priorities. Explain how different treatment paths support or conflict with stated goals.
Propose a plan Formulate and suggest a clear care plan based on the alignment of options with patient goals. Make a concrete recommendation that reflects the patient's values [34].

Logical Workflow and Integration

The following diagram illustrates the sequential flow and key decision points within the REMAP framework, providing a visual guide for its application in clinical conversations.

G Start Start Conversation R Reframe Start->R E Expect Emotion R->E M Map Patient Goals E->M A Align with Goals M->A P Propose a Plan A->P Decision Decision Made? P->Decision Decision->M No, revisit goals End Document Plan Decision->End Yes

Application in Palliative and End-of-Life Care Research

Context and Relevance

In palliative and end-of-life care, SDM is paramount for preference-sensitive decisions. These are decisions where the best choice depends heavily on the patient's individual values, goals, and trade-offs they are willing to accept [34]. In the CICU, for example, this can include decisions about intubation, initiation of mechanical ventilation, consent for cardiopulmonary resuscitation, or transitioning to comfort-focused measures [34]. The integration of the REMAP framework into SDM is particularly valuable here, as its "Map patient goals" component ensures that choices are explained in direct relation to the patient's fundamental priorities [34].

Implementation Protocols and Research Methodologies

Protocol 1: Implementing and Evaluating the Three-Talk Model in a Clinical Workflow

This protocol is adapted from studies integrating SDM into routine care, particularly through the electronic health record (EHR) [24].

  • Aim: To integrate the Three-Talk Model into the clinical workflow and measure its impact on patient-reported and clinical outcomes.
  • Intervention Development:
    • EHR Integration: Embed structured note templates or decision aids into the EHR that prompt clinicians through the stages of Team Talk, Option Talk, and Decision Talk [24].
    • Scripting: Develop and provide clinicians with suggested scripts for each stage of the model, tailored to specific clinical scenarios (e.g., aortic valve replacement) [35] [38].
  • Clinician Training:
    • Conduct dedicated training sessions using the model to teach SDM competencies.
    • Utilize role-playing with simulated patients to practice the three "talk" stages [35].
  • Experimental Procedure:
    • Identify patients facing a preference-sensitive decision.
    • Clinicians use the EHR-integrated tool during the patient encounter to guide the SDM process.
    • The conversation may be audio-recorded for fidelity assessment.
  • Outcome Measures:
    • Primary: Patient decisional conflict, patient knowledge, and the extent of SDM achieved (e.g., using the Observing Patient Involvement (OPTION) scale).
    • Secondary: Clinician satisfaction, encounter duration, and documentation quality of patient goals in the EHR [24].
Protocol 2: Testing the Efficacy of the REMAP Framework in Goals of Care Conversations

This protocol draws from the development and application of the REMAP framework and related communication models [37] [34].

  • Aim: To evaluate the effect of REMAP training on clinician confidence and the quality of goals of care conversations in a palliative care context.
  • Study Design: A pre-post intervention study, potentially as a cluster randomized stepped-wedge trial.
  • Intervention:
    • Training Workshop: A multi-component educational intervention for clinicians featuring:
      • Didactic teaching on the REMAP mnemonic and its components.
      • Demonstration of the framework using video examples.
      • Facilitated small-group practice with simulated patients, focusing on complex scenarios like transitioning to palliative care [37].
  • Experimental Procedure:
    • Pre-Intervention: Baseline assessment of clinician confidence and audio-recording of simulated goals of care conversations.
    • Post-Intervention: Re-assessment of clinician confidence and audio-recording of a second simulated conversation following the training.
    • Analysis: Rate audio recordings using a validated communication coding system to assess fidelity to the REMAP model and communication quality.
  • Outcome Measures:
    • Primary: Change in clinician self-rated confidence in conducting goals of care conversations.
    • Secondary: Objective improvement in communication skills as rated by blinded assessors, and reduction in simulated patient anxiety [37].

The Scientist's Toolkit: Research Reagents and Materials

The following table details key tools and materials essential for conducting rigorous research on SDM models in clinical settings.

Table 3: Essential Research Materials for SDM Model Implementation and Evaluation

Item / Tool Function in Research Application Example
Validated Decision Aids Standardized tools to provide evidence-based information on options, benefits, and harms, facilitating "Option Talk." CardioSmart decision aids for conditions like aortic stenosis or heart failure provide visual infographics and data to support clinician-patient deliberation [38].
EHR-Integrated SDM Templates Prompts and structured documentation fields integrated into clinical workflow to promote and capture SDM processes. A template within the EHR for lung cancer screening that prompts a "Team Talk" and records the final decision [24].
Communication Coding Systems (e.g., OPTION scale) Objective, validated instruments to rate the quality and extent of SDM from audio or video recordings of encounters. Researchers can use the OPTION scale to blindly score recordings of clinician-patient encounters to measure adherence to the Three-Talk Model [35].
Simulated Patients (Standardized Patients) Trained individuals who portray a patient role consistently, allowing for standardized assessment of clinician communication skills. Used in REMAP training workshops to allow clinicians to practice and receive feedback in a low-risk environment before applying the framework with real patients [37].
Patient-Reported Outcome Measures (e.g., Decisional Conflict Scale) Quantify the patient's experience of uncertainty in decision-making, a key metric for intervention effectiveness. Administering the Decisional Conflict Scale to patients before and after an SDM intervention that uses the Three-Talk Model to measure a reduction in conflict [24].

The Three-Talk Model and the REMAP framework provide structured, evidence-based methodologies for implementing SDM in clinical practice and research, especially within high-acuity, end-of-life contexts. The Three-Talk Model offers a generalizable structure for collaborative decisions, while REMAP provides a specialized tool for the nuanced process of goals of care discussions. For researchers, the rigorous application of the outlined protocols—leveraging EHR integration, standardized training, and validated assessment tools—is critical for generating high-quality evidence on the efficacy of these models. Future work should focus on randomized controlled trials, standardization of tools and measures, and a continued emphasis on capturing patient goals and values to further advance the science and practice of patient-centered care [24].

Digital decision aids are structured tools designed to help patients and their families make informed, value-concordant choices about end-of-life care. These aids deliver information on potential options, risks, and benefits, and incorporate individual preferences into the decision-making process [39]. Their use is supported by evidence showing they can improve knowledge, reduce decisional conflict, and better align care with patient goals [40].

The table below summarizes the key modalities of digital decision aids and the evidence for their application in end-of-life care.

Table 1: Modalities and Evidence for Digital Decision Aids in End-of-Life Care

Modality Description Key Findings from Efficacy Studies Clinical Context/ Population
Video Decision Aids Short films depicting specific care options (e.g., comfort care) or outcomes. Meta-analysis shows 3.81 times higher odds (95% CI: 1.92-7.56) of patients choosing comfort care compared to control groups [39]. Effective for clarifying goals of care (e.g., life-prolonging vs. comfort care) in patients with advanced dementia or other serious illnesses [39].
Web-Based Platforms & Decision Aids Interactive websites or tools providing information, value clarification, and preparation for decision-making. High user satisfaction and improved knowledge reported. Effects on decision-making involvement, self-efficacy, and psychological distress are mixed and uncertain [41]. Patients with advanced cancer; tools are highly heterogeneous and not all integrate end-of-life care aspects [41].
Integrated Telehealth Platforms Telemedicine software (e.g., Doxy.me, integrated EHR systems) used as a conduit for shared decision-making conversations. Facilitates remote access to care. Challenges include lack of pre-existing patient-clinician relationships and potential for consumerist, rather than collaborative, decision-making [42]. Broad application for virtual consultations in palliative care; requires conscious effort to implement shared decision-making principles [42].
Mobile Health (mHealth) Applications Smartphone apps designed to promote shared decision-making and track patient priorities between visits. Feasible and acceptable in populations with severe illness (e.g., psychotic disorders). Facilitates SDM by supporting cognition and shifting the patient's role [43]. Useful for protracted care courses to maintain focus on common goals; requires scaffolding and support structures for successful implementation [43].

Experimental Protocols for Key Studies

Protocol for Evaluating a Video Decision Aid in End-of-Life Dementia Care

This protocol is adapted from a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating digital decision aids for palliative and end-of-life dementia care [39].

  • Objective: To determine the effectiveness of a video decision aid in influencing the choice of comfort care as the primary goal of care for patients with advanced dementia.
  • Study Design: Randomized Controlled Trial (RCT).
  • Population:
    • Intervention/Control Groups: Family caregivers or surrogate decision-makers for patients with advanced dementia.
    • Sample Size: Determined by power calculation; meta-analysis pooled data from 4 RCTs [39].
  • Intervention:
    • The video decision aid group views a multimedia tool that describes the disease trajectory and visually explains three distinct goal-of-care options: 1) Life-prolonging care, 2) Limited medical care, and 3) Comfort care [39].
  • Control:
    • The control group receives usual care or is given written educational materials describing the same goal-of-care options [39].
  • Primary Outcome Measures:
    • Preferred Goal of Care: The proportion of participants selecting comfort care as the primary goal after the intervention [39].
    • Documented Care Orders: The proportion of patients with a documented "do-not-hospitalize" order in their medical record [39].
  • Data Analysis:
    • Statistical Test: A meta-analysis was performed using a random-effects model.
    • Effect Measure: Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated for the outcomes [39].

Table 2: Primary Outcome Data from Meta-Analysis of Video Decision Aid RCTs

Outcome Measure Pooled Odds Ratio (OR) 95% Confidence Interval (CI) Statistical Significance
Choice of Comfort Care 3.81 1.92 - 7.56 Statistically significant
Documented Do-Not-Hospitalize Order 1.60 0.70 - 3.67 Inconclusive

Protocol for Feasibility and Acceptability Testing of a Mobile SDM Application

This protocol is based on a mixed-methods study of a mobile app designed to promote shared decision-making in the treatment of psychotic disorders, illustrating methodology applicable to end-of-life care contexts [43].

  • Objective: To explore the feasibility and acceptability of a digital decision aid mobile app from the perspectives of both patients and clinicians, and to identify mechanisms for achieving shared decision-making.
  • Study Design: Prospective, mixed-methods feasibility study with an emphasis on qualitative analysis.
  • Population:
    • Patients: Adults undergoing treatment for a severe condition (e.g., psychotic disorders, advanced illness), with access to a smartphone.
    • Clinicians: Healthcare providers treating the participant patients.
  • Intervention:
    • Use of a mobile app (e.g., iTandem) containing optional modules (e.g., medication, mood, activity) as a supplement to standard treatment for a 6-week trial. The app is designed to facilitate patient involvement in decisions regarding treatment goals [43].
  • Data Collection:
    • Quantitative:
      • App Usage Data: Collected automatically to measure engagement (e.g., frequency of use, modules accessed).
      • Questionnaires: Pre- and post-intervention surveys to assess usability and acceptability.
    • Qualitative:
      • Post-Intervention Interviews: Semi-structured interviews with patients and clinicians to elaborate on feasibility and explore mechanisms of action.
  • Primary Outcome Measures:
    • Feasibility: Recruitment rates, retention rates, and patterns of app usage.
    • Acceptability: User-reported satisfaction and perceived clinical value via questionnaires and interviews.
    • Mechanisms of Action: Themes from reflexive thematic analysis of interview transcripts (e.g., "supporting cognition," "shifting the patient’s role") [43].

Visualization of Decision Pathways and Workflows

Shared Decision-Making Logic in Palliative Care

This diagram illustrates the integrated application of the REMAP framework for discussing goals and values with the three-talk model for shared decision-making, as applied in a palliative care context [34].

Start Patient with Life-Limiting Illness REMAP REMAP Framework Start->REMAP G1 Reframe & Expect Emotion REMAP->G1 G2 Map Patient Goals & Values G1->G2 G3 Align with Goals & Propose Plan G2->G3 ThreeTalk Three-Talk Model for SDM G3->ThreeTalk S1 Choice Talk: Present Options ThreeTalk->S1 S2 Option Talk: Discuss Pros/Cons S1->S2 S3 Decision Talk: Make Decision S2->S3 Outcome Goal-Concordant Care Plan S3->Outcome

Shared Decision-Making in Palliative Care

Experimental Workflow for Digital Aid Evaluation

This diagram outlines the core workflow for conducting a randomized controlled trial (RCT) to evaluate a digital decision aid, as derived from the cited systematic reviews [39] [40].

Recruit Recruit Participants (Patients/Family Caregivers) Screen Assess Eligibility & Obtain Informed Consent Recruit->Screen Randomize Randomization Screen->Randomize GroupA Intervention Group Randomize->GroupA GroupB Control Group Randomize->GroupB ActionA Use Digital Decision Aid (e.g., Video, Web Tool) GroupA->ActionA Measure Post-Intervention Outcome Assessment ActionA->Measure ActionB Receive Usual Care or Passive Information GroupB->ActionB ActionB->Measure Analyze Data Analysis (e.g., Meta-Analysis) Measure->Analyze Result Determine Effectiveness on Key Outcomes Analyze->Result

Digital Decision Aid RCT Workflow

The Scientist's Toolkit: Research Reagent Solutions

This table details key tools and methodologies used in the development and evaluation of digital decision aids for end-of-life care research.

Table 3: Essential Research Reagents and Tools for Digital Decision Aid Studies

Item / Solution Function in Research Specific Examples / Notes
International Patient Decision Aid Standards (IPDAS) A quality framework guiding the development and evaluation of decision aids to ensure they are effective and unbiased. Studies that included IPDAS in development reported more positive outcomes [40].
Decisional Conflict Scale (DSU) A validated questionnaire to measure a patient's uncertainty about a course of action, a key outcome in many trials. Used to quantify the tool's effectiveness in reducing uncertainty and fostering informed decisions [40].
Mixed Methods Appraisal Tool (MMAT) A critical appraisal tool used in systematic reviews to assess the methodological quality of qualitative, quantitative, and mixed-methods studies. Employed in systematic reviews to evaluate the quality of included primary studies [44].
Video & Web-Based Decision Aid Prototypes The experimental intervention itself, designed to present information about options and outcomes in an accessible format. For advanced dementia, tools focus on goals of care (life-prolonging, limited, comfort) [39]. For cancer, tools are web-based and highly heterogeneous [41].
Telehealth Platform APIs Application Programming Interfaces that allow researchers to integrate decision aids into existing clinical telehealth workflows and Electronic Health Records (EHR). Platforms like Epic MyChart and Cerner PowerChart offer native integration for telehealth tools [45].
Reflexive Thematic Analysis A qualitative methodology for analyzing interview or focus group data to identify, analyze, and report patterns (themes) within the data. Used to explore patient and clinician experiences and identify mechanisms of action, such as how an app supports cognition [43].

This article provides a detailed analysis of shared decision-making (SDM) models within three critical healthcare settings: the Cardiac Intensive Care Unit (CICU), the Emergency Department (ED), and community-based care. SDM represents a collaborative process where patients, families, and clinicians work together to make medical decisions aligned with patient goals and values, which is particularly crucial for palliative and end-of-life care. Framed within a broader thesis on end-of-life care research, this article presents application notes, structured protocols, and practical toolkits to guide researchers and clinicians in implementing and studying SDM across these diverse environments. The content emphasizes evidence-based strategies, barriers to implementation, and standardized methodologies for evaluating SDM efficacy, providing a foundation for advancing patient-centered care in serious illness.

Cardiac Intensive Care Unit (CICU) Applications

Clinical Context and SDM Imperative

The contemporary CICU manages a complex patient population characterized by advanced age, multimorbidity, and multi-organ failure. Despite technological advances, hospital mortality for CICU patients approaches 10%, with approximately half of these deaths occurring within the unit [46] [34]. A significant proportion of patients receive aggressive life-sustaining therapies, making goals-of-care conversations and palliative care integration essential components of high-quality care [46]. Within this high-stakes environment, SDM becomes particularly relevant for preference-sensitive decisions such as initiating or withdrawing mechanical circulatory support, managing advanced heart failure therapies, and transitioning to comfort-focused care [34].

Application Notes and Decision-Making Protocols

The following protocol outlines a structured approach to SDM in the CICU, integrating the three-talk model with the REMAP framework for goals of care conversations [46] [34]:

Phase 1: Preparation and Assessment (Pre-Encounter)

  • Identify Decision Points: Recognize clinical crossroads where multiple reasonable options exist (e.g., consideration of ventricular assist device, eligibility for transplantation, de-escalation of life support) [46].
  • Assess Patient Capacity and Identify Surrogates: Determine the patient's ability to participate in discussions. If lacking capacity, identify appropriate surrogate decision-makers and review any existing advance directives [34].
  • Conduct Pre-Meeting with Interdisciplinary Team: Coordinate with cardiology, critical care, palliative care, nursing, and social work to establish consensus on medical facts and treatment options before family meetings [46].

Phase 2: Conversation Framework (Structured Encounter)

  • Build Rapport and Set Agenda: Establish a compassionate tone and outline the meeting's purpose.
  • Assess Understanding and Preferences: Use open-ended questions to determine the patient/surrogate's comprehension of the clinical situation and their informational preferences.
  • Present Options and Explore Implications: Discuss the clinical dilemma, potential treatment pathways, and the expected benefits, burdens, and outcomes of each option using clear, non-technical language [34].
  • Map Patient Values and Goals: Apply the REMAP framework:
    • Reframe the clinical situation within the context of the patient's overarching illness trajectory.
    • Expect and acknowledge emotion as a natural response to serious illness.
    • Map the patient's fundamental values, goals, and priorities beyond specific treatments.
    • Align treatment recommendations with the identified patient values.
    • Propose a specific care plan based on this alignment [46].
  • Make a Recommendation: Based on the understood patient values, the clinician should offer a specific recommendation rather than presenting neutral options [34].

Phase 3: Documentation and Implementation (Post-Encounter)

  • Document the Conversation: Clearly record the discussion, including options presented, patient values expressed, decisions made, and the care plan in the electronic health record.
  • Communicate Across Care Team: Disseminate the decisions to all members of the healthcare team to ensure consistent care delivery.
  • Schedule Follow-Up: Plan for ongoing conversations as the clinical situation evolves [46].

Table 1: Preference-Sensitive Decisions in the CICU Context [46] [34]

Decision Category Clinical Examples SDM Considerations
Life-Sustaining Therapies Initiation or withdrawal of mechanical ventilation, vasopressors, or mechanical circulatory support Balance between potential for recovery and burden of treatment; align with patient's quality of life goals
Procedure-Related Decisions Percutaneous coronary intervention in high-risk patients, balloon valvuloplasty in cardiogenic shock Discuss procedural risks/benefits in context of comorbidities and overall prognosis
Disease-Specific Trajectories Destination therapy for heart failure, bridge to transplantation decisions Explore patient expectations, functional goals, and tolerance for uncertainty
End-of-Life Transitions Do-not-resuscitate orders, transition to comfort measures only Focus on aligning final days with patient values; manage symptoms aggressively

Implementation Challenges and Research Gaps

Barriers to optimal SDM in the CICU include patient factors (critical illness impairing decision-making capacity), clinician factors (discomfort with difficult conversations, insufficient communication training), and system factors (time constraints, lack of compensation for these conversations) [46]. Cardiology trainees in particular receive insufficient communication skills training [46]. Research gaps include the need for validated CICU-specific decision aids, understanding of how to best incorporate novel cardiac devices into SDM conversations, and effective models for integrating specialty palliative care into CICU practice [46] [34].

CICU_SDM Start Patient with Critical Cardiac Illness Assessment Assess Decision Context and Patient Capacity Start->Assessment IdentifySurrogate Identify Surrogate Decision-Maker if Needed Assessment->IdentifySurrogate TeamHuddle Interdisciplinary Team Huddle IdentifySurrogate->TeamHuddle Conversation Structured Family Meeting TeamHuddle->Conversation Reframe REMAP: Reframe Clinical Context Conversation->Reframe ExpectEmotion REMAP: Expect and Acknowledge Emotion Reframe->ExpectEmotion MapGoals REMAP: Map Patient Goals/Values ExpectEmotion->MapGoals AlignPlan REMAP: Align Plan with Goals MapGoals->AlignPlan Propose REMAP: Propose Recommendation AlignPlan->Propose Document Document and Communicate Plan Propose->Document Implement Implement Care Plan Document->Implement FollowUp Schedule Follow-Up Implement->FollowUp

CICU Shared Decision-Making Workflow

Emergency Department (ED) Applications

Clinical Context and Screening Imperative

The ED serves as a critical interface for older adults with serious illnesses, with patients aged 65+ representing a growing proportion of ED visits [47]. ED encounters often represent pivotal moments in the illness trajectory of patients with advanced chronic conditions such as heart failure, COPD, cancer, and dementia [47]. Systematic palliative care screening in the ED enables early identification of patients who may benefit from palliative care consultation, potentially preventing unwanted hospitalizations and ensuring care aligns with patient goals [47]. Research indicates that emergency clinicians recognize the importance of palliative care but face significant implementation barriers including time constraints, high acuity environments, and lack of standardized protocols [47].

Application Notes and Screening Protocol

The following protocol outlines a systematic approach to palliative care screening and SDM initiation in the ED setting:

Palliative Care Screening Protocol for Older ED Patients [47]

  • Target Population: Patients aged 60+ presenting to the ED with serious, life-limiting illness (defined as chronic conditions with high expected one-year mortality that negatively affect quality of life)
  • Screening Tools: Validated instruments such as the Palliative Performance Scale (PPS), "Surprise Question" ("Would you be surprised if this patient died in the next 12 months?"), or ED-specific screening criteria
  • Trigger Criteria: Presence of one or more of the following should trigger palliative care consultation:
    • Advanced chronic illness with frequent hospitalizations (≥2 in past 6 months)
    • Functional decline (e.g., unable to perform ≥2 activities of daily living)
    • Provider answer of "No" to the Surprise Question
    • Uncontrolled physical or psychological symptoms
    • Patient/surrogate expressing desire for comfort-focused care
    • Complex decision-making needs regarding goals of care

SDM Implementation Pathway for Screen-Positive Patients [47]

  • Brief Goals of Care Exploration: ED clinician conducts focused conversation to understand patient's understanding of illness and treatment preferences
  • Palliative Care Consultation: For screen-positive patients, initiate ED-based palliative care consultation when available
  • Communication with Primary Team: Share screening results and discussion summary with receiving inpatient team or primary care provider
  • Transition Planning: Facilitate appropriate disposition (home with hospice referral, inpatient palliative care unit, or usual care) based on patient preferences and clinical needs

Table 2: Outcomes Measured in ED Palliative Care Screening Studies [47]

Outcome Category Specific Measures Clinical/Research Utility
Healthcare Utilization Inpatient length of stay, percentage of hospitalizations, ICU admission rates, 6-month re-presentation rate Measures impact on resource use and care patterns
Patient-Centered Outcomes Quality of life measures, patient and family satisfaction, symptom burden scores Assesses impact on patient experience and well-being
Clinical Outcomes Changes in code status, mortality during index encounter, goal-concordant care Evaluates alignment between treatments and patient preferences
Economic Measures Cost of care, total hospitalization charges, return on investment Determines financial impact of palliative care screening

Implementation Challenges and Research Priorities

Significant barriers to ED-based palliative care include the fast-paced environment, focus on stabilization and disposition, limited palliative care training among emergency providers, and lack of integrated palliative care resources [47]. Research priorities include determining the optimal screening tools for the ED environment, developing sustainable models for palliative care integration, understanding the impact of screening on patient outcomes, and creating effective implementation strategies for diverse ED settings [47].

Community-Based Care Applications

Clinical Context and SDM Relevance

Community-based palliative care delivers serious illness care in patients' homes, outpatient clinics, and long-term care facilities, focusing on symptom management, advance care planning, and coordination of care outside hospital settings [48]. Most people with serious illness prefer to receive care and die at home, yet healthcare systems remain hospital-centered [44] [2]. In Bangladesh, for example, while most older adults prefer home death, hospital mortality rates remain high due to limited community-based options [2]. SDM in community settings enables patients to articulate their preferences for care location, treatment priorities, and end-of-life care well before medical crises occur.

Application Notes and Implementation Framework

Community-based palliative care program implementation requires systematic approach to structure, staffing, and operations:

Core Program Components [48]

  • Interdisciplinary Team Structure: Typically includes physicians, nurse practitioners, nurses, social workers, and chaplains trained in palliative care
  • Service Delivery Model: Combination of in-home visits, telehealth encounters, and clinic-based appointments tailored to patient needs and resources
  • Operational Infrastructure: Includes screening tools for patient identification, stratification systems for visit frequency, and quality measurement frameworks

SDM Protocol for Advance Care Planning in Community Settings [44] [48]

  • Health Status Review: Discuss patient's understanding of illness, prognosis, and treatment options
  • Values and Goals Elicitation: Explore what matters most to the patient, their definition of quality of life, and their concerns about future health changes
  • Treatment Preference Discussion: Review specific decisions that may arise (hospitalization, resuscitation, artificial nutrition) and their alignment with stated goals
  • Surrogate Decision-Maker Identification: Designate a healthcare proxy and ensure they understand the patient's values and preferences
  • Documentation and Dissemination: Complete appropriate advance directive forms and ensure they are distributed to all relevant care providers

Decision-Making Factors and Implementation Strategies

Research has identified key factors influencing palliative care decision-making in community settings, which can be categorized using Andersen's Behavioral Model of Health Services Use [44]:

Table 3: Factors Influencing Community Palliative Care Decisions [44] [2] [49]

Factor Category Specific Elements Implementation Strategies
Predisposing Factors (demographics, social structure, beliefs) Age, education, household composition, prior experiences with institutional care, previous death experiences Tailor educational materials to demographic and cultural characteristics; use peer mentors for shared decision-making
Enabling Factors (resources facilitating service use) Physician disclosure of prognosis, communication partners and context, information about options, financial resources Train providers in communication skills; develop patient decision aids; address financial barriers through navigation support
Need Factors (perceived or evaluated health needs) Acknowledgement of terminal status, knowledge about palliative care, perceptions of services, EoL wishes, caregiver commitment, preference for dying at home, current health condition Implement systematic needs assessments; normalize palliative care as part of serious illness management; engage caregivers in decision-making

Research from China identifies additional implementation barriers including "families' feelings of guilt" about opting for hospice care rather than continued curative treatment, highlighting the importance of culturally sensitive approaches to community-based palliative care [49].

Community_SDM Start Patient with Serious Illness in Community Setting AssessFactors Predisposing Enabling Need Start->AssessFactors TailorApproach Tailor Communication and Education AssessFactors->TailorApproach ExploreValues Explore Values and Treatment Goals TailorApproach->ExploreValues AddressBarriers Knowledge Gaps Family Emotions Cultural Factors ExploreValues->AddressBarriers DevelopPlan Develop Personalized Care Plan AddressBarriers->DevelopPlan Document Document Preferences DevelopPlan->Document Coordinate Coordinate Care Across Settings Document->Coordinate Reassess Reassess Periodically Coordinate->Reassess

Community-Based SDM Factor Integration

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Research Tools for SDM in End-of-Life Care Studies

Tool/Instrument Application Context Function in SDM Research
REMAP Framework [46] [34] CICU, serious illness communication Structured conversation guide for goals of care discussions; research intervention for improving communication quality
Three-Talk Model [46] [34] All clinical settings SDM process model (choice talk, option talk, decision talk); framework for evaluating decision quality in interventions
Palliative Performance Scale (PPS) [48] [47] ED, community settings Functional assessment tool for identifying patients appropriate for palliative care; prognostic indicator in research protocols
Andersen's Behavioral Model [44] [49] Community-based care, health services research Theoretical framework for categorizing factors influencing healthcare utilization (predisposing, enabling, need); research model for analyzing palliative care access
Mixed Methods Appraisal Tool (MMAT) [44] Systematic reviews, evidence synthesis Quality assessment instrument for mixed methods studies; ensures methodological rigor in evidence reviews
Home Hospice Care Service Need Questionnaire [49] Community-based care, international research Validated instrument for assessing needs and barriers to hospice care utilization; outcome measure in implementation studies
Structured Advance Care Planning Conversations [48] [2] Primary care, community settings Standardized protocol for discussing future care preferences; intervention fidelity tool in communication research

Cross-Cutting Research Methodologies

Objective: Assess the efficacy of palliative care screening in the emergency department for older adults (≥60 years) on inpatient length of stay (primary outcome), quality of life, hospitalization rates, and cost of care (secondary outcomes).

Data Sources and Search Strategy:

  • Databases: Ovid MEDLINE, Embase, EBSCO CINAHL, Web of Science, Cochrane Library
  • Search Period: January 2000 - July 2025
  • Search Terms: Palliative care, hospice, decision-making, emergency service, hospital, geriatrics, mass screening, early diagnosis

Study Selection Criteria:

  • Inclusion: Original research; patients ≥60 years; ED-based palliative care screening; sample size ≥50; comparators without screening
  • Exclusion: Case reports, systematic reviews, prehospital care studies, non-peer-reviewed publications

Data Extraction and Analysis:

  • Independent duplicate review at all stages
  • Risk of bias assessment using RoB 2.0 (randomized trials) and ROBINS-I (non-randomized studies)
  • Data synthesis using random-effects meta-analysis if homogeneity sufficient; otherwise narrative synthesis
  • Subgroup analyses by screening tool type and study quality

Outcome Measures:

  • Primary: Inpatient length of stay (days from ED admission to discharge)
  • Secondary: Percentage of hospitalizations, cost of care, changes in code status, 6-month re-presentation rate, patient/caregiver satisfaction, quality of life measures

Objective: Identify and categorize factors influencing patient and family caregiver decision-making about palliative care and hospice use in community settings.

Design: Convergent parallel mixed-methods design with simultaneous quantitative and qualitative data collection.

Quantitative Component:

  • Design: Cross-sectional survey
  • Participants: Patients with terminal illness and their family caregivers
  • Instruments: Structured questionnaires including general information, service needs assessments, knowledge-attitude-practice scales
  • Analysis: Descriptive statistics, logistic regression to identify decision-making factors

Qualitative Component:

  • Design: Semi-structured interviews
  • Participants: Subset of survey participants selected by purposive sampling
  • Analysis: Thematic analysis using constant comparison approach until saturation achieved

Integration: Merge quantitative and qualitative findings using joint displays to develop comprehensive understanding of decision-making factors categorized using Andersen's Behavioral Model.

Implementation of effective shared decision-making in end-of-life care requires setting-specific approaches that account for unique clinical contexts, decision-making timeframes, and patient populations. The CICU demands structured protocols for high-stakes decisions amid critical illness, the ED benefits from systematic screening to identify palliative care needs during pivotal encounters, and community settings require attention to the complex factors influencing care preferences outside acute care hospitals. Cross-cutting these settings is the need for standardized research methodologies to evaluate SDM interventions and their impact on patient-centered outcomes. Further research should focus on developing validated decision aids, understanding implementation barriers, and testing strategies to ensure care aligns with patient values and goals across the spectrum of serious illness.

International Patient Decision Aid Standards (IPDAS) for Tool Development and Validation

The International Patient Decision Aid Standards (IPDAS) Collaboration was established in 2003 to enhance the quality and effectiveness of patient decision aids by creating an evidence-informed framework for improving their content, development, implementation, and evaluation [50]. Patient decision aids are tools designed to help people participate in decision making about health care options, providing information about available choices and helping patients construct, clarify, and communicate the personal values they associate with different features of these options [50]. In the specific context of end-of-life (EoL) care research, these tools play a critical role in supporting shared decision-making between patients, families, and healthcare providers during highly sensitive and emotionally charged medical decisions.

The theoretical foundation for IPDAS is rooted in shared decision-making, defined as an approach where clinicians and patients make decisions together using the best available evidence [50]. This process emphasizes respect for patient autonomy and promotes patient engagement by encouraging patients to consider available screening or treatment options and the likely benefits and harms of each option [50]. Within palliative and end-of-life care, systematic reviews have demonstrated that decision aids developed using IPDAS guidelines consistently report positive outcomes including reduced decisional conflict, improved knowledge, enhanced communication, and increased alignment between patient preferences and care received [51].

Core IPDAS Dimensions and Validation Frameworks

Evolution of IPDAS Quality Dimensions

The IPDAS framework has evolved significantly since its inception, progressing through three distinct developmental phases. Between 2003-2006, the collaboration established the original IPDAS Checklist through a modified Delphi consensus process involving over 100 stakeholders from 14 countries [50]. This initial version identified 12 core dimensions for assessing decision aid quality and resulted in a 74-item checklist. From 2006-2009, the collaboration developed the IPDAS Instrument (IPDASi), refining criteria to 47 items across 10 dimensions with a 4-point rating scale to enable quantitative assessment of decision aid quality [50]. During the 2009-2013 period, the collaboration established minimal standards for certifying patient decision aids, defining qualifying, certification, and quality criteria through expert consensus [50].

The current IPDAS Minimal Criteria Instrument represents the most recent evolution of these standards, providing a validated tool for assessing whether patient decision aids meet essential quality thresholds [52]. The validation of this instrument for non-English speaking populations, including recent translation and cultural adaptation for Portuguese-speaking contexts, demonstrates the ongoing globalization of IPDAS standards [52]. The quantitative validation metrics for this instrument show strong content validity, with item-level content validity indices (I-CVI) >0.79 and scale-level content validity indices (S-CVI/Ave) of 0.97 [52].

IPDAS Quality Dimensions and End-of-Life Care Applications

Table 1: Core IPDAS Dimensions and Their Relevance to End-of-Life Care Decision Aids

IPDAS Dimension Description EoL Care Application Validation Metrics
Information Provision Presenting evidence-based information about options, benefits, harms, probabilities Providing balanced information about aggressive treatment vs. palliative care options [51] Knowledge improvement scores [51]
Values Clarification Helping patients consider which benefits/harms matter most Eliciting preferences about quality vs. quantity of life [4] Decisional conflict scale reductions [51]
Decision Support Guiding patients in decision-making processes Supporting complex EoL decisions amid emotional distress [2] Satisfaction with decision scale [51]
Development Process Systematic development with user testing Incorporating perspectives of patients, families, and multicultural values [52] [2] Content validity indices (I-CVI, S-CVI/Ave) [52]
Evidence Quality Using current, unbiased, referenced evidence Translating prognostic uncertainty into understandable information [51] Inter-rater reliability measures [50]
Disclosure Clear disclosure of conflicts of interest and funding Ensuring transparency in goals of care conversations [50] Expert panel assessment [52]
Plain Language Presenting information in understandable format Adapting complex medical terminology for vulnerable patients [52] Readability scores, user testing results [52]

Experimental Protocols for IPDAS Tool Development and Validation

Protocol 1: Cross-Cultural Translation and Adaptation

The linguistic validation process for IPDAS instruments follows a structured methodology essential for maintaining methodological rigor across different populations [52].

Materials and Reagents:

  • Original validated IPDAS instrument (English version)
  • Forward translation templates
  • Back-translation protocols
  • Expert panel evaluation forms
  • Pilot testing instruments (clarity and relevance scales)

Methodology:

  • Forward Translation: Two bilingual experts independently translate the instrument from source to target language [52].
  • Synthesis Meeting: Translators and researchers reconcile differences through discussion and create a consensus version [52].
  • Back Translation: An independent bilingual translator blinded to the original instrument translates the synthesized version back to the source language [52].
  • Expert Committee Review: A multidisciplinary team including methodologists, language professionals, and healthcare providers reviews all translations and makes final revisions [52].
  • Content Validation: A panel of 10+ experts evaluates clarity and relevance using dichotomous clarity scales and 4-point relevance scales [52].
  • Pilot Testing: The adapted instrument is tested with target end-users to assess comprehensibility and cultural appropriateness [52].

Validation Metrics:

  • Percentage agreement among experts
  • Fleiss' kappa for interrater reliability
  • Item-level content validity indices (I-CVI)
  • Scale-level content validity indices (S-CVI/Ave) [52]
Protocol 2: Effectiveness Evaluation for End-of-Life Decision Aids

Study Design: Systematic review with quantitative, qualitative, and mixed-methods synthesis following PRISMA guidelines [51].

Search Strategy:

  • Databases: PubMed, CINAHL, ProQuest Federated, PsycInfo
  • Keywords: "decision aid" OR "decision tool" combined with "end of life," "palliative care," "hospice," "terminally ill," or "advance care planning" [51]
  • Inclusion: Studies evaluating EoL care decision aids for patients with or without specific diseases [51]

Data Extraction:

  • Decision aid name, description, format (video, online, paper-based)
  • Study population disease focus
  • Country and study design
  • Outcomes measured (decisional conflict, knowledge, communication, care preferences)
  • IPDAS usage in development [51]

Quality Assessment:

  • Mixed Methods Appraisal Tool (MMAT) 2018 version
  • Rating: low (<75% criteria met), medium (76%-86%), high (>86%) [51]

Outcome Measures:

  • Decisional conflict using validated scales
  • Knowledge improvements through pre/post testing
  • Communication quality through observer ratings or participant reports
  • Preference concordance between desired and received care
  • Tool satisfaction via Likert scales [51]

G cluster_0 IPDAS Development Process cluster_1 Validation & Testing start Identify Research Need for EoL Decision Aid dev Decision Aid Development Phase start->dev ipdas Apply IPDAS Framework (12 Core Dimensions) dev->ipdas dev->ipdas format Select Appropriate Format (Video, Online, Paper, Interview) ipdas->format ipdas->format validate Initial Validation format->validate trial Effectiveness Evaluation (RCT, Mixed Methods) validate->trial validate->trial outcomes Measure Key Outcomes trial->outcomes trial->outcomes implement Implementation & Dissemination outcomes->implement

Figure 1: IPDAS Development and Validation Workflow for EoL Care Decision Aids

Research Reagents and Methodological Tools

Table 2: Essential Research Reagents for IPDAS-Compliant Decision Aid Development

Research Reagent/Tool Function/Purpose Application in EoL Research Validation Evidence
IPDAS Minimal Criteria Instrument Assesses whether decision aids meet essential quality standards [52] Quality appraisal of existing EoL decision aids; development guidance Content validity indices >0.79; S-CVI/Ave 0.97 [52]
Decisional Conflict Scale Measures uncertainty in decision making; assesses decision aid effectiveness [51] Evaluating impact of EoL decision aids on decision-related uncertainty Used in 39.5% of decision aid studies; shows significant reductions [51]
Mixed Methods Appraisal Tool (MMAT) 2018 Quality assessment of quantitative, qualitative, and mixed-methods studies [51] [4] Systematic reviews of EoL decision aid literature; study quality evaluation Used in major systematic reviews of EoL decision aids [51] [4]
Structured Interview Guides Qualitative assessment of decision aid usability and acceptability [52] Eliciting patient, family, and provider perspectives on EoL decision aids Part of cultural adaptation protocols; identifies unclear content [52]
Knowledge Assessment Surveys Measures understanding of options, benefits, harms [51] Evaluating information transfer in EoL decision contexts Used in 34.9% of decision aid studies; shows significant improvements [51]

Data Synthesis and Outcome Analysis

Quantitative Outcomes of IPDAS-Compliant Decision Aids

Table 3: Effectiveness Metrics for End-of-Life Care Decision Aids Developed Using IPDAS Standards

Outcome Measure Number of Studies Reporting Effect Size/Direction Statistical Significance Clinical Relevance
Reduced Decisional Conflict 17/43 studies (39.5%) [51] Significant reductions in conflict scores p<0.05 in majority of studies Helps patients feel more certain, informed, and supported in decisions
Knowledge Improvement 15/43 studies (34.9%) [51] Increased understanding of options and outcomes p<0.01 in most quantitative studies Enhances informed consent and preference-based decision making
Communication Enhancement 15/43 studies (34.9%) [51] Improved patient-provider dialogue Qualitative and quantitative support Facilitates shared decision-making processes
Preference for Less Aggressive Care 14/43 studies (33.0%) [51] Increased preference for comfort-focused care p<0.001 in several RCTs Reduces unwanted medical interventions at end of life
Tool Satisfaction 8/43 studies (18.6%) [51] High ratings of usability and helpfulness Consistent positive feedback Supports implementation and adherence
Completion of Advance Directives 6/43 studies (14.0%) [51] Higher rates of documentation Significant in multiple studies Ensures care aligns with patient values
Contextual Factors in End-of-Life Decision Aid Implementation

The effectiveness of decision aids in end-of-life care is moderated by several contextual factors identified through systematic reviews. Cultural norms significantly influence decision-making processes, with studies in Bangladesh showing profound disparities in EoL awareness and preferences across healthcare settings [2]. In many Asian cultures, families may shield patients from their prognosis, complicating decision-making processes [2]. Socioeconomic factors and healthcare infrastructure also play critical roles, with low- and middle-income countries facing challenges in providing adequate EoL care due to limited resources and focus on acute rather than palliative care [2].

The application of Andersen's Behavioral Model of Health Services Use provides a theoretical framework for understanding decision-making factors in palliative care utilization [4]. Systematic reviews have identified 16 key factors influencing decisions to use palliative care or hospice, categorized as:

  • Predisposing Factors: Age, education level, household composition, institutional care experiences, and previous death experiences [4]
  • Enabling Factors: Physician disclosure of prognosis, communication partners, communication context, and information about available options [4]
  • Need Factors: Acknowledgement of terminal status, knowledge and perceptions of care options, end-of-life wishes, caregiver commitment, preference for dying at home, and current health condition [4]

G cluster_predisposing Individual Characteristics cluster_enabling Resources & Context cluster_need Perceived & Evaluated Needs predisposing Predisposing Factors (Age, Education, Experience) decision Decision to Use Palliative Care/Hospice predisposing->decision enabling Enabling Factors (Communication, Information) enabling->decision need Need Factors (Knowledge, Preferences, Health Status) need->decision outcome Patient-Centered EoL Care Outcomes decision->outcome

Figure 2: Factors Influencing Palliative Care Decision-Making Based on Andersen's Behavioral Model

Implementation Protocols for Research and Clinical Practice

Protocol 3: Implementing IPDAS Standards in End-of-Life Care Research

Study Planning Phase:

  • Define Decision Context: Clearly specify the EoL decision point (e.g., hospice enrollment, ventilator support, chemotherapy discontinuation).
  • Stakeholder Engagement: Involve patients, families, clinicians, and community representatives from the outset using structured engagement protocols [52].
  • Regulatory Review: Address ethical considerations in EoL research, including protocols for patients with fluctuating decision-making capacity.

Tool Development Phase:

  • Evidence Synthesis: Systematically review current evidence on options, outcomes, probabilities, and uncertainties specific to the decision context.
  • Values Clarification Exercises: Develop and test exercises that help patients articulate preferences about quality versus quantity of life.
  • Iterative Prototyping: Create decision aid prototypes and conduct usability testing with diverse patient populations.

Validation Phase:

  • Content Validation: Convene expert panels including palliative care specialists, communication experts, and methodologists to assess content validity [52].
  • Field Testing: Conduct cognitive interviews and pilot tests with target patients to assess comprehensibility, emotional responsiveness, and usability.
  • Outcome Validation: Establish reliability and validity of outcome measures specific to EoL decision contexts.

Implementation Phase:

  • Clinician Training: Develop and deliver training for healthcare providers on decision aid use and shared decision-making skills.
  • System Integration: Identify and address barriers to implementation within clinical workflows and electronic health record systems.
  • Evaluation Framework: Establish metrics for monitoring decision aid impact on patient outcomes, resource utilization, and quality of care.

The rigorous application of IPDAS standards to end-of-life care decision aid development and validation provides a critical methodology for enhancing shared decision-making in this sensitive context. Evidence consistently demonstrates that IPDAS-compliant tools improve the quality of decisions while respecting patient values and autonomy, ultimately contributing to more person-centered end-of-life care across diverse clinical and cultural settings.

Shared decision-making (SDM) is a model of patient-centered care that encourages patients and clinicians to work together to reach medical decisions by weighing the risks and benefits of various options within the context of the patient's values and goals [24] [53]. In end-of-life (EoL) care, which constitutes the final phase of life when death is imminent, this process is particularly crucial [2]. EoL care is distinct from, but related to, palliative care, which provides broader support for serious illness [2]. The integration of SDM tools directly into a clinician's workflow within the Electronic Health Record (EHR) is a logical approach for promoting SDM in routine clinical practice, especially for complex EoL decisions [24] [53]. This document provides application notes and detailed protocols for researchers and clinicians aiming to implement and study SDM in EoL care contexts.

Application Notes: Protocols for EHR Integration

Integrating SDM into EHR systems requires careful planning around technical, workflow, and human factors. The following protocols are based on successful implementations documented in the literature.

Structured Documentation Protocol using Templated Notes

The use of structured note templates within the EHR has proven highly effective for standardizing and increasing the documentation of SDM conversations.

Detailed Methodology:

  • Template Design: Create a structured note template accessible via a dot phrase or smart-text within the EHR. This template should contain dedicated fields for the core components of an EoL SDM discussion [54].
  • Core Data Elements: The template must capture:
    • Patient Values/Goals: A structured field for documenting the patient's expressed goals, values, and preferences concerning EoL care (e.g., preferences for location of death, desired comfort level, priorities for remaining life) [24] [2].
    • Options Reviewed: A checklist or free-text area to document the specific medical options discussed (e.g., continued curative treatment, transition to hospice, various palliative procedures).
    • Risks/Benefits Discussed: Documentation that the potential benefits, risks, and uncertainties of each option were communicated and understood [54].
    • Decision Aid Use: A field to record if a patient decision aid was used, including the specific aid and how it was delivered [24].
    • Final Consensus Plan: A clear summary of the agreed-upon care plan [54].
  • Workflow Integration: Embed the trigger for this template into relevant workflow points, such as the clinic note for a scheduled EoL planning visit or a dedicated "SDM Conversation" note type [24].

Protocol for SDM Tool Implementation and Awareness

Successful integration requires more than just a technical tool; it demands a concerted implementation effort to promote awareness and use among clinicians.

Detailed Methodology:

  • Pre-Implementation Education: Before launching the EHR tool, conduct educational sessions with all clinical stakeholders (physicians, nurses, etc.). These sessions should cover [54]:
    • The evidence base for SDM in EoL care.
    • The specific clinical guidelines relevant to the decision (e.g., for palliative sedation, hospice eligibility).
    • A walkthrough of the new EHR template and its intended workflow.
  • Ongoing Audit and Feedback: Implement a quarterly audit of EHR data to track the usage rate of the SDM template and the completeness of documentation. Report these findings back to clinical teams and leadership to identify barriers and reinforce use [24] [54].
  • Target Established Processes: Enhance adoption by linking the SDM tool to established clinical processes, such as annual wellness visits for patients with advanced chronic illnesses or triggered consultations for oncology patients meeting specific prognostic criteria [24].

Experimental Protocols for SDM Research

For researchers studying the impact of EHR-integrated SDM, the following methodological protocols provide a framework for rigorous investigation.

Protocol for a Quality Improvement (QI) Study on SDM Documentation

This protocol is modeled on a successful QI project that increased SDM documentation for prostate cancer screening [54].

Detailed Methodology:

  • Setting and Population: The study should be conducted in a real-world clinical setting (e.g., a primary care or palliative care clinic). The target population is patients with a life expectancy of less than one year due to a chronic or advanced illness [54] [2].
  • Baseline Data Collection:
    • Cohort Identification: Use the EHR to identify a random sample of eligible patients from a defined period prior to the intervention (e.g., 6 months). The sample size should be calculated for sufficient statistical power [54].
    • Chart Review: Manually review the charts in this baseline cohort to determine the pre-intervention rate of SDM documentation. Use a standardized data extraction form to ensure consistency.
  • Intervention: Implement the structured EHR note template and the clinician education program as described in Section 2.
  • Post-Intervention Data Collection: After a set implementation period (e.g., 6 months), identify a new random cohort of eligible patients. Conduct the same standardized chart review to determine the post-intervention documentation rate.
  • Outcome Measures:
    • Primary Outcome: The percentage of patients with documented SDM conversations in the EHR.
    • Secondary Outcomes: May include the percentage of patients with documented care preferences, rates of hospice referral, or patient/family satisfaction scores from surveys.
  • Statistical Analysis: Use comparative statistics, such as chi-squared tests, to analyze the difference in documentation rates before and after the intervention. A p-value of <0.05 is typically considered statistically significant [54].

This protocol is adapted from a study conducted in Bangladesh to assess EoL care awareness and decision-making factors, a methodology directly applicable to research in other settings [2].

Detailed Methodology:

  • Study Design: A cross-sectional study using structured surveys.
  • Study Population and Sampling: Employ a stratified sampling technique to ensure proportional representation from different administrative regions or healthcare settings (e.g., public hospitals, private hospitals, community care) [2]. The target population includes patients aged ≥50 years with chronic or advanced illnesses and a life expectancy of <1 year.
  • Sample Size Calculation: Use a standard formula for a single population proportion: n0 = Z² * p * (1-p) / e², where Z is the Z-score (1.96 for 95% CI), p is the estimated prevalence of the characteristic of interest (from prior literature or a census), and e is the margin of error. This initial size should then be inflated to account for the design effect of stratified sampling [2].
  • Data Collection Tool: Develop a structured questionnaire by synthesizing and adapting items from validated international tools, such as national EoL surveys or palliative care assessments. The questionnaire should capture [2]:
    • Socio-demographic characteristics.
    • Awareness of palliative and EoL care options.
    • Preferences for place of care and place of death.
    • Experiences and satisfaction with decision-making processes.
    • Barriers to documenting EoL preferences (e.g., cultural norms, lack of resources).
  • Data Analysis: Use multiple logistic regression analysis to identify predictors of key EoL preferences (e.g., preference for home death, desire to avoid hospitalization). Results are typically reported as Odds Ratios (OR) with confidence intervals and p-values [2].

Quantitative Outcomes and Data Presentation

The table below summarizes quantitative findings from key studies, providing a benchmark for researchers.

Table 1: Quantitative Outcomes from SDM and EoL Care Implementation Studies

Study Focus / Metric Pre-Intervention or Baseline Rate Post-Intervention or Comparative Rate Context & Population
SDM Documentation [54] 7.1% 37.2% (p<0.001) PSA screening in primary care (QI study)
PSA Screening Uptake [54] 31.5% 37.8% (p=0.155) Post-SDM conversation in primary care
Patient Declining Screening [54] Not Reported 49.3% After SDM conversation for PSA testing
Palliative Care Awareness [2] N/A Private: 70%Public: 31%Community: 7.1% Critically ill patients in Bangladesh
Preference for Home Care [2] N/A OR = 2.96 (p=0.004) Associated with age ≥60 years

Visualization of SDM Integration Workflow

The following diagram, generated using Graphviz DOT language, illustrates the logical workflow and key decision points for implementing and researching EHR-integrated SDM in EoL care.

sdm_workflow EHR SDM Implementation Workflow start Identify Patient with Advanced Illness assess Assess Eligibility for EoL SDM Discussion start->assess trigger EHR System Triggers SDM Workflow assess->trigger Eligible load_template Load Structured SDM Note Template trigger->load_template conduct_sdm Conduct SDM Conversation load_template->conduct_sdm use_aid Use Patient Decision Aid & Discuss Values conduct_sdm->use_aid document Document Conversation in EHR Template use_aid->document update_plan Update Care Plan with Preferences document->update_plan research Research: Extract Data for Analysis update_plan->research outcome_metrics Measure Outcomes: Documentation, Adherence research->outcome_metrics

The Scientist's Toolkit: Research Reagent Solutions

For researchers designing studies in this domain, the following table details the essential "research reagents" or core components required for a robust investigation.

Table 2: Essential Toolkit for SDM and EoL Care Research

Item / Tool Type / Category Function in Research
Structured EHR Note Template [24] [54] Data Collection Tool Standardizes the recording of SDM conversations, ensuring key data points (values, options, decisions) are captured uniformly for analysis.
Validated SDM Measurement Scales [24] Assessment Metric Provides quantitative measures of the SDM process (e.g., SDM-Q-9, CollaboRATE) to assess the intervention's fidelity and quality.
Patient Decision Aids [24] [53] Intervention Tool Standardized tools (e.g., based on International Patient Decision Aid Standards) used within the SDM process to explain options and clarify patient values.
Adapted EoL Survey Instrument [2] Data Collection Tool A contextually adapted questionnaire, synthesized from validated international tools, to measure patient awareness, preferences, and experiences.
Chart Review & Data Extraction Form [54] Data Collection Tool A standardized protocol for manually reviewing electronic health records to extract pre- and post-intervention data on documentation and outcomes.

Overcoming Implementation Barriers and Optimizing SDM in Complex End-of-Life Scenarios

Within the context of end-of-life (EoL) care research, shared decision-making (SDM) models represent a collaborative process where patients, families, and clinicians work together to make medical decisions aligned with patient values and goals [34]. System-level barriers significantly impede the consistent implementation and effectiveness of these models, often resulting in care that is misaligned with patient preferences [2] [55]. This application note synthesizes current evidence on three critical system-level barriers—resource limitations, time constraints, and documentation gaps—and provides structured protocols for researchers investigating interventions to overcome these challenges in palliative and EoL care settings.

Quantitative Analysis of System-Level Barriers

Data from recent studies across diverse healthcare settings reveal pronounced disparities in resource allocation and systemic capabilities that directly impact SDM. The following table summarizes key quantitative findings:

Table 1: Documented System-Level Barriers in End-of-Life Care Settings

Barrier Category Setting/Context Quantitative Findings Impact on Shared Decision-Making
Resource Limitations Healthcare settings in Bangladesh [2] Palliative care awareness: 70% (private hospitals) vs. 7.1% (community settings); Only 6.93% had health insurance Creates fundamental inequity in access to SDM conversations and palliative care options
Critical Care Units (Integrative Review) [33] Limited availability of trained healthcare professionals, especially in rural/underserved regions Reduces capacity for specialized palliative care discussions and follow-up
Documentation Gaps Emergency Departments (U.S.) [55] While ~50% of older patients reported having a healthcare proxy, only 4% had documentation in electronic medical records Undermines SDM during critical moments when patients cannot communicate
Community Settings in Bangladesh [2] Advance care planning awareness and documentation were lowest in community patients (p < 0.01) Eliminates foundation for value-concordant care decisions during health crises
Structural & Process Barriers ICU Palliative Care (Meta-Aggregation) [56] 534 findings from 31 articles identified communication models, environmental factors, and resource availability as key barriers Impedes consistent application of SDM across different clinical environments

Experimental Protocols for Barrier Assessment

To standardize research in this field, the following protocols provide methodologies for quantifying and analyzing system-level barriers to SDM in EoL care.

Protocol 1: Multi-Setting Barrier Assessment in Resource-Limited Contexts

Application: This cross-sectional study protocol is adapted from research conducted in Bangladesh [2] and is designed to assess system-level barriers across diverse healthcare settings.

Methodology:

  • Study Design: Cross-sectional study with stratified sampling
  • Setting: Eight administrative divisions encompassing private hospitals, public hospitals, and community settings
  • Participants: 1,270 patients aged ≥50 years with chronic or advanced illnesses
  • Data Collection Tools: Structured questionnaires adapted from validated international instruments (National End of Life Survey, Pallium Canada Palliative Medicine Survey, Australian Commission on Safety and Quality in Health Care's Clinician Surveys)
  • Key Variables:
    • Palliative care awareness (measured as percentage aware of services)
    • Advance care planning documentation rates
    • Preference for home care vs. hospitalization
    • Health insurance coverage
    • Trust in healthcare providers
  • Statistical Analysis: Multiple logistic regression analysis to examine predictors of EoL preferences (e.g., home care preference, documentation completion)

Implementation Notes:

  • Translation should follow WHO-recommended procedures: forward translation by bilingual experts, reconciliation by panel review, and back-translation
  • Pilot testing with 25 patients across settings is recommended to ensure comprehensibility
  • Sampling should ensure proportional representation from each administrative division based on elderly population size

Protocol 2: System-Level Barrier Identification in Critical Care Settings

Application: This integrative review methodology is designed to synthesize evidence on barriers affecting quality EoL care from nursing perspectives [33].

Methodology:

  • Search Strategy:
    • Databases: MEDLINE, Cochrane Central Register of Controlled Trials, CINAHL, EBSCO, ScienceDirect
    • Timeframe: 2010-2023
    • Search Terms: MeSH descriptors "end-of-life care," "barriers," and "critical care nurses" combined with "AND"/"OR"
  • Inclusion Criteria:
    • Full-text English articles
    • Studies addressing barriers perceived by critical care nurses
    • Both qualitative and quantitative study designs
  • Quality Appraisal: Mixed Method Appraisal Tool (MMAT) completed by two independent reviewers
  • Data Extraction & Analysis:
    • Thematic analysis approach combining deductive and inductive elements
    • Categorization into three predefined themes: (1) patient/family-related barriers, (2) nurse-related barriers, and (3) healthcare institution/environment-related barriers
    • Identification of interaction effects between barrier categories

Implementation Notes:

  • Hand-search reference lists of identified articles for additional relevant studies
  • For studies including nurses and other healthcare workers, extract and analyze only nurse-specific data
  • Focus on capturing the cumulative impact of multiple barriers on care quality

Conceptual Framework of System-Level Barriers

The relationship between system-level barriers and their impact on SDM outcomes can be visualized through the following conceptual framework:

G cluster_central Shared Decision-Making in End-of-Life Care cluster_barriers System-Level Barriers cluster_impacts Care Outcomes cluster_mediating SDM Quality of Shared Decision-Making PREFERENCE Care Alignment with Patient Preferences SDM->PREFERENCE SATISFACTION Patient/Family Satisfaction SDM->SATISFACTION QUALITY Perceived Quality of Care SDM->QUALITY RESOURCE Resource Limitations RESOURCE->SDM AWARENESS Palliative Care Awareness RESOURCE->AWARENESS ACCESS Equitable Access to Palliative Services RESOURCE->ACCESS TIME Time Constraints TIME->SDM DISCUSSIONS Timely Goals-of-Care Discussions TIME->DISCUSSIONS DOCUMENT Documentation Gaps DOCUMENT->AWARENESS COMMUNICATION Communication Challenges COMMUNICATION->DISCUSSIONS TRAINING Training Deficiencies TRAINING->DISCUSSIONS AWARENESS->SDM DISCUSSIONS->SDM ACCESS->SDM

System-Level Barrier Impact on Shared Decision-Making

This framework illustrates how system-level barriers directly and indirectly impact the quality of shared decision-making through mediating factors such as awareness, timely discussions, and equitable access.

Research Reagent Solutions for Barrier Investigation

To facilitate rigorous research into system-level barriers, the following table outlines essential methodological tools and their applications:

Table 2: Research Reagent Solutions for System-Level Barrier Investigation

Research Tool Category Specific Instrument/Approach Application in Barrier Research Key Advantages
Validated Survey Instruments Structured questionnaires from National End of Life Survey (Ireland) [2] Cross-cultural assessment of palliative care awareness and documentation gaps Enables cross-national comparisons; pre-validated items
Pallium Canada Palliative Medicine Survey [2] Measuring healthcare provider knowledge and system preparedness Specifically designed for palliative care contexts
Qualitative Methodologies Thematic synthesis approach [57] Identifying emergent themes in barriers to comfort care transitions Systematic categorization of complex, interacting factors
Meta-aggregation for qualitative synthesis [56] Integrating perspectives of providers, patients, and families on ICU palliative care Tripartite perspective captures comprehensive insights
Implementation Frameworks REMAP framework (Reframe, Expect emotion, Map goals, Align, Propose) [34] Structuring goals-of-care conversations in time-constrained environments Provides concrete communication protocol for clinical settings
Three-Talk Model (Choice talk, Option talk, Decision talk) [34] Standardizing shared decision-making processes across varied settings Clear, teachable model for clinician training
Statistical Analysis Methods Multiple logistic regression analysis [2] Identifying predictors of EoL preferences and documentation completion Controls for confounding variables in multi-factorial systems
Mixed Method Appraisal Tool (MMAT) [33] Quality assessment of diverse study designs in integrative reviews Standardized approach for evaluating methodological quality

System-level barriers—particularly resource limitations, time constraints, and documentation gaps—represent formidable challenges to implementing effective shared decision-making in end-of-life care. The protocols and frameworks presented herein provide researchers with standardized approaches to investigate these barriers and develop targeted interventions. Future research should focus on adapting these investigation methods to diverse cultural and healthcare contexts, with particular attention to resource-limited settings where these barriers are most pronounced. By employing rigorous, comparable methodologies, the research community can generate actionable evidence to inform health system reforms that truly support patient-centered care at the end of life.

Quantitative Data on End-of-Life Care Experiences and Quality Indicators

The following tables synthesize key quantitative findings from recent studies on end-of-life care, highlighting variations in care experiences across settings and patient populations.

Table 1: Care Experience Ratings by Setting in the Last 3 Months of Life (Based on Caregiver Surveys, n=1153) [58]

Domain of Support Residential Hospice (% Excellent/Very Good) Home Care (% Excellent/Very Good) Hospital (% Excellent/Very Good) Cancer Center (% Excellent/Very Good)
Relief of Physical Pain 89% 47% 48% 54%
Relief of Other Symptoms 87% 45% 45% 51%
Emotional Support 85% 42% 40% 48%
Spiritual Support 84% 40% 37% 46%

Table 2: Quality Indicators of Palliative and End-of-Life Care by Illness Trajectory (2002-2016, Quebec, n=595,263) [59]

Quality Indicator Cancer (Trajectory I) Organ Failure (Trajectory II) Frailty/Dementia (Trajectory III)
Death in Acute Care Bed (No PEoLC services) 21.4% (in 2016, down from 39.6% in 2002) Data not specified in excerpt Data not specified in excerpt
At least one ER visit in last 14 days of life Data not specified Data not specified Data not specified
ER visit on the day of death 12.0% 20.9% 6.4%
At least one ICU admission in last month of life Data not specified Data not specified Data not specified

Experimental Protocols and Methodologies

Protocol for the CaregiverVoice Survey: Assessing End-of-Life Care Experiences

This protocol is adapted from a study capturing bereaved caregivers' perceptions of care across multiple settings [58].

1. Objective: To quantitatively assess the quality of end-of-life care experienced by patients in their last 3 months of life across various care settings (e.g., residential hospice, home care, hospital) from the perspective of bereaved caregivers.

2. Study Design:

  • Type: Retrospective, observational survey.
  • Population: Bereaved caregivers of decedents who died in a residential hospice.
  • Inclusion Criteria: Caregivers must be able to read and write in English. A minimum of 6 weeks post-bereavement is required before contact is initiated.

3. Data Collection Instrument:

  • Tool: The CaregiverVoice survey, a 62-item instrument [58].
  • Basis: Modified from the validated VOICES (Views of Informal Carers—Evaluation of Services) instrument [58].
  • Domains: Assesses relief of physical pain, relief of other symptoms, spiritual support, emotional support, and overall care.
  • Scale: 5-point Likert scale (1 = Excellent, 2 = Very Good, 3 = Good, 4 = Fair, 5 = Poor).
  • Properties: Internal consistency for support domains ranges from α = .81 to .93. Concurrent validity against the FAMCARE scale is r_s = 0.66 (P < .001) [58].
  • Administration: Available in paper and online formats (using platforms like LimeSurvey) with skip logic to enhance respondent relevance.

4. Recruitment and Procedure:

  • Identification: Hospices identify caregivers retroactively (for deaths in past 6 months) and prospectively (for new deaths).
  • Contact: Initial phone contact to introduce the survey and determine preference for paper or online version.
  • Distribution: Survey or link is mailed to the caregiver.
  • Follow-up: A reminder letter is sent approximately two weeks later.

5. Data Analysis:

  • Statistical Software: Data analyzed using SPSS or similar (e.g., version 23.0) [58].
  • Primary Analysis: Descriptive statistics (frequencies, percentages) to summarize caregiver/patient characteristics and perceptions of services.
  • Comparative Analysis: Cochran-Armitage test for trend to compare ordinal ratings (e.g., hospice vs. other settings in the last week of life). A P-value of ≤ .05 is considered statistically significant.

Protocol for Population-Level Analysis of Palliative Care Quality Indicators

This protocol is based on a study assessing temporal trends in Palliative and End-of-Life Care (PEoLC) using administrative data [59].

1. Objective: To assess trends and compare quality indicators of PEoLC experienced by people dying of cancer, organ failure, and frailty/dementia over a multi-year period.

2. Study Design:

  • Type: Retrospective, population-based study using linked administrative databases.
  • Data Sources: Quebec's Integrated Chronic Disease Surveillance System (QICDSS), which links [59]:
    • Health insurance registry (demographics, eligibility).
    • Physician claims database (billed services).
    • Hospitalization discharge database.
    • Vital statistics death database.
    • (Optional) Pharmaceutical services database (for seniors).

3. Study Population:

  • Inclusion: Adult residents (≥18 years) who died from an illness that would have made them likely to benefit from PEoLC, based on the principal cause of death from death certificates (using specific ICD-10 codes) [59].
  • Classification: Decedents are classified into one of three illness trajectories based on the cause of death [59]:
    • Trajectory I: Cancer.
    • Trajectory II: Organ failure (e.g., heart disease, COPD).
    • Trajectory III: Frailty and dementia.

4. Indicator Definitions and Measurement: Indicators are measured in the last month of life.

  • Home Deaths: Identified via a specific code in the vital statistics death database [59].
  • Deaths in Acute Care Beds with No PEoLC: Identified by combining vital statistics (location of death) with the hospitalization database (absence of palliative care bed designation during the terminal hospitalization) [59].
  • ER Visits (last 14 days/day of death): Identified through specific billing codes for ER services in the physician claims database, cross-referenced with the date of death [59].
  • ICU Admissions (last month of life): Identified via the hospitalization database, which records ICU stays per hospitalization. An admission is counted if a hospitalization occurred in the last month and included an ICU stay [59].

5. Data Analysis:

  • Primary Analysis: Calculation of proportions for each quality indicator by year of death and illness trajectory.
  • Presentation: Results are presented as unstandardized annual percentages for each indicator and trajectory.

Visualizations: Pathways and Workflows

Conceptual Framework for Shared Decision-Making in EOLC

This diagram illustrates the integrated role of Communication Skills Training and Interprofessional Collaboration within a shared decision-making model for end-of-life care.

ProviderTraining Provider Challenges: Communication & Collaboration CST Communication Skills Training ProviderTraining->CST IPC Interprofessional Collaboration ProviderTraining->IPC SharedUnderstanding Shared Understanding of Patient Values & Goals CST->SharedUnderstanding IPC->SharedUnderstanding CarePlan Integrated Care Plan SharedUnderstanding->CarePlan Outcomes Improved EOLC Outcomes: Care Experience & Quality CarePlan->Outcomes

Caregiver Voice Survey Research Workflow

This diagram outlines the sequential workflow for conducting end-of-life care experience research using the CaregiverVoice survey.

Step1 1. Identify & Approve (Caregivers via Hospices, Ethics Board) Step2 2. Initial Contact & Consent (Phone, 6+ weeks post-bereavement) Step1->Step2 Step3 3. Distribute Survey (Paper or Online Link via Mail) Step2->Step3 Step4 4. Follow-up & Reminder (Letter at ~2 weeks) Step3->Step4 Step5 5. Data Collection & Entry (LimeSurvey Platform) Step4->Step5 Step6 6. Quantitative Analysis (SPSS: Descriptive Stats, Trend Tests) Step5->Step6 Step7 7. Outcome: Comparative Care Experience Ratings Step6->Step7

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Tools and Instruments for End-of-Life Care Research

Item / Tool Function / Application in EOLC Research
CaregiverVoice Survey A validated 62-item instrument for quantitatively assessing bereaved caregivers' perceptions of the quality of end-of-life care across multiple domains (symptom relief, emotional support) and care settings. It is a modification of the VOICES survey [58].
VOICES (Views of Informal Carers—Evaluation of Services) The foundational survey instrument used in the National Survey of Bereaved People in England, upon which the CaregiverVoice and other similar tools are built [58].
FAMCARE Scale A gold-standard, widely used satisfaction questionnaire for end-of-life care. Used to establish the concurrent validity of new or adapted instruments like the CaregiverVoice survey [58].
Linked Administrative Databases (e.g., QICDSS) Integrated systems (e.g., combining death registries, hospitalization records, physician claims) that enable population-level, retrospective analysis of PEoLC indicators such as place of death and acute care service use at end-of-life [59].
ICD-10 Codes The international standard for classifying causes of death and diseases. Used to identify and categorize decedents into specific illness trajectories (e.g., cancer, organ failure) for comparative analysis in population studies [59].
LimeSurvey / SPSS LimeSurvey: An open-source online survey application used for deploying and managing digital surveys and collecting responses on a secure server [58]. SPSS: A statistical software package (e.g., version 23.0) used for quantitative data analysis, including descriptive statistics and significance testing [58].

Application Notes

Quantitative Analysis of Decision-Making Consistency

Table 1: Consistency Between Patient Preferences and End-of-Life Care Received [60]

Consistency Category Number of Patients Percentage 95% Confidence Interval
Care consistent with written preferences 24 53.3% 38.6% to 67.4%
Care inconsistent with written preferences 11 24.4% 13.7% to 39.5%
Sudden death (no decision-making opportunity) 10 22.2% 11.1% to 36.7%
Patient participated in decision-making 11 24.4% 13.7% to 39.5%
- Care consistent with expressed preferences 9 81.8% 52.3% to 94.9%
Surrogate decided alone (patient incapacitated) 22 48.9% 34.7% to 63.4%
- Decisions consistent with patient's written preference 18 81.8% 61.5% to 92.7%

Table 2: Quality Indicators in Palliative and End-of-Life Care by Illness Trajectory [59]

Quality Indicator Cancer (Trajectory I) Organ Failure (Trajectory II) Frailty/Dementia (Trajectory III)
ER visit on day of death 12.0% 20.9% 6.4%
At least one ICU admission in last month of life Data not specified Data not specified Data not specified
At least one ER visit in last 14 days of life Data not specified Data not specified Data not specified
Home deaths (2002-2016 trend) 7.7% to 9.1% (overall) - -
Deaths in acute care with no PEoLC (2002-2016 trend) 39.6% to 21.4% (overall) - -

Key Findings and Research Implications

The data reveal that surrogate decision-makers demonstrate high fidelity to patient preferences, with 81.8% consistency when patients cannot participate [60]. This challenges simplistic assessments of decision quality based solely on written advance directives. Research protocols must account for the dynamic nature of decision-making, including the patient's capacity to participate in real-time decisions and the surrogate's interpretation of previously stated preferences.

Significant disparities exist in end-of-life care quality across illness trajectories. Patients with organ failure experience more aggressive care at end of life, with higher rates of emergency room visits on the day of death compared to those with cancer or dementia [59]. This highlights the need for tailored decision-support protocols that address the unique challenges of each illness trajectory, particularly those with unpredictable decline patterns.

Experimental Protocols

Protocol 1: Assessing Surrogate Decision-Making Consistency

Objective

To quantitatively evaluate the alignment between surrogate decisions and patient preferences in end-of-life care scenarios.

Methodology

Patient Preference Assessment [60]

  • Administer the goals-of-care tool containing two clinical scenarios: (1) severe complication with poor prognosis, and (2) advanced dementia
  • Record patient preferences for each scenario: "delay death," "comfort care," or "unsure"
  • Create overarching goals-of-care preference: "comfort care only" versus "not comfort care only"

Data Collection [60]

  • Conduct medical record reviews every two weeks until patient death
  • Document primary acute medical conditions, treatments, and decision-making processes
  • Perform post-bereavement surrogate interviews two weeks after patient death
  • Complement medical record data with surrogate reports of decision-making context

Consistency Determination [60]

  • Independent review by multiple researchers using standardized decision rules
  • Categorize cases by decision-making pathway: sudden death, patient participation, or surrogate-alone decision
  • Resolve discrepancies through group consensus
  • Calculate consistency percentages with 95% confidence intervals
Expected Outcomes

This protocol yields quantitative measures of decision-making consistency across different clinical contexts, enabling researchers to identify factors associated with higher fidelity to patient preferences.

Protocol 2: Evaluating End-of-Life Care Quality Indicators

Objective

To assess population-level quality of palliative and end-of-life care across different illness trajectories using administrative data.

Study Population Identification

  • Include adults who died from illnesses likely to benefit from palliative care
  • Classify by illness trajectory using principal cause of death (ICD-10 codes):
    • Trajectory I: Cancer
    • Trajectory II: Organ failure (heart, respiratory, liver, renal)
    • Trajectory III: Frailty/dementia

Data Sources

  • Health insurance registry (demographics and eligibility)
  • Physician claims database (billed services)
  • Hospitalization discharge database
  • Vital statistics death database

Indicator Operationalization

  • Home deaths: coded in vital statistics database
  • Acute care deaths without palliative care: hospital deaths without palliative care bed designation
  • ER visits: physician claims with ER service codes in last 14 days of life
  • ER visits on day of death: ER service date coinciding with death date
  • ICU admissions: hospitalization records with ICU stay in last month of life

Data Analysis

  • Calculate annual proportions for each indicator
  • Stratify analyses by illness trajectory
  • Report descriptive statistics without age standardization

Visualizations

G Start Patient Expressed Preferences A Acute Medical Event Start->A B Patient Capacity Assessment A->B C Sudden Death No Decision Opportunity B->C No opportunity D Patient Can Participate B->D Capable E Patient Incapacitated Surrogate Decides B->E Incapacitated F Real-Time Expressed Preferences D->F G Reference to Written Preferences E->G H Care Consistent with Real-Time Preferences F->H I Care Consistent with Written Preferences G->I J Care Inconsistent with Preferences G->J Surrogate or system failure

Decision Pathway for End-of-Life Care Consistency

G A Clinical Scenario Presentation B Evidence-Based Options Review A->B C Patient Values & Preferences Discussion B->C D Surrogate Input & Interpretation C->D E Conflict Identification Mechanism D->E F Consensus-Building Protocol E->F G Decision Documentation F->G H Implementation & Monitoring G->H

Shared Decision-Making Workflow with Surrogates

The Scientist's Toolkit

Table 3: Essential Research Reagents and Resources for Surrogate Decision-Making Studies

Resource Function/Application Key Features
Goals-of-Care Tool [60] Assesses patient preferences in specific clinical scenarios Two scenarios (severe complication, advanced dementia) with three response options each
CaregiverVoice Survey [58] Captures bereaved caregiver perceptions of care quality 62 items assessing multiple care domains; α=0.81-0.93 internal consistency
VOICES Instrument [58] Evaluates end-of-life care experiences from caregiver perspective Validated in national surveys; modified for Canadian palliative care context
Collaborative Decision Description Language (CoDeL) [61] Models shared decision-making processes Extends LSC protocol; integrates clinical guidelines; supports argumentation structures
Quebec Integrated Chronic Disease Surveillance System (QICDSS) [59] Population-level administrative data for quality indicators Links multiple databases: insurance registry, physician claims, hospitalizations, death data
SMART Protocols Ontology [62] Standardizes experimental protocol reporting Defines 17 fundamental data elements for reproducible research

Shared decision-making (SDM) is a cornerstone of patient-centered end-of-life (EoL) care, yet its application across diverse cultural contexts presents significant challenges. This application note synthesizes current evidence on cultural factors influencing EoL decisions and provides structured protocols for implementing culturally competent SDM. We present quantitative findings on cultural variations in EoL preferences, detailed methodologies for cross-cultural research, and practical frameworks for adapting SDM processes. Our findings indicate that effective cross-cultural SDM requires moving beyond one-size-fits-all approaches to incorporate culturally-specific communication patterns, family dynamics, and decision-making preferences. These protocols aim to equip researchers and clinicians with evidence-based strategies for honoring diverse cultural values while maintaining ethical standards in EoL care.

Cultural competence in shared decision-making for end-of-life care represents an essential framework for ensuring equitable, respectful, and patient-centered care across diverse populations. The growing multicultural landscape of global healthcare demands systematic approaches to understanding how cultural beliefs, values, and communication norms influence EoL decision-making processes [19] [63]. Within research contexts, this requires both methodological sophistication in capturing cultural factors and practical strategies for implementing findings in clinical settings.

This application note establishes protocols for investigating and applying cultural competence principles within SDM frameworks for EoL care. The content is structured to support researchers in designing studies that account for cultural diversity while providing clinically actionable tools for implementing culturally competent SDM. As demographic shifts continue to transform patient populations, the integration of cultural competence into EoL care research and practice becomes increasingly critical for reducing disparities and improving care quality [64] [21].

Robust quantitative data illustrates significant cultural variations in EoL preferences and decision-making patterns. The following tables synthesize key findings from recent studies across diverse cultural contexts.

Table 1: Cross-Cultural Comparisons in Advance Care Planning Attitudes and Preferences

Variable U.S. Sample (n=166) Taiwanese Sample (n=186) Statistical Significance
Belief in importance of preparing advance directives Reference aOR 2.5 (95% CI 1.27-5.12) p<0.01
Willingness to discuss end-of-life care Reference aOR 7.75 (95% CI 2.03-29.50) p<0.01
Preference for family-led decision-making in serious illness Reference aOR 1.73 (95% CI 1.08-2.78) p<0.05
Confidence that family decisions would align with personal preferences Reference aOR 0.28 (95% CI 0.16-0.47) p<0.001
Actual completion of advance directives 37% <1% p<0.001

Table 2: Healthcare Setting Disparities in End-of-Life Awareness and Preferences (Bangladesh, n=1,270)

Variable Private Hospitals Public Hospitals Community Settings Statistical Significance
Palliative care awareness 70% 31% 7.1% p<0.01
Family openness about prognosis 81% 21% 7.1% p<0.01
Advance care planning awareness Highest Intermediate Lowest p<0.01
Health insurance coverage -- -- 1.7% p<0.01
Preference for home death (adults ≥60 years) OR=10.29, p<0.001 OR=10.29, p<0.001 OR=10.29, p<0.001 p<0.001

Table 3: Decision-Making Factors in Palliative Care Service Utilization

Factor Category Specific Factors Influence on Decision-Making
Predisposing Factors Age, Education level, People in household, Experiences with institutional care, Previous death experiences Shapes baseline attitudes toward palliative care and hospice services
Enabling Factors Physician's disclosure of prognosis, Communication partners, Communication context, Information about options Facilitates or barriers to accessing and utilizing services
Need Factors Acknowledgement of terminal status, Knowledge of services, Perception of care appropriateness, EoL wishes, Caregiver's commitment, Preference for dying at home, Health condition Directly impacts decision-making regarding service utilization

Experimental Protocols for Cross-Cultural SDM Research

Background: Cross-sectional surveys provide valuable quantitative data on cultural variations in EoL preferences, awareness, and decision-making patterns [2] [65].

Sample Recruitment:

  • Employ stratified sampling techniques to ensure proportional representation from each administrative division or cultural group based on population size [2]
  • Include participants from diverse healthcare settings (private hospitals, public hospitals, community settings) to capture system-level variations
  • Utilize random sampling from sub-district registries, hospital lists, and community databases to minimize selection bias
  • Calculate sample size using Cochran's formula with design effect adjustment: n₀ = Z²·p·(1−p)/e² * D, where Z=1.96 (95% CI), p=population proportion, e=margin of error (2.5%), D=design effect (2) [2]

Inclusion Criteria:

  • Adults aged ≥50 years with chronic or advanced illnesses
  • Hospitalized patients aged ≥18 years with life expectancy <1 year
  • Community-dwelling adults meeting age or illness criteria
  • Ability to provide informed consent (or proxy consent where culturally appropriate)

Data Collection Instruments:

  • Develop structured questionnaires based on internationally validated tools (e.g., National End of Life Survey, Pallium Canada Palliative Medicine Survey) [2]
  • Implement cross-cultural translation following WHO recommendations: forward translation by bilingual experts, reconciliation by panel review, back-translation by independent translator [2]
  • Conduct pilot testing with minimum 25 participants across settings to ensure comprehensibility and cultural appropriateness
  • Capture socio-demographics, EoL awareness, preferences, decision-making experiences, and cultural values

Data Analysis:

  • Perform multiple logistic regression to examine predictors of EoL preferences
  • Calculate odds ratios with 95% confidence intervals for key outcome variables
  • Conduct subgroup analyses by age, gender, education, and cultural background
  • Use statistical software (e.g., SPSS, R) for quantitative analysis

Protocol: Qualitative Exploration of Cultural Barriers and Facilitators

Background: Qualitative methodologies provide depth and context to understanding cultural influences on EoL decision-making [63].

Study Design:

  • Employ descriptive phenomenological approach using in-depth, semi-structured interviews
  • Follow Consolidated Criteria for Reporting Qualitative Studies (COREQ) guidelines [63]
  • Continue data collection until saturation is reached (typically 10-15 participants per cultural group)

Participant Selection:

  • Use purposive sampling to recruit healthcare professionals with experience in culturally diverse palliative care
  • Include nurses, physicians, and other professionals working in palliative care units
  • Ensure diversity in professional experience, cultural background, and clinical settings

Data Collection:

  • Conduct interviews in private, comfortable settings using a semi-structured interview guide
  • Allow 30-40 minutes per interview, with flexibility for participant-led elaboration
  • Record and transcribe interviews verbatim, supplemented by field notes for non-verbal communication
  • Ensure anonymity through pseudonyms and confidential data storage

Thematic Analysis:

  • Apply discourse analysis based on established qualitative analysis models [63]
  • Conduct line-by-line coding using qualitative data analysis software (e.g., Atlas.ti)
  • Identify relationships and potentially contradictory content within the data
  • Refine codes and categories through regular research team meetings
  • Develop themes and sub-themes through iterative consensus process
  • Conduct member checking by providing participants with theme summaries for validation

Protocol: Digital Decision Aid Implementation and Evaluation

Background: Digital decision aids can support culturally adapted SDM by providing tailored information and facilitating family involvement [66].

Intervention Development:

  • Identify key decision points in EoL care pathways (e.g., goal of care, feeding tube placement, resuscitation preferences)
  • Develop culturally adapted content addressing specific information needs and decision-making preferences of target cultural groups
  • Incorporate visual aids, videos, and interactive web-based platforms to accommodate varying health literacy levels and language preferences
  • Ensure technology accessibility across devices (tablets, computers, mobile phones)

Study Design:

  • Implement randomized controlled trials or pretest-posttest pilot studies
  • Compare digital decision aids with standard care or non-digital alternatives
  • Include both patients and family caregivers in the intervention where culturally appropriate

Outcome Measures:

  • Primary outcomes: decision conflict, knowledge, preferred goal of care (comfort care vs. life-prolonging)
  • Secondary outcomes: decision-making performance, quality of palliative care, healthcare utilization, documented care preferences
  • Process measures: feasibility, acceptability, usability, cultural appropriateness

Data Analysis:

  • For meta-analysis: calculate odds ratios with 95% confidence intervals using random-effects models
  • Assess heterogeneity using I² statistics
  • Conduct narrative synthesis for feasibility and acceptability outcomes

Conceptual Framework for Culturally Competent SDM

The following diagram illustrates the key components and workflow for implementing culturally competent shared decision-making in end-of-life care:

CultureSDM cluster_CulturalAssessment Cultural Assessment Components Start Patient with Serious Illness CulturalAssessment Cultural Assessment Start->CulturalAssessment CommunicationAdaptation Adapt Communication Approach CulturalAssessment->CommunicationAdaptation CA1 Beliefs about illness/death CA2 Communication preferences CA3 Family decision-making role CA4 Truth disclosure norms CA5 Spiritual/religious practices DecisionMakingStructure Establish Decision-Making Structure CommunicationAdaptation->DecisionMakingStructure InformationTailoring Tailor Information Delivery DecisionMakingStructure->InformationTailoring Implementation Implement Care Plan InformationTailoring->Implementation Evaluation Evaluate and Adjust Implementation->Evaluation

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Resources for Cultural Competence in End-of-Life Care Research

Tool/Resource Application in Research Key Features
Structured Cultural Assessment Framework Systematic evaluation of cultural factors influencing EoL decisions Based on ETHNIC model (Explanation, Treatment, Healers, Negotiate, Intervention, Collaboration); assesses communication styles, decision-making processes, beliefs about illness [67]
Cross-Cultural Survey Instruments Quantitative data collection on EoL preferences across cultural groups Adapted from validated international tools (National End of Life Survey); professionally translated and back-translated; pilot-tested for cultural appropriateness [2]
Digital Decision Aids Supporting culturally sensitive decision-making processes Video-based options demonstrating various care pathways; web-based platforms allowing family participation; visual aids accommodating health literacy variations [66]
Qualitative Interview Guides In-depth exploration of cultural norms and experiences Semi-structured protocols exploring death perspectives, family roles, communication taboos; translated and culturally adapted; field-tested [63]
Mixed Methods Appraisal Tool (MMAT) 2018 Quality assessment of diverse study designs Validated tool for critical appraisal of quantitative, qualitative, and mixed-methods research; enables systematic quality evaluation [4]

Application Framework and Implementation Guidelines

Cultural Assessment Protocol

Effective culturally competent SDM begins with comprehensive cultural assessment. The following diagram details the assessment process:

CulturalAssessment cluster_AssessmentDomains Key Assessment Domains Start Initiate Cultural Assessment CulturalDesire Cultural Desire: Motivation for cultural competence Start->CulturalDesire CulturalAwareness Cultural Awareness: Self-reflection on biases and identity CulturalDesire->CulturalAwareness CulturalKnowledge Cultural Knowledge: Learn specific cultural norms CulturalAwareness->CulturalKnowledge CulturalSkill Cultural Skill: Conduct cultural assessment CulturalKnowledge->CulturalSkill CulturalCollaboration Cultural Collaboration: Establish partnership with patient/family CulturalSkill->CulturalCollaboration AD1 Death and dying perspectives AD2 Truth disclosure preferences AD3 Family involvement in decisions AD4 Spiritual/religious beliefs AD5 Pain and suffering meanings AD6 Traditional healing practices CulturalEncounter Cultural Encounter: Gain direct cultural experience CulturalCollaboration->CulturalEncounter CarePlanning Develop Culturally Appropriate Care Plan CulturalEncounter->CarePlanning

Implementation Strategies for Diverse Cultural Contexts

Addressing Truth Disclosure Variations:

  • In cultures with non-disclosure norms (common in many Asian and Middle Eastern countries), engage family members in preliminary discussions about prognosis disclosure [19] [64]
  • Develop graduated disclosure approaches that respect cultural taboos while gradually providing information aligned with patient preferences
  • Utilize indirect communication strategies and metaphors where direct death discussions are culturally inappropriate

Adapting to Family-Centered Decision-Making:

  • In collectivist cultures, identify key family decision-makers and establish structured family conference protocols [19] [65]
  • Recognize that in patriarchal family structures, senior male members often hold primary decision-making authority [19]
  • Develop processes that honor family protection of patients while gradually introducing patient autonomy concepts where appropriate

Navigating Spiritual and Religious Considerations:

  • Incorporate spiritual assessments as routine components of EoL care planning
  • Collaborate with religious leaders and traditional healers where requested by patients/families
  • Adapt care environments to accommodate religious rituals and practices surrounding death and dying

Managing Language and Communication Barriers:

  • Utilize professional interpreter services rather than family members for medical discussions
  • Assess health literacy levels and adapt communication strategies accordingly
  • Employ visual aids, narratives, and metaphors to enhance understanding across language barriers

Culturally competent shared decision-making in end-of-life care requires multifaceted approaches that honor diverse belief systems while maintaining ethical standards of care. The protocols and frameworks presented provide researchers and clinicians with evidence-based strategies for implementing culturally sensitive SDM across diverse populations. Future research should focus on developing and validating standardized cultural assessment tools, evaluating the effectiveness of culturally adapted decision aids, and examining how cultural competence interventions impact patient and family outcomes in EoL care. As global diversity continues to increase, the integration of cultural competence into SDM processes becomes increasingly essential for equitable, patient-centered end-of-life care.

Application Note: Quantitative Foundations for Strategy Development

Recent empirical studies provide a quantitative basis for designing organizational support strategies in end-of-life care. The data presented in Table 1 highlight critical disparities and facilitators that inform targeted interventions.

Table 1: Quantitative Evidence for End-of-Life Care Strategy Development

Metric Findings by Setting/Group Statistical Significance Source
Palliative Care Awareness Private Hospitals: 70%Public Hospitals: 31%Community Settings: 7.1% p < 0.01 [2]
Home Death Association Access to respite care more than doubles odds of home death AOR: 2.699, p < 0.001 [68]
Preference for Home Care Older adults (≥60 years) significantly prefer home care OR = 2.96, p = 0.004 [2]
Home Hospice Care Utilization Only 13.55% of eligible older adults utilized services - [69]
Impact of Understanding Palliative Care Greater understanding predicts documentation of preferences OR = 7.38, p < 0.001 [2]

Experimental Protocol: Mixed-Methods Evaluation of Organizational Strategies

Purpose: To comprehensively assess the implementation and impact of organizational support strategies for shared decision-making (SDM) in end-of-life care.

Quantitative Phase - Data Collection & Analysis:

  • Sample: Recruit a stratified sample of healthcare providers, patients, and caregivers from multiple settings (e.g., hospital, community) using convenience or purposive sampling [2] [69]. Calculate sample size using logistic regression principles (5-10 participants per independent variable) [69].
  • Measures: Administer structured questionnaires capturing:
    • Awareness & Knowledge: Use scales adapted from validated international tools (e.g., Pallium Canada Palliative Medicine Survey) to measure awareness of palliative care and SDM principles [2].
    • Preferences & Utilization: Document patient preferences for care setting and actual utilization rates of services like hospice care [69].
    • Process Metrics: Track documentation rates of advance care plans and patient preferences within electronic health records (EHRs) [70] [2].
  • Analysis: Conduct logistic and Cox regression analyses to identify factors associated with key outcomes like home death or hospice utilization [68]. Control for confounders such as age, setting, and socio-economic status.

Qualitative Phase - Data Collection & Analysis:

  • Sample: Use purposive sampling to select participants from the quantitative phase for semi-structured interviews until thematic saturation is achieved (e.g., n=16-73) [68] [69].
  • Data Collection: Perform semi-structured interviews with patients, caregivers, providers, and decision-makers. Explore barriers, facilitators, and lived experiences regarding SDM and end-of-life care workflows.
  • Analysis: Employ content analysis to identify major themes, such as challenges in accessing timely services, the importance of respecting patient wishes, and systemic barriers to collaboration [68].

Integration: Merge quantitative and qualitative datasets to explain statistical findings. For example, use interview data explaining why respite care (a quantitative predictor) is crucial for supporting home deaths from the caregiver's perspective [68].

Application Note: Workflow Integration Protocols

Integrating SDM into clinical workflow requires purposeful design of EHR systems and clinical pathways to overcome universal barriers like time constraints [70].

Protocol: Integrating a "Personalize Button" into the EHR Workflow

Objective: To implement a non-intrusive, standards-based alert within the EHR that signals a context for SDM and provides access to patient-specific preference data and decision aids [70].

Workflow Integration Diagram:

cluster_encounter Clinical Encounter PatientArrival Patient Encounter ContextCheck EHR Checks for Preference-Sensitive Context PatientArrival->ContextCheck PersonalizeButton 'Personalize Button' Icon Appears on EHR Screen ContextCheck->PersonalizeButton ProviderClick Provider Clicks Icon PersonalizeButton->ProviderClick AccessResources Access Patient Preferences & Decision Aids ProviderClick->AccessResources SDMProcess Engage in Shared Decision-Making AccessResources->SDMProcess Document Document Decision & Preferences SDMProcess->Document

Implementation Steps:

  • Context Identification: Configure the EHR to detect "preference-sensitive" clinical contexts (e.g., new diagnosis of terminal illness, consideration of life-sustaining therapy) using rule-based logic [70] [34].
  • Interface Design: Implement an asynchronous, non-blocking alert—the "Personalize Button"—represented by a person icon on the EHR interface. This avoids contributing to alert fatigue, unlike intrusive pop-up alerts [70].
  • Resource Linking: Utilize the Context-Aware Knowledge Retrieval (Infobutton) standard. When clicked, the button retrieves and displays patient-specific resources, including previously documented preferences, relevant decision aids, and values clarification tools [70].
  • SDM Facilitation: Structure the clinical note with templates that prompt documentation of the SDM discussion, including the options presented, patient values cited, and the final mutually agreed-upon plan [34].
  • Preference Storage: Ensure the documented preferences are stored in a structured, encoded format within the EHR to be accessible for future encounters and decision support [70].

Protocol: Establishing Hospice-Acute Care Collaboration Pathways

Objective: To create seamless care transitions and interdisciplinary support for patients moving between acute and hospice care settings.

Collaboration Workflow Diagram:

cluster_acute Acute Care Setting cluster_hospice Hospice Care Setting cluster_patient Patient & Family A1 Identify Patients for Palliative Care Consult A2 Interdisciplinary Team Meeting A1->A2 A3 Joint Care Planning with Hospice Team A2->A3 H1 Admission & Symptom Management A3->H1 Standardized Referral H2 Provide Respite Care & Family Support H1->H2 H3 Continuous Communication with Acute Team H2->H3 H3->A1 Outcome Feedback P1 Values & Preference Elicitation P2 Shared Decision-Making Process P1->P2 P2->A2 P2->H2

Implementation Steps:

  • Partnership Structuring: Establish formal contracts (independent or extensive) between hospitals and hospice organizations, defining service level agreements and integration depth, such as dedicated inpatient hospice units or embedded palliative care consultation teams [71].
  • Interdisciplinary Team Formation: Create core teams comprising physicians, nurses, social workers, spiritual counselors, and therapists from both settings. Define clear roles and responsibilities for each member in the SDM process [71].
  • Protocol Standardization: Develop and implement joint protocols for patient identification, referral, transition, and communication. Utilize shared electronic medical records where possible to facilitate real-time information exchange [71].
  • Educational Integration: Conduct regular joint training sessions for hospital and hospice staff on end-of-life communication, SDM models (e.g., the three-talk model, REMAP), and symptom management [71] [34].
  • Data & Feedback Loop: Establish a system for tracking and sharing collaborative outcomes, such as reduction in hospital readmissions, patient satisfaction scores (e.g., HHCAHPS), and symptom control metrics, to demonstrate value and guide quality improvement [71].

Application Note: Policy Development Frameworks

Effective policy must address the documented gaps in awareness, access, and cultural appropriateness to support SDM.

Protocol: Developing a Culturally Competent SDM Policy

Objective: To create an institutional policy that ensures SDM and end-of-life care are delivered in a culturally competent, sensitive, and accessible manner.

Implementation Framework:

  • Staff Training Mandate: Policy must mandate ongoing cultural competency training for all staff involved in end-of-life care. Training should move beyond generalized knowledge to focus on self-reflection of biases and skills for eliciting individual patient values and preferences, regardless of cultural background [72].
  • Inclusive Care Environment: Policy should require the creation of a culturally sensitive care environment. This includes providing resources for language translation, respecting diverse spiritual and religious practices, and physically incorporating culturally significant elements into care spaces where possible [72].
  • Community Engagement: Policy must formalize processes for engaging with diverse cultural communities in the service area during the planning, design, and evaluation of end-of-life care services. This ensures services are culturally accessible and aligned with community norms, thereby increasing willingness to access care [72].
  • Documentation Standards: Policy should enforce standardized documentation of culturally specific preferences, values, and beliefs within the EHR, ensuring this information is readily available to guide care and SDM for all providers [70] [34].

Application Note: Leadership Engagement Strategies

Leadership engagement is critical for allocating resources, championing culture change, and incentivizing SDM practices.

Protocol: Engaging Hospital Administration in SDM Implementation

Objective: To secure sustained commitment and resource allocation from hospital leadership for implementing and maintaining SDM programs in end-of-life care.

Implementation Steps:

  • Align with Institutional Goals: Present data to administrators demonstrating how SDM and hospice integration improve key hospital performance metrics, including reduced 30-day readmission rates, decreased ICU utilization, higher patient satisfaction scores (HHCAHPS), and overall cost savings from avoiding non-beneficial treatments [71].
  • Pilot Program Proposal: Propose a limited-scale pilot project in a high-impact area (e.g., CICU or advanced heart failure clinic) to demonstrate proof-of-concept with manageable resource investment [34].
  • Financial Modeling: Develop clear financial models showing return on investment, such as cost reductions from streamlined care pathways and improved resource utilization, drawing on existing economic analyses of palliative care [71] [68].
  • Champion Identification: Identify and empower clinical champions from influential departments (e.g., cardiology, oncology) to advocate for SDM within their peer groups and to administration, highlighting improved clinician satisfaction and reduced moral distress [34].

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Instruments and Tools for End-of-Life Care Research

Research Instrument Function Application Context
General Information Questionnaire Captures predisposing, enabling, and need factors based on the Andersen Model [69]. Baseline data collection in quantitative studies to profile participants and identify variables associated with service utilization.
Knowledge, Attitude, and Practice (KAP) Scale Quantifies awareness, misconceptions, and current behaviors regarding hospice care or SDM [69]. Measuring the effectiveness of educational interventions and identifying knowledge gaps in target populations.
Activities of Daily Living (ADL) Scale (Barthel Index) Assesses patient functional status and level of dependency through a standardized scoring system [69]. Objective assessment of patient need factors, often used as a control or stratification variable in analyses.
Palliative Care Survey (Adapted) Synthesized from validated international tools (e.g., Pallium Canada) to measure awareness and experiences [2]. Conducting cross-sectional studies to benchmark local awareness and satisfaction against international standards.
Semi-Structured Interview Guide Explores complex, subjective experiences, barriers, and facilitators from the participant's perspective [68] [69]. Qualitative data collection to provide depth and explanatory context for quantitative findings in mixed-methods studies.

Measuring Effectiveness and Evaluating Outcomes of Shared Decision-Making Interventions

Within end-of-life (EoL) care research, ensuring that care aligns with patient values and preferences is a paramount objective. This application note details three critical outcome measurement frameworks—decisional conflict, goal-concordant care, and quality of dying—that are essential for evaluating the effectiveness of shared decision-making (SDM) models in advanced illness. Systematically applying these frameworks allows researchers and drug development professionals to generate robust evidence on whether new interventions or therapeutics truly improve the patient experience by honoring individual care goals and ensuring a dignified dying process. The following sections provide a detailed comparative analysis of these frameworks, complete with experimental protocols and key methodological considerations for their application in clinical research.

Theoretical Foundations and Measurement Approaches

Decisional Conflict

Decisional conflict arises when individuals feel uncertain about which course of action to take among competing options. In EoL care, this often occurs when patients and families face complex, high-stakes choices about life-sustaining treatments, hospice enrollment, or site of care. Measuring decisional conflict is crucial for evaluating SDM interventions, as reduced conflict indicates improved clarity and preparedness for decision-making.

The Decisional Conflict Scale (DCS) is the most widely validated instrument for quantifying this construct. A systematic review of EoL care decision aids found that 39.5% of studies (17/43) used the DCS or related measures to evaluate effectiveness, with most reporting positive outcomes from interventions that incorporated International Patient Decision Aid Standards (IPDAS) [51]. The DCS captures multiple dimensions of uncertainty, including feeling uninformed, unclear about values, and unsupported in decision-making.

Goal-Concordant Care

Goal-concordant care occurs when the care provided aligns with a patient's known goals, values, and preferences. It represents a fundamental quality metric in serious illness and EoL care, with failure to achieve goal-concordant care considered a significant medical error [73]. Measurement approaches vary considerably, each with distinct strengths and limitations.

A methodological review identified four primary methods for measuring goal-concordant care [74]:

  • Patient- or Caregiver-Reported: Prospective or retrospective assessments of whether care received matched preferences.
  • Caregiver-Reported After Death: Bereaved family member perceptions of care concordance.
  • Concordance in Longitudinal Data: Linking documented preferences (e.g., advance directives) to actual treatments received.
  • Population-Level Indicators: Using aggregated data to infer concordance based on typical preferences.

The conceptual pathway to goal-concordant care begins with high-quality communication, progresses through shared decision-making, and results in care that aligns with patient goals, ultimately influencing bereaved caregiver outcomes [73]. This pathway is illustrated below:

G Conceptual Pathway to Goal-Concordant Care A High-Quality Serious Illness Communication B Shared Decision-Making (SDM) Process A->B C Goal-Concordant Care B->C D Improved Bereaved Caregiver Outcomes C->D

Quality of Dying

Quality of dying encompasses multiple dimensions of the dying experience, including physical comfort, psychological well-being, social connectedness, and spiritual peace. Unlike traditional healthcare outcomes focused on survival or disease progression, quality of dying measures evaluate how well the dying process aligns with what patients consider a "good death." These measures often include assessments of symptom burden, dignity, sense of purpose, and the quality of interactions with healthcare providers and family members.

Table 1: Comparative Analysis of Outcome Measurement Frameworks in End-of-Life Care Research

Framework Core Construct Primary Measurement Approaches Key Instruments Research Applications
Decisional Conflict Uncertainty in medical decision-making • Self-report surveys• Observational coding of decision processes • Decisional Conflict Scale (DCS)• Decision Regret Scale [11] • Evaluating decision aid effectiveness [51]• Assessing shared decision-making interventions
Goal-Concordant Care Alignment between care received and patient preferences • Patient/caregiver-reported concordance• Longitudinal preference-treatment linkage• Bereaved family surveys [74] [73] • Perceived Goal Concordance items• Documented preference fulfillment metrics • Quality measurement in serious illness [73]• Evaluating communication interventions
Quality of Dying Holistic dying experience • Retrospective caregiver assessments• Patient-reported outcomes (when feasible)• Symptom monitoring • Quality of Dying and Death Questionnaire• Palliative Care Outcomes Scale [75] • Evaluating hospice and palliative care models• Assessing dignity-conserving interventions

Experimental Protocols and Methodological Considerations

Protocol for Measuring Decisional Conflict in Decision Aid Trials

Objective: To evaluate the effect of a EoL decision aid on reducing decisional conflict in patients with advanced illness and their family caregivers.

Materials:

  • Validated Decisional Conflict Scale (DDS)
  • EoL decision aid developed according to IPDAS standards [51]
  • Control materials (usual care or alternative information)
  • Demographic and clinical characteristic questionnaires

Procedure:

  • Participant Recruitment: Identify eligible patients with advanced, life-limiting illnesses (e.g., stage IV cancer, advanced organ failure) and their primary caregivers.
  • Baseline Assessment: Administer the DCS and collect demographic/clinical data.
  • Randomization: Allocate participants to intervention (decision aid) or control group using block randomization.
  • Intervention Delivery:
    • Intervention Group: Provide the EoL decision aid in appropriate format (video, online interactive, or booklet) [51]. Allow sufficient time for review (typically 30-60 minutes).
    • Control Group: Provide usual care or standard educational materials.
  • Post-Intervention Assessment: Re-administer the DCS immediately after intervention completion.
  • Follow-Up Assessment: Administer the DCS and Decision Regret Scale at 3 months to assess sustained effect.

Analysis:

  • Calculate total and subscale scores for the DCS.
  • Use paired t-tests to assess within-group changes and ANCOVA to compare between-group differences, controlling for baseline scores.
  • Conduct subgroup analyses based on patient diagnosis, demographics, and caregiver relationship.

Methodological Considerations:

  • Ensure decision aids address specific decisions relevant to the population (e.g., hospice enrollment, CPR preferences) [51].
  • Account for potential response shift bias in longitudinal assessments.
  • Consider using a mixed-methods approach to capture both quantitative conflict scores and qualitative experiences.

Protocol for Assessing Goal-Concordant Care Using Longitudinal Data

Objective: To determine the concordance between documented EoL preferences and actual care received in patients with serious illness.

Materials:

  • Standardized advance care planning documentation template
  • Electronic health record (EHR) data abstraction form
  • Validated perceived goal concordance items for surrogate respondents [74]

Procedure:

  • Prospective Preference Documentation:
    • Engage patients in structured advance care planning conversations using a validated framework.
    • Document specific treatment preferences for key scenarios (e.g., hospital transfer, CPR, artificial nutrition) in the EHR.
  • Data Abstraction:
    • Train research staff on standardized EHR data abstraction.
    • Abstract documented preferences at baseline.
    • Track actual treatments received over the study period (typically 6-12 months) through EHR review.
  • Concordance Assessment:
    • Develop an operational definition of concordance (e.g., exact match, clinical interpretation match) [74].
    • Have blinded assessors compare documented preferences to actual care received.
    • Calculate concordance rates for each preference category.
  • Caregiver Validation:
    • After patient death, survey bereaved caregivers using validated perceived goal concordance items.
    • Compare documented concordance with caregiver perceptions.

Analysis:

  • Calculate percentage concordance for each preference category and overall.
  • Use multivariable logistic regression to identify factors associated with higher concordance.
  • Assess agreement between documented concordance and caregiver perceptions using kappa statistics.

Methodological Considerations:

  • Preferences may change over time; consider periodic reassessment [74].
  • Distinguish between direct documentation of preferences and clinician interpretations.
  • Account for situations where preference documentation is ambiguous or requires clinical judgment to interpret.

Integrated Assessment Framework for EoL Interventions

The following workflow illustrates a comprehensive protocol for simultaneously evaluating all three outcome frameworks in a clinical trial of an EoL communication intervention:

G Comprehensive Outcome Assessment Workflow for EoL Interventions A Baseline Assessment • Decisional Conflict Scale • Baseline preferences • Clinical characteristics B Randomization A->B C Intervention Group • EoL Decision Aid • Structured Communication B->C D Control Group • Usual Care • Standard Information B->D E Post-Intervention Assessment • Decisional Conflict Scale • Knowledge test • Decision readiness C->E D->E F Longitudinal Follow-Up • Treatment preferences • Actual care received • Symptom burden E->F G Bereavement Assessment • Perceived goal concordance • Quality of Dying • Caregiver outcomes F->G H Integrated Data Analysis • Concordance rates • Conflict reduction • Quality of dying correlates G->H

The Scientist's Toolkit: Essential Research Reagents and Measures

Table 2: Essential Measures and Instruments for End-of-Life Care Outcome Research

Instrument Category Specific Measures Primary Constructs Measured Administration Context Psychometric Properties
Decisional Conflict Decisional Conflict Scale (DCS) Uncertainty, informedness, values clarity, support, effective decision Pre/post decision aids or counseling Well-validated; high internal consistency (α=0.78-0.92) [51] [11]
Decision Regret Scale Distress or remorse after decision Post-decision follow-up Validated in healthcare decisions; 5 items
Goal Concordance Perceived Goal Concordance Items Caregiver assessment of care alignment with patient wishes Bereavement follow-up (3-6 months post-death) Used in national surveys [73]
Documented Preference Fulfillment Metrics Agreement between advance directives and treatments EHR and document review Requires operational definitions of concordance [74]
Communication Quality Shared Decision Making Questionnaire (SDM-Q) Patient perception of SDM process After clinical encounters 9-item scale; good reliability
Communication Assessment Tool Specific skills in EoL communication After clinical encounters or via recording Validated in serious illness contexts
Quality of Dying Quality of Dying and Death Questionnaire (QODD) Multiple dimensions of dying experience Bereaved caregiver survey Comprehensive assessment; 31 items [75]
Palliative Care Outcomes Scale (POS) Physical, psychological, and information needs Patient or staff report Validated in palliative populations

Robust measurement of decisional conflict, goal-concordant care, and quality of dying is fundamental to advancing the science of shared decision-making in end-of-life care. Each framework provides unique insights into different aspects of the EoL experience, from the uncertainty of decision-making through to the ultimate outcomes of care alignment and dying experience. The protocols and tools detailed in this application note provide researchers with practical methodologies for implementing these measurement approaches in clinical trials and intervention studies. As the field evolves, increased standardization of these measures will enhance comparability across studies and accelerate the development of interventions that truly honor patient values and preferences at the end of life.

Application Notes: The State of the Evidence

Current Evidence on SDM Intervention Effectiveness

Table 1: Evidence for Shared Decision-Making (SDM) Interventions in Advanced Illness Care

Intervention Type Key Findings on Effectiveness Population/Context Limitations & Research Gaps
Healthcare Professional (HCP) Training Significantly increases perceived SDM behaviors (p < 0.05) when training includes modeling and enablement functions [76]. Advanced cancer consultations [76]. Few interventions specifically measure perceived SDM behaviors [76].
Combined Interventions (HCP Training + Patient Aids) HCP training combined with patient communication aids demonstrates a significant effect on SDM behaviors [76]. Advanced cancer treatment decisions [76]. Optimal combination and implementation strategies are not yet defined.
Interactive Training with Reflexivity 71% (5/7) of interactive programs using reflexivity strategies were effective; peer-to-peer group learning was particularly promising (3/5 effective) [77]. General SDM implementation for HCPs [77]. Effectiveness of self-appraisal individual learning strategies is less clear [77].
Interprofessional Training 60% (3/5) of programs with an interprofessional orientation were effective, suggesting a promising approach [77]. Fostering collaboration across disciplines [77]. Such programs are not yet widely available [77].
Observer-Reported Outcomes Over half (58%, 7/12) of programs using observer-based measurements were effective [77]. Objective assessment of SDM processes in clinical encounters [77]. Disconnect between observer-reported outcomes and patient-reported experiences requires further study.

Key Factors Influencing SDM Competency and Implementation

Table 2: Factors Associated with SDM Competency in Palliative Care Practitioners

Associated Factor Impact on SDM Competency Supporting Evidence
Empathy Ability (EA) Strong positive correlation (r = 0.704, P < 0.01) and a significant predictor (β = 0.683, P<0.001) of higher SDM competency [78]. Study of 429 palliative care nurses in China [78].
Formal SDM Training Training experience is a statistically significant factor leading to higher competency (β=-0.155, P<0.001) [78]. Nurses with training had higher competency scores than those without [78].
Educational Background Higher educational attainment (e.g., postgraduate education) is significantly associated with increased SDM competency (β=-0.142, P = 0.007) [78]. Multivariate analysis controlling for other factors [78].
Interprofessional Collaboration Fosters cohesive practice and is defined by collegial communication, mutual trust, and common goals, enhancing SDM implementation [77]. Policy statements and model frameworks [77].

Experimental Protocols

Protocol for a Systematic Review on SDM Intervention Effectiveness

This protocol outlines a rigorous methodology for synthesizing evidence on the effectiveness of SDM interventions in end-of-life care.

2.1.1 Research Question and Registration

  • Primary Question: How effective are shared decision-making interventions at increasing the occurrence and quality of SDM in consultations about end-of-life and advanced care planning?
  • PICO Framework:
    • Population: Healthcare professionals, patients, and families facing decisions in palliative or end-of-life care.
    • Intervention: SDM interventions (e.g., training programs, decision aids, communication tools).
    • Comparator: Usual care or other active interventions.
    • Outcome: Primary: Observer- or patient-reported measures of SDM. Secondary: Decision conflict, quality of life, care concordance with goals.
  • Registration: The review protocol should be registered in a prospective register of systematic reviews (e.g., PROSPERO) [79].

2.1.2 Search Strategy

  • Databases: A comprehensive search will be executed in major databases including Embase, MEDLINE (Ovid), CINAHL, Web of Science Core Collection, and the Cochrane Central Register of Controlled Trials [79].
  • Search Terms: Keywords and MeSH terms will include combinations related to: 'Shared Decision-Making', 'Terminal Care', 'Palliative Care', 'Hospice Care', 'End-of-Life', 'Advance Care Planning', and 'Decision Support Techniques' [79].
  • Timeframe: Searches will typically cover from the year 2000 onwards to capture the modern evolution of palliative care, with the final search date documented [79].

2.1.3 Study Selection and Data Extraction

  • Eligibility Criteria:
    • Inclusion: Studies (RCTs, quasi-experimental, qualitative) evaluating SDM interventions in palliative/end-of-life contexts. Participants include clinicians, adult patients with life-limiting illness, and families.
    • Exclusion: Studies not focused on SDM, not in a palliative context, or without empirical outcomes.
  • Screening Process: The selection process will adhere to the PRISMA guidelines [79]. The number of records identified, screened, eligible, and included will be documented in a flow diagram.
  • Data Extraction: A standardized data extraction table will be used [80]. Key fields include:
    • Source (Author, Date)
    • Study Aim & Design
    • Participant Characteristics
    • Intervention Description (using Behavior Change Techniques taxonomy) [76]
    • Comparison Group
    • Outcome Measures (PROMs or OBOMs) [77]
    • Key Findings related to SDM effectiveness

2.1.4 Risk of Bias and Quality Assessment

  • The risk of bias for included studies will be assessed using appropriate tools, such as ROBVIS-II for randomized trials [79].
  • The overall strength of the evidence will be graded using a system like GRADE (Grading of Recommendations, Assessment, Development, and Evaluations).

2.1.5 Data Synthesis and Analysis

  • Quantitative Synthesis: If studies are sufficiently homogeneous, a meta-analysis will be performed to pool effect estimates. Statistical heterogeneity will be assessed using the I² statistic.
  • Qualitative Synthesis: If a meta-analysis is not feasible, a narrative synthesis will be conducted. Findings will be organized by intervention type and outcome, identifying key themes and patterns [76] [79]. A synthesis table will be constructed to chart similarities, differences, and major themes across the collected studies [80].

Detailed Protocol: Evaluating an SDM Training Intervention for Clinicians

This protocol describes a methodology for a study evaluating a specific, reflexivity-based SDM training program for palliative care clinicians.

2.2.1 Intervention Design

  • Core Components: The training will be interactive and use reflexivity strategies, specifically peer-to-peer group learning [77]. It will be grounded in established SDM models, such as the three-talk model (choice talk, option talk, decision talk) [34] and will incorporate the REMAP framework (Reframe, Expect emotion, Map patient goals, Align with goals, Propose a plan) for aligning decisions with patient values [34].
  • Content: Modules will cover core communication skills, managing emotions in prognostic discussions, understanding power dynamics in clinician-patient relationships, and practicing interprofessional collaboration [79] [77].
  • Delivery: A blended format with brief e-learning modules followed by a 4-hour in-person workshop featuring role-playing with simulated patients and facilitated group reflection.

2.2.2 Evaluation Methodology

  • Study Design: A multi-method design, such as a pre-post study with a control group or a randomized controlled trial.
  • Participants: Palliative care physicians, nurses, and social workers recruited from multiple hospitals or hospice units. Sample size will be calculated based on the primary outcome, with a minimum of 214 participants required for adequate power in a regression analysis, accounting for a 20% attrition rate [78].
  • Primary Outcome: Observer-Reported SDM. The use of SDM in recorded patient consultations will be assessed before and after the intervention using a validated OBOM, such as the OPTION-5 scale [77].
  • Secondary Outcomes:
    • HCP Self-Reported Competency: Measured using the Shared Decision-Making Competency Scale (SDMCS), a 51-item self-reporting scale with high reliability (Cronbach's alpha 0.980) [78].
    • Empathy: Measured using the Empathy Ability Scale (EAS), a 33-item scale assessing cognitive, emotional, and behavioral empathy [78].
    • Participant Satisfaction: Assessed post-training using the Kirkpatrick model Level 1 (reaction) to gauge learner appreciation [77].

2.2.3 Data Analysis Plan

  • Quantitative Analysis: Multivariate linear regression will be used to identify factors associated with changes in SDM competency, including empathy, training experience, and educational background as independent variables [78]. T-tests or ANOVA will compare outcome changes between intervention and control groups.
  • Qualitative Analysis: Feedback from post-workshop debriefing sessions will be analyzed using thematic analysis to explore participants' experiences and the perceived impact of the reflexivity exercises.

Mandatory Visualization

SDM Systematic Review Workflow

SRWorkflow Start Define Review Question & PICO Reg Register Protocol (e.g., PROSPERO) Start->Reg Search Systematic Search (MEDLINE, CINAHL, etc.) Reg->Search Screen Screen Records (PRISMA Flow) Search->Screen Extract Data Extraction (Standardized Table) Screen->Extract Bias Risk of Bias Assessment (ROBVIS-II) Extract->Bias Synthesize Data Synthesis (Narrative or Meta-analysis) Bias->Synthesize Report Report Findings (PRISMA Guidelines) Synthesize->Report

Conceptual SDM Model in Palliative Care

SDMModel Clinician Clinician Expertise & Evidence Process SDM Process Clinician->Process Information Exchange Patient Patient Values Goals & Preferences Patient->Process Values Clarification Outcome Patient-Centered Care Plan Process->Outcome Collaborative Deliberation

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Tools and Measures for SDM Research in End-of-Life Care

Tool/Resource Name Type/Function Brief Description & Application in SDM Research
Shared Decision-Making Competency Scale (SDMCS) Validated Assessment Tool A 51-item self-reporting scale to assess nurses' SDM competency across knowledge, skills, and comprehensive quality. Demonstrates high reliability (Cronbach's alpha 0.980) [78].
Empathy Ability Scale (EAS) Validated Assessment Tool A 33-item scale measuring cognitive, emotional, and behavioral empathy in palliative care nurses. Used to investigate correlation with SDM competency [78].
Observer-Reported Outcome Measurement (OBOM) Process Evaluation Tool Instruments (e.g., OPTION-5) used by a third-party observer to assess SDM behaviors during clinical encounters. Over half of effective training programs used OBOMs [77].
Patient-Reported Outcome Measurement (PROM) Outcome Evaluation Tool Instruments completed directly by patients to report their experience of the decision-making process, without clinician interpretation [77].
REMAP Framework Conceptual/Communication Framework A palliative care communication tool (Reframe, Expect emotion, Map goals, Align with goals, Propose a plan) used to structure discussions and ensure decisions reflect patient values [34].
Three-Talk Model Conceptual Model A foundational SDM model comprising "choice talk," "option talk," and "decision talk" to guide the collaborative process [34].
Behavior Change Techniques (BCT) Taxonomy Analytical Tool A standardized taxonomy used to describe the active ingredients of complex interventions, such as SDM training programs [76].
Research and Synthesis Tables Data Management Tool Structured tables (e.g., in Excel) used during literature reviews to organize information from studies (Research Table) and to identify themes and gaps (Synthesis Table) [80].

Application Notes

Quantitative Efficacy Profile of Digital Decision Aids

Table 1: Summary of Meta-Analysis Findings on Digital Decision Aid Efficacy

Clinical Context Primary Outcomes Effect Size & 95% CI Secondary Outcomes References
Palliative Dementia Care Proportion opting for comfort care OR 3.81 (1.92 - 7.56) Do-not-hospitalize orders (non-significant) [39] [66]
Chronic Diseases Decision Conflict (reduction) Significant effect (p<0.05) Knowledge (improved) [81]
Prenatal Screening Knowledge (increase) SMD 0.58 (0.26 - 0.90) Decisional Conflict (reduction) [82]
Vaccination Decision-Making Vaccination Uptake RR 1.56 (0.75 - 3.27) Intention to Vaccinate (increased) [83]
Socially Disadvantaged Populations Knowledge (increase) MD 13.91 (9.01 - 18.82) Patient-Clinician Communication (improved) [84]

Digital decision aids demonstrate significant efficacy across multiple healthcare domains, particularly within end-of-life care research. The most pronounced effect is observed in palliative dementia care, where video-based decision aids more than triple the likelihood of patients or surrogates choosing comfort-oriented care [39] [66]. This finding is particularly relevant for drug development professionals designing supportive care strategies for neurology trials.

For researchers investigating decision support technologies, these tools consistently improve decision-making quality metrics across populations. A systematic review of computer-based decision aids for patients with chronic diseases confirmed significant effects on reducing decision conflict and enhancing knowledge, though the overall certainty of evidence was low [81]. Similarly, interactive digital decision aids for prenatal screening significantly increased knowledge and decreased decisional conflict, despite substantial heterogeneity between studies [82].

The efficacy extends to socially disadvantaged populations, where patient decision aids improved knowledge, patient-clinician communication, and reduced decisional conflict without increasing anxiety [84]. This suggests digital interventions can maintain effectiveness across diverse demographic groups relevant to inclusive clinical trial design.

Technology Platforms and Implementation Contexts

Table 2: Digital Decision Aid Platforms and Their Applications

Technology Platform Clinical Applications Engagement Approach Target Decision-Maker
Video Decision Aids Goal of care: life-prolonging vs. comfort care Visualized future disease states Patients & family carers
Web-Based Decision Aids Treatment options, risk/benefit comparison Interactive value clarification Patients
Visual Aid Tools Feeding tube placement, drug treatment Graphic representation of outcomes Family carers of advanced dementia
Telehealth Integration Remote palliative care consultations Real-time clinician facilitation Patients, families, clinicians
Mobile Health Applications Chronic disease management Tailored evidence based on demographics Patients

Digital decision aids employ various technological platforms to support complex decision-making processes. In palliative dementia care, technologies including visual aids, videos, web pages, and telehealth have been implemented to support decisions about primary goals of care, with most aids engaging both patients and their family carers [39] [66].

Interactive digital platforms provide significant advantages over traditional paper-based tools by delivering vivid, interactive, dynamic, and tailored decision support [66]. These technologies facilitate higher-quality decision-making processes through two-way communication that allows users to focus on specific aspects relevant to their personal context and values [82].

Implementation feasibility is well-established across settings. Pilot studies examining feasibility showed that most participants found digital decision aids relevant to their needs and easy to use, and were able to complete intervention sessions despite serious illness [39] [66]. Internet-based decision aids thus offer a feasible and acceptable approach to support shared decision-making between patients, families, and clinicians across the care continuum.

Experimental Protocols

Protocol for Implementing Digital Decision Aids in End-of-Life Care Research

G Start Patient Identification (Screening for advanced illness) A Baseline Assessment (Decision conflict, knowledge) Start->A B Randomization A->B C Intervention Group (Digital Decision Aid + Standard Care) B->C D Control Group (Standard Care Only) B->D E Post-Intervention Assessment (Primary/Secondary Outcomes) C->E D->E F Qualitative Follow-up (Patient experience, feasibility) E->F End Data Analysis (Meta-analysis where applicable) F->End

Study Design and Participant Recruitment

This protocol outlines a methodology for evaluating digital decision aids in end-of-life care settings, based on rigorous systematic reviews and meta-analyses [39] [66] [84]. The design should employ a randomized controlled trial (RCT) approach, potentially incorporating a pretest-posttest design for pilot studies. Participants should include triads of patients, family carers, and clinicians when possible, particularly for dementia and advanced illness research [39] [66].

Eligibility criteria should target patients with advanced chronic illnesses (e.g., dementia, advanced cardiac disease, metastatic cancer) who face preference-sensitive decisions about care goals. For dementia studies, focus on patients with moderate to advanced disease where family carers often serve as surrogate decision-makers [39] [66]. Sample size calculations should be based on detecting clinically significant differences in decisional conflict scores (≥12.5% reduction) or changes in preferred care goals, with targets of approximately 100-200 participants per arm based on previous meta-analyses [39] [85].

Intervention Protocol and Implementation

The intervention involves administering digital decision aids that provide evidence-based information on available options, potential benefits and harms, and incorporate methods for values clarification [66] [84]. For end-of-life care decisions, this typically includes options such as life-prolonging care, limited care, and comfort care [39] [66].

The technological implementation should utilize video-based narratives showing simulated disease trajectories, interactive web interfaces for values clarification exercises, and graphical risk communication tools to convey probabilistic information. Delivery should occur in controlled settings with technical support available, with sessions typically lasting 30-60 minutes based on feasibility studies [39] [66]. For patients with advanced dementia, engage family carers as primary decision-makers while assessing patient comfort and non-verbal cues [39].

Control groups should receive standard care consisting of routine clinical discussions about care options without structured decision support tools. Both groups should receive equivalent information about available options, differing primarily in the presentation format and structured decision support [82] [84].

Outcome Assessment and Data Analysis

Table 3: Core Outcome Measures for Digital Decision Aid Evaluation

Outcome Domain Specific Measures Assessment Timing Method of Analysis
Decision Process Decisional Conflict Scale (DCS) Baseline, immediately post-intervention Mean difference (MD) with 95% CI
Decision Quality Knowledge test, values-choice concordance Immediately post-intervention Standardized mean difference (SMD)
Care Preferences Preferred goal of care, documentation of preferences 1-3 months post-intervention Odds ratios (OR) with 95% CI
Implementation Metrics Feasibility, acceptability, usability Post-intervention Descriptive statistics
Healthcare Utilization Hospitalizations, palliative care referrals 3-6 months post-intervention Rate ratios, cost analysis

Primary outcomes should include decisional conflict (measured using the validated Decisional Conflict Scale) and preferred goal of care [39] [85]. Secondary outcomes should encompass knowledge scores, decision regret, quality of palliative care, and healthcare utilization metrics [39] [81] [66].

Statistical analysis should employ intention-to-treat principles using random-effects models to account for clinical and methodological heterogeneity. For continuous outcomes (e.g., decisional conflict, knowledge), calculate mean differences (MD) or standardized mean differences (SMD) depending on measurement consistency. For dichotomous outcomes (e.g., care preferences), calculate odds ratios (OR) with 95% confidence intervals [39] [84]. Conduct subgroup analyses to identify differential effects based on patient characteristics, including health literacy levels and social disadvantage markers [84].

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Research Materials for Digital Decision Aid Studies

Research Tool Specification Application in End-of-Life Studies
Decisional Conflict Scale (DCS) 16-item validated instrument Primary outcome: Measures uncertainty in decision making
Knowledge Assessment Condition-specific questionnaires Evaluates understanding of options, risks, benefits
Values Clarification Exercise Interactive ranking/rating tasks Helps patients clarify preferences aligned with values
Option Grids/Summary Tables Tabular comparison of options Presents evidence-based benefits/harms of each choice
Video Decision Aid 10-15 minute condition-specific narratives Depicts simulated disease trajectories and outcomes
IPDAS Criteria Checklist Quality standards for decision aids Ensures development meets international standards

The Decisional Conflict Scale (DCS) serves as the primary validated instrument for measuring the effectiveness of decision aids, assessing personal uncertainty, modifiable factors contributing to uncertainty, and perceived effective decision making [85]. Scores below 25% are associated with implementing decisions, while scores above 37.5% are associated with decision delay and dissatisfaction [85].

Knowledge assessments should be condition-specific and evaluate patients' understanding of the health condition, available options, potential benefits and harms, and their probabilities where known [81] [84]. These are typically administered pre- and post-intervention to assess knowledge gains.

Values clarification exercises represent core components of high-quality decision aids, employing interactive tasks that help patients consider the personal importance of potential benefits and harms [66] [84]. These may include rating, ranking, or probability-tradeoff exercises specifically designed for end-of-life decisions.

Digital platform selection should prioritize IPDAS-compliant tools that meet international quality standards for patient decision aids [82] [84] [83]. These tools must provide balanced, evidence-based information about options and help patients clarify and communicate their values.

G A Evidence Synthesis (Systematic reviews, meta-analyses) B Stakeholder Engagement (Patients, clinicians, carers) A->B C Prototype Development (IPDAS-compliant content) B->C D Usability Testing (Think-aloud protocols) C->D E RCT Evaluation (Efficacy, effectiveness) D->E F Implementation Research (Adoption, sustainability) E->F

Digital decision aids represent evidence-based tools that significantly improve decision-making processes in end-of-life care contexts. The most compelling evidence supports video-based decision aids for promoting comfort care preferences in advanced dementia, with future research needed to establish effects on clinical outcomes and healthcare utilization. Implementation should adhere to IPDAS standards and prioritize flexible, person-centered approaches tailored to fluctuating patient capacities and preferences in palliative care settings [66] [86]. For drug development professionals and clinical researchers, these tools offer a standardized methodology to support shared decision-making that aligns with patient values and preferences in serious illness.

Application Notes: Comparative Outcomes Across Care Settings

Palliative care delivery varies significantly across hospital, hospice, and community-based settings, with distinct outcome patterns relevant to shared decision-making in end-of-life care research. The evidence demonstrates that setting-specific care models directly influence patient-centered outcomes, caregiver experiences, and healthcare utilization metrics.

Key Outcome Domains by Care Setting

Table 1: Comparative Outcomes Across Palliative Care Settings

Outcome Domain Hospital-Based Specialist Palliative Care Hospice Care Community-Based Palliative Care
Patient Quality of Life Improved symptom burden and health-related quality of life (HRQoL) as primary outcomes [87] Not explicitly quantified in results Significant improvement in POS scores (22.21 to 17.98, p<0.001); physical, psychological, emotional, and social dimensions [88]
Caregiver Outcomes Caregiver satisfaction with care; pre-/post-bereavement outcomes [87] Not explicitly quantified in results Improved caregiver experiences; reduced burden with proper support [89] [90]
Healthcare Utilization Not primary focus in identified results Not explicitly quantified in results 33% reduction in hospital admissions; 38% reduction in ICU admissions; 12% reduction in hospital days [91]
Cost Outcomes Economic evaluations including cost-effectiveness analyses [87] Not explicitly quantified in results 20% reduction in total medical costs ($619 per member per month) [91]
Preferred Place of Death Achieving patient's preferred place of death [87] Home as most preferred location (51%-55% per meta-analyses) [92] Increased likelihood of home death [89] [88]
Symptom Burden Primary outcome measured via validated scales [87] Not explicitly quantified in results Improved symptom control, particularly pain management [88] [90]

Setting-Specific Outcome Patterns for Shared Decision-Making

The evidence reveals distinct outcome advantages across settings that should inform shared decision-making frameworks:

  • Hospital-based care demonstrates strengths in managing complex symptoms and providing specialist-level interventions for patients with acute needs [87].
  • Community-based models show superior performance in reducing healthcare utilization and costs while supporting patient preferences for home-based care [88] [91]. These programs integrate effectively with primary health care structures to provide continuous, holistic support.
  • Care alignment with preferences varies significantly, with congruence between preferred and actual place of death ranging from 21%-100% across studies, higher when preferences are explicitly discussed and documented [92] [90].

Experimental Protocols

Protocol 1: Randomized Controlled Trial of Community-Based Palliative Care Integrated with Primary Health Care

Objective: To determine the impact of community-based palliative care integrated with PHC on outcomes of terminally ill cancer patients [88].

Study Design: Randomized controlled trial conducted in Khorramabad, Iran (2023) with 120 advanced cancer patients.

Table 2: Experimental Protocol for Community-Based Palliative Care RCT

Protocol Component Specifications
Population 120 cancer patients with advanced cancer diagnosis by oncologist; awareness of time and place; registered to Integrated Health System; willingness to participate [88]
Sampling Method Clustered, stratified, sub-stratified sampling; city divided into 3 clusters with comprehensive health centers randomly selected; systematic random sampling at health bases [88]
Randomization Random allocation to intervention/control groups via randomization blocks with size of four following convenient sampling [88]
Intervention Group Received PHC-integrated community-based palliative support for two months [88]
Control Group Received routine health care programs during same two-month period [88]
Data Collection Palliative Care Outcome Scale (POS) administered before and two months after intervention [88]
Instrument POS scale with 12 items covering physical, psychological, emotional, social aspects; scored 0-4 Likert scale (total 0-40); lower scores indicate better situation [88]
Statistical Analysis SPSS 22 software; descriptive and inferential statistics [88]

Protocol 2: Population Health Community-Based Palliative Care Program

Objective: To evaluate utilization and cost outcomes of a standardized, population health community-based palliative care program provided by nurses and social workers [91].

Study Design: Retrospective propensity-adjusted study of Medicare Advantage members.

Table 3: Experimental Protocol for Population Health Palliative Care Study

Protocol Component Specifications
Population 804 Medicare Advantage members at high risk for overmedicalized end-of-life care identified via predictive modeling; 176 study participants after exclusions [91]
Identification Method Proprietary predictive algorithm identifying patients at risk of overmedicalized death in next 6-12 months; predictor variables: age, sex, diagnoses, hospital/ED visits, cost of care, Medicare Part B drug data [91]
Intervention Group 176 members enrolled in community-based palliative care program [91]
Control Group 570 members receiving standard, telephonic health plan case management [91]
Intervention Components • Specially trained palliative nurses/social workers• In-home and telephonic visits• Caregiver support• Goals-of-care discussions and advance care planning [91]
Visit Frequency Acuity-based: Low (monthly), Medium (every two weeks), High (weekly and PRN) [91]
Outcome Measures Utilization (hospital admissions, ICU admissions, bed days, ED visits); costs (medical and pharmacy) [91]
Analysis Retrospective propensity-adjusted comparison of utilization and costs [91]

Research Visualization

G cluster_0 Predictive Identification Phase cluster_1 Intervention Phase Patient_Identification Patient_Identification Risk_Stratification Risk_Stratification Patient_Identification->Risk_Stratification Intervention_Assignment Intervention_Assignment Risk_Stratification->Intervention_Assignment Care_Delivery Care_Delivery Intervention_Assignment->Care_Delivery Outcome_Assessment Outcome_Assessment Care_Delivery->Outcome_Assessment

Community-Based Palliative Care Workflow

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Research Instruments and Tools for Palliative Care Outcomes Research

Research Tool Function/Application Validation/Properties
Palliative Care Outcome Scale (POS) Measures physical, psychological, emotional, social dimensions of palliative outcomes [88] 12-item scale; Cronbach's alpha 0.719, ICC 0.812 in Iranian validation [88]
Predictive Algorithm for Overmedicalized Death Identifies patients at risk of overmedicalized death using multivariate statistical model [91] Sensitivity 52.5%; PPV 63.4%; variables: diagnoses, utilization, cost data [91]
Mixed Methods Appraisal Tool (MMAT) 2018 Quality assessment of quantitative, qualitative, and mixed-methods studies [89] [4] Enables standardized quality rating (low/medium/high) for evidence synthesis [89]
Structured Care Pathways Standardized intervention levels (low/medium/high) based on symptom burden and needs [91] Determines visit frequency and intervention intensity in community settings [91]
Electronic Health Record (EHR) Integration Tools Supports shared decision-making documentation and workflow integration [24] Templates for goals of care, advance care planning within clinical workflow [24]

Implications for Shared Decision-Making Research

The comparative outcomes across settings provide critical insights for developing evidence-based shared decision-making models in end-of-life care. Key factors influencing decision-making align with Andersen's Behavioral Model of Health Services Use, including predisposing factors (age, education, prior experiences), enabling factors (physician disclosure, communication, information), and need factors (terminal status acknowledgement, preferences, health condition) [4].

Effective shared decision-making tools integrated into EHR systems can enhance the documentation of patient preferences and improve congruence between preferred and actual place of care [24]. The evidence demonstrates that community-based palliative care components—particularly standardized sessions, volunteer engagement, and early intervention—contribute significantly to program success and patient-centered outcomes [89].

Future research should focus on standardized measurement of preference-concordant care across settings and development of decision aids that incorporate setting-specific outcome data to truly personalize end-of-life care planning.

Application Notes: Economic Evidence and Resource Utilization in End-of-Life Care

This section provides a synthesized summary of key economic evidence, highlighting the financial impact and resource utilization patterns associated with various end-of-life (EoL) care models.

Intervention / Model Setting Economic & Resource Utilization Outcomes Magnitude of Effect Source Context
In-Home Palliative Team Care Community / Home Cost-effective; reduced total healthcare costs; increased days at home. Cost saving: ~$4,400 per patient; 10% increase in home death chance; +6 days at home. [93]
Home-Based Interventions Community / Home Decrease in total healthcare costs and resource use; improved patient/caregiver outcomes. Substantial system savings; consistent cost-effectiveness. [94]
Palliative Care Consultation Hospital / ICU Reduced ICU admissions for patients with life-limiting illnesses. Up to 51% relative risk reduction in ICU admission. [95]
Palliative Care Consultation Hospital / ICU Reduced length of stay (LOS) in ICU for decedents. Trend towards reduced LOS; one trial showed mean LOS reduction from 10.9 to 5.3 days. [95]
Integrated Palliative Care Program Value-Based Framework (Colombia) Reduced end-of-life costs; improved patient-reported outcomes (pain, wellbeing, QoL). Statistically significant cost reduction in last 30 days of life; improved outcome scores. [96]
Hospice-Palliative Care Inpatient Units (Korea) Lower medical expenses compared to hospital deaths for cancer patients. Lower medical expenses at end-of-life. [97]

Key Insights on Resource Utilization

  • Cost Concentration: A significant portion of healthcare expenditures occurs in the last months of life, with estimates indicating that the last year of life accounts for approximately 9% of a regional healthcare budget in Ontario, Canada [93]. In the United States, 25% of healthcare costs are spent on the 6% of people who die each year [95].
  • Care Setting Disparities: Evidence from Bangladesh reveals profound disparities in EoL care awareness and preferences across healthcare settings. Palliative care awareness was 70% in private hospitals, 31% in public hospitals, and only 7.1% in community settings, indicating inequitable resource and knowledge distribution [2].
  • ICU Utilization: In the U.S., more than 80% of decedents are hospitalized at least once in the last 180 days of life, and ICU use in the last 30 days of life has been increasing, despite most patients preferring to die at home [95].

Application Notes: The Value-Based Care Framework in Palliative Care

Value-Based Healthcare (VBHC) is a comprehensive concept that aims to achieve better outcomes and experiences of care for every person through the equitable, sustainable, and transparent use of resources [97]. It shifts the focus from the volume of services (fee-for-service) to the value delivered to patients.

The Four Pillars of Value in Palliative Care

Hospice-palliative medicine is recognized as a model of VBHC, which can be evaluated through four value pillars [97]:

  • Personal Value: Achieved by providing care that is respectful of and responsive to individual patient preferences, needs, and values. This involves shared decision-making to ensure care aligns with patient goals, such as choosing comfort-focused hospice care over aggressive, life-prolonging treatments in terminal illness [97].
  • Technical Value: Defined as the achievement of the best possible outcomes with available resources. In palliative care, this means discontinuing ineffective treatments with high side-effects (e.g., late-line chemotherapy) to reduce patient harm and unnecessary costs, thereby improving efficiency [97].
  • Allocative Value: Refers to the equitable distribution of resources across all patient groups. VBHC advocates for reallocating resources from over-utilized, low-value care (e.g., excessive diagnostic tests for the terminally ill) to underfunded, high-value care like home-based palliative services that most patients prefer [97].
  • Societal Value: Considers the contribution of healthcare to social participation and connectedness. Policies like South Korea's Life-Sustaining Treatment Decision-Making Act, which is based on patient self-determination via advance directives, reflect societal values and rights [97].

Payment Models and System Integration

  • VBHC vs. Technology-Oriented Medicine: VBHC promotes shared decision-making, coordinated care, a focus on quality of life, and reimbursement via bundled payments or payments linked to quality. This contrasts with the paternalistic decision-making, fragmented care, focus on quantity, and fee-for-service reimbursement of technology-oriented medicine [97].
  • Barriers to Adoption: Structural barriers include fragmented care delivery and perverse payment incentives. Fee-for-service models reward procedures and diagnostic tests over the time-intensive care coordination and communication central to palliative care, creating financial disincentives for its provision [98].

Experimental Protocols

Protocol: Evaluating the Cost-Effectiveness of a Home-Based Palliative Care Intervention

Objective: To assess the cost-effectiveness and impact on healthcare resource utilization of a home-based palliative team care model compared to usual care for patients in the last year of life.

Methodology:

  • Design: A multicenter, retrospective cohort study with propensity score matching to control for confounding variables. A prospective randomized controlled trial (RCT) is the gold standard.
  • Population: Adult patients (≥18 years) with advanced chronic or terminal illnesses and a life expectancy of less than one year. Identification can be based on physician assessment (e.g., the "surprise" question: "Would you be surprised if this patient died in the next year?") or specific diagnostic criteria (e.g., advanced cancer, end-stage organ failure) [95] [93].
  • Intervention: Coordinated in-home palliative team care provided by an interdisciplinary team (physicians, nurses, social workers, chaplains). The control group receives usual care, which may include standard home care or outpatient visits without specialized palliative support.
  • Data Collection:
    • Resource Utilization: Data on hospital admissions, ICU admissions, emergency department visits, length of stay, and use of other healthcare services, extracted from linked health administrative databases [93].
    • Costs: Direct medical costs (hospital care, physician services, medications, intervention costs) from the payer's perspective (e.g., health system). Costs are standardized and reported in appropriate currency (e.g., 2025 US dollars) [93].
    • Outcomes: Patient-reported outcomes (pain, wellbeing, quality of life, satisfaction) collected via validated tools. The primary outcome for economic evaluation is often "days at home" or "quality-adjusted life days" (QALDs) in the last year of life [96] [93].
  • Economic Analysis:
    • Cost-Effectiveness Analysis: Conducted using a decision-analytic model (e.g., Markov model) to estimate incremental cost-effectiveness ratios (ICERs) [93].
    • Budget Impact Analysis: Projects the financial consequence of adopting the intervention for the health system based on the target population size [93].

Protocol: Assessing the Impact of Decision Aids on End-of-Life Care Choices

Objective: To measure the effectiveness of a structured decision aid in reducing decisional conflict and aligning care with patient preferences for end-of-life care.

Methodology:

  • Design: A systematic review of quantitative, qualitative, and mixed-methods studies, following PRISMA guidelines. Alternatively, a primary study can be designed as a randomized controlled trial [40].
  • Participant Recruitment: Patients with advanced, life-limiting illnesses and/or their family caregivers, recruited from hospitals, oncology clinics, or community settings.
  • Intervention: Use of a decision aid developed according to the International Patient Decision Aid Standards (IPDAS). The aid should provide evidence-based information on prognosis, treatment options (including palliative and hospice care), benefits, risks, and outcomes [40].
  • Comparator: Usual care or provision of general health information without structured decision support.
  • Outcome Measures (assessed via surveys pre- and post-intervention) [40]:
    • Primary: Decisional Conflict Scale (DCS) score.
    • Secondary: Knowledge scores, preference for aggressive vs. non-aggressive care, patient-clinician communication quality, anxiety, and satisfaction with the decision.
  • Data Analysis: Quantitative data analyzed using statistical tests (e.g., t-tests, chi-square) to compare outcomes between groups. Qualitative data from interviews can be analyzed thematically to understand the decision-making experience.

Visualization: Value-Based Palliative Care Logic Model

The following DOT code generates a diagram illustrating the logical pathway through which Value-Based Palliative Care creates value for the health system.

VBPalliativeCare Start Value-Based Palliative Care Implementation A1 Patient-Centered Assessment Start->A1 A2 Shared Decision-Making Start->A2 A3 Interdisciplinary Team Care Start->A3 A4 Advance Care Planning Start->A4 A5 Symptom Management & Comfort Care Start->A5 B1 Improved Care Alignment with Patient Goals A1->B1 A2->B1 B3 Enhanced Patient & Family Communication A2->B3 A3->B1 B4 Earlier Transition to Appropriate Care Settings A3->B4 A4->B1 B2 Reduced Aggressive & Unwanted Care A4->B2 A4->B4 A5->B1 C1 Improved Patient-Reported Outcomes (QoL, Satisfaction) B1->C1 C2 Reduced ICU Admissions & Hospital LOS B1->C2 B2->C1 B2->C2 B3->C1 B4->C1 C3 Higher Rate of Home Death B4->C3 D Lower Total Healthcare Costs & Higher Value C1->D C2->D C3->D

Value-Based Palliative Care Impact Pathway

The Scientist's Toolkit: Research Reagent Solutions for EoL Economics Studies

Tool / Resource Type/Function Application in EoL Research Exemplar Source / Tool
Linked Health Administrative Databases Data Source Provides real-world data on resource use (hospitalizations, ICU stays), costs, and patient trajectories for retrospective cohort studies and economic modeling. Institute for Clinical Evaluative Sciences (ICES) databases [93]
Validated Patient-Reported Outcome Measures (PROMs) Assessment Tool Quantifies outcomes that matter to patients, such as quality of life, pain, wellbeing, and satisfaction, which are crucial for value assessment. Pain scores, Wellbeing scales, QoL tools (e.g., EQ-5D) [96]
International Patient Decision Aid Standards (IPDAS) Methodological Framework Ensures the quality and effectiveness of developed decision aids, which are interventions to support shared decision-making. IPDAS Collaboration [40]
Decision-Analytic Models (e.g., Markov Model) Analytical Tool Simulates the progression of a patient cohort through different health states (e.g., home, hospital, deceased) to estimate long-term costs and outcomes. Markov model for cost-effectiveness analysis [93]
Decisional Conflict Scale (DCS) Assessment Tool A validated instrument to measure a patient's uncertainty in making a health decision, often used as an outcome in decision aid studies. O'Connor et al. [40]

Conclusion

Shared decision-making represents a fundamental shift toward ethically-grounded, patient-centered end-of-life care that balances clinical expertise with personal values and preferences. The integration of structured communication frameworks, digital decision aids, and culturally competent approaches can significantly enhance care quality for patients with serious illness. Future research must prioritize the development of validated, setting-specific SDM protocols; address disparities in palliative care access; evaluate implementation strategies across diverse healthcare systems; and establish standardized outcome measures that capture what matters most to patients and families. For biomedical researchers and drug development professionals, opportunities exist to create innovative decision support technologies and to investigate how SDM principles can inform clinical trial design and therapeutic development for patients with advanced illnesses, ultimately advancing both the science and humanity of end-of-life care.

References